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 Ageing of Bruch’s membrane is associated with structural and functional 
deterioration. Accumulation of normal and abnormal collagen in ageing Bruch’s has 
led to the hypothesis of diminished matrix degradation mediated normally by a family 
of protease enzymes called the matrix metalloproteinases (MMPs). Underlying 
mechanisms leading to diminished MMP activity in ageing Bruch’s remain unknown 
but functional changes of diminished transport are well documented. Ageing remains 
the biggest risk factor in AMD with nearly 30% of all individuals reaching the age of 
85 years showing some loss of central vision. 
 In the present thesis, the gelatinase system (constituting MMPs 2&9) has 
been examined resulting in the identification and characterisation of three additional 
high molecular weight species termed HMW 1&2 and a large macromolecular weight 
MMP complex (LMMC). HMW1&2 were shown to be covalently bonded homo- 
and/or hetero- polymers of pro-MMPs 2&9. HMW species in effect sequester pro-
MMPs 2&9 reducing the pool available for activation and the age-related increase in 
HMW species is expected to augment this reduction. 
 In Bruch’s membrane from donors with AMD, levels of HMW1&2 were 
considerably elevated (p<0.05) with a concomitant reduction in the amount of active 
MMPs 2&9 (p<0.05). The reduction in activated MMP species therefore underlies the 
reduced degradative capacity of Bruch’s in these patients.  
 Elution studies demonstrated the existence of a free-bound equilibrium for the 
gelatinases with the bound forms being retained by hydrophobic, ionic or metal 
mediated interactions. Since divalent metal ions are deposited in Bruch’s of AMD 
5 
 
donors, metal chelation was assessed as a possible means of inducing MMP release. 
Metal chelation with EGTA resulted in the release of active forms of MMP2 and 
significantly improved the fluid transport properties of the membrane (p<0.005). This 
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 Bruch’s membrane is an acellular pentalaminated extracellular matrix (ECM) 
located between the retinal pigment epithelium (RPE) and the fenestrated capillaries 
of the choroidal circulation. It therefore mediates the passive bi-directional transport 
processes for the exchange of nutrients and waste products between the 
RPE/photoreceptor complex and the choroidal circulation. The high metabolic activity 
of photoreceptor cells requires similarly high metabolic exchange rates across 
Bruch’s and the RPE. The structural and functional integrity of Bruch’s membrane is 
maintained by tightly coupled processes of continuous synthesis and degradation, 
the latter mediated by a family of zinc-containing, calcium dependent proteolytic 
enzymes called the matrix metalloproteinases (MMPs). Despite the presence of this 
rejuvenation cycle, ageing of Bruch’s results in structural and functional deterioration 
with considerably compromised transport capacities across the membrane. In the 
very elderly, signs of diminished vitamin A transport are often detected clinically as 
diminished scotopic thresholds. More severe reductions in fluid and macromolecular 
traffic across Bruch’s have been observed in the advanced ageing associated with 
age related macular degeneration (AMD). 
 
1.1 Transport systems in the outer retina 
 The neural retina maintains one of the highest rates of oxidative metabolism 
of any tissue in the body and as such requires a rapid and uninterrupted supply of 
blood-borne metabolic substrates (Ahmed et al., 1993; Bui et al., 2003; Cohen et al., 
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1960; Cringle et al., 2002; Warburg, 1927; Winkler, 1983). The transport pathways 
for both nutritional supply and waste removal are therefore of paramount importance 
in maintaining the structural and functional integrity of the neural retina. Rate-limiting 
sites for transport are provided across two anatomically distinct blood retinal barriers 
formed between the endothelium cells of retinal capillaries in the inner retina and by 
RPE cells in the outer retina (Cunha-Vaz et al., 1966; Foulds, 1990; Marshall, 1998).  
 In the inner retinal capillaries, blood-borne metabolites are selectively 
transported across the endothelium cells and then traverse a basement membrane 
prior to uptake by retinal neurones. In the outer retina, blood-borne constituents are 
readily released from the fenestrated choroidal capillaries onto Bruch’s and are 
sieved by the membrane according to size prior to presentation at the basal surface 
of the RPE cell for eventual transport to photoreceptor cells.  
 From measurements of blood flow and oxygen extraction, it has been shown 
that in those regions of the fundus with a dual supply, the choroidal contribution 
accounts for over 90% of the metabolic requirements of photoreceptor cells (Bill, 
1970; Tornquist et al., 1979; Wilson et al., 1973). In the foveolar region of the human 
fundus, the absence of inner retinal capillaries means that the choroidal circulation 
must provide metabolic support to the whole retina.  The importance of the choroidal 
circulation in the macular area is emphasised by the nearly 8-fold higher blood flow 




1.1.1 Inward transport pathway: Nutritional maintenance  
 The numerous endothelium fenestrations of the choriocapillary network allow 
easy passage out of most blood constituents including large carrier proteins and 
lipoprotein species for presentation to the outer aspects of Bruch’s membrane (Burns 
et al., 1980; Cunha-Vaz et al., 1966; Hazlett et al., 1974; Pino et al., 1981). The 
spectrum of substances presented to Bruch’s membrane for transport will therefore 
range from simple sugars and amino acids to carrier bound species such as those 
for vitamin A, fatty acids, heavy metals and finally the supramolecular complexes 
associated with the plasma lipoproteins. 
 If the diameter of the traversing molecules (such as glucose, amino acids) is 
considerably small in comparison to the inter-fibre spaces within Bruch’s membrane, 
then their diffusion fluxes would only be governed by their free diffusion coefficients 
(D):       
J = -D (d¢/dx) 
where J is the experimental flux (mol/m2/s), ¢ is the concentration of traversing 
molecule (mol/m3), and x is the thickness of Bruch’s membrane. Thus the flux would 
be directly proportional to the concentration gradient across the membrane. 
 For larger molecules, such as carrier proteins, the degree of resistance 
encountered during transit will be governed by their size, charge distribution, 
hydrophobic/hydrophilic nature, and the likelihood of collisions with structural 
parameters of the conducting pathway. Transport schemes across Bruch’s 






















Figure 1.1 Transport pathways for delivery of blood-borne metabolites to 
photoreceptor cells. 
[a] Small metabolites. After release from the choriocapillaris [1], metabolites diffuse passively across 
Bruch’s membrane [2] to be presented at the basal convoluted surface of the RPE [3].  The basal 
membrane is traversed by free diffusion or carrier mediated translocation, the latter involving active or 
passive transporters. Having negotiated the cytoplasmic space, metabolites are released into the 
interphotoreceptor matrix (IPM) by undefined mechanisms at the apical surface [4a,b].  Following 
diffusion down concentration gradients across the IPM, metabolites are finally taken up by the inner 
segment regions of the photoreceptor layer [5]. Rapid uptake into outer segments may be possible at 
sites of microvillus ensheathment  [4b].  A, photoreceptor layer; B, RPE layer; C, Bruch’s membrane; 
D, choriocapillaris. 
[b] Macromolecules.  Large molecules including ligand-carrier complexes are released by the 
fenestrated endothelium of the choriocapillaris [1]. Depending on their size, these species may either 
diffuse across Bruch’s [2] or partially penetrate the membrane to release their payloads [2a]. The 
ligand-free complex can then return to the choroidal circulation [2b]. Interaction with specific receptors 
at the basal surface of the RPE leads to internalisation of the ligand [3]. Ligands may then cross the 
cytoplasmic space either in free form or bound to specific carriers, but again, the release mechanism 
at the apical surface is poorly understood. Carriers may again facilitate diffusion across the IPM for 

































 For smaller molecules, their passage through Bruch’s is sustained by passive 
transport down concentration gradients with rates being subject to Fick’s laws of 
diffusion (Pappenheimer, 1953; Pappenheimer et al., 1951). Larger proteins such as 
the broad spectrum albumin, ceruloplasmin, transferrin, retinol binding protein and 
various species of ferritin can cross Bruch’s membrane.  Interestingly, 
immunohistochemical techniques have shown that some proteins were capable of 
entering Bruch’s but were unable to traverse it (Pino et al., 1983). The size of protein 
or proteo-lipid complex that can enter Bruch’s will be determined by the inter-fibrillar 
spacing within Bruch’s membrane.  
 Several studies have now shown that this spacing is not uniform across the 
thickness of Bruch’s membrane. Both excimer ablation studies and morphometric 
analyses of sub-layers have shown tight packing of collagenous fibres in the so-
called ‘resistance barrier’ in the inner collagenous zone in juxtaposition to the elastin 
layer of the membrane (Hussain et al., 2004; Marshall, 1998; Starita et al., 1997). 
This region, with an anatomically determined spacing between fibres of about 10-
14nm will therefore determine the size exclusivity of macromolecules that can be 
transported. Outside this region of the resistance barrier, the spacing is much larger 
allowing the entry of much larger molecules but blocking their translocation across 
Bruch’s membrane. A schematic of the variation in fibrillar spacing across the 





Figure 1.2 Collagenous fibre spacing within Bruch’s membrane: Topography 
of the conducting pathway. 
Panel [A]: Transverse electron micrograph of Bruch’s membrane from a donor aged 38 years. ICL, 
inner collagenous layer; EL, elastin layer; OCL, outer collagenous layer; RB, resistance barrier, site 
assigned on the basis of excimer laser ablation experiments (see Starita et al., 1997). Bar = 0.25m. 
Panel [B]: Tangential electron micrographs through the inner collagenous, elastin and outer 
collagenous layers of Bruch’s membrane showing the construction of potential pores for fluid transport. 
The presence of debris was not taken into account during assignment of pores. Bar = 0.5m. 
Panel [C]: High magnification micrograph of the resistance region allowing visualisation of the tight 
‘weave’ of 10nm filaments that constitute the barrier. These filaments have been highlighted in the 
micrograph. The average distance between the fibres taken from many micrographs was determined 
to be about 14nm, suggesting a pore radii of 7nm for passage of molecules. Bar = 30 nm. 
Panel [D]: Data from the morphometric analysis together with experiments to localise the resistance 
barrier (Starita et al., 1997) allowed the construction of the pore model to describe the transport 





 The topography of the conducting channels shows that species larger than 
the confines of the ‘resistance’ barrier can enter the much wider crevices in the outer 
collagenous layer but cannot traverse the membrane. This aspect may be very 
important in allowing large ligand-bound carriers to enter Bruch’s and the 
subsequent interaction, with perhaps localised charged regions, may lead to 
disassociation of their payloads which then continue through the remainder of the 
membrane. The possible interaction of carrier molecules with the hydrophobic and 
hydrophilic domains within the microenvironment of Bruch’s membrane has received 
little attention and yet may be a key mechanism in the transport of lipids.  
 The likely effect of the constrained topography of the conducting channel on 
diffusion will be dependent on the size of the traversing molecules. Small molecules 
such as amino acids and glucose possess a hydrated radii that is infinitesimal 
compared to the radii at the pore constriction and such species will therefore be 
oblivious to the presence of the barrier.  Since the microviscosity of fluid within a 
barrier of similar dimensions has been shown to be the same as in bulk solution, the 
rate of diffusion of small molecules will be dictated simply by the trans-membrane 
concentration gradients (Pappenheimer, 1953; Pappenheimer et al., 1951).  Larger 
molecules will interact with the barrier boundaries and in addition to steric hindrance 
may also undergo hydrophilic and hydrophobic interactions. Excellent studies have 
delineated the effect of steric hindrance on the diffusion of biological molecules 
through artificial membranes (Curry, 1984). It has been shown that flux rates were 
reduced to about 60% of those expected from free diffusion when the solute radius 
was about 10% of pore radius (Beck et al., 1972; Renkin, 1954; Wendt et al., 1979).   
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 Having traversed Bruch’s, blood-borne metabolites are then presented at the 
basolateral surface of the RPE.  Adjacent RPE cells are coupled by extensive 
junctional complexes called ‘zonulae occludentes’ and these constitute the 
anatomical site of the outer blood-retinal barrier (Shakib et al., 1972; Taniquchi, 
1976).  All metabolites must therefore gain access to the interior of the RPE cell for 
further translocation.  Small molecules (including the dissolved gases oxygen and 
carbon dioxide) can diffuse rapidly across the basal membrane of the RPE and move 
down their concentration gradients.  Larger species require the assistance of 
membrane carriers and these fall into two categories. Passive carriers bind the 
ligand on the outer surface and then diffuse across the membrane to release their 
load down a concentration gradient. Active transporters often utilise the inward 
sodium gradient and can thereby actively transport ligands against their 
concentration gradients. Detailed characteristics of carriers have been presented for 
glucose, retinol, taurine and glutamate (Heller et al., 1976; Kundaiker et al., 1996; 
Miyamoto et al., 1994; To et al., 1998).  Large transport molecules such as the 
retinol-retinal binding protein-transthyretin complex and lipoproteins interact with 
specific receptors on the RPE to unload their ligands (Bavik et al., 1992; Hayes et al., 
1989).  
 The basolateral aspect of the RPE cell rests in intimate contact with Bruch’s 
membrane and thereby minimises the diffusional distance allowing rapid movement 
of released metabolites. More importantly, the convolutions in the membrane greatly 
increase the surface area over which exchange can occur. 
 Most metabolites will move across the cytoplasmic space of the RPE down 
their concentration gradients. Some potentially toxic substances such as the 
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retinoids are transported across bound to specific carriers such as the cellular retinol 
binding protein (CRBP).  Little is known of the release processes at the apical 
surface of the RPE cell but it is assumed that metabolites leave by passive diffusion.  
 Metabolites released into the IPM are taken up by photoreceptors by a 
combination of active and passive processes.  Two routes are possible for delivery to 
photoreceptor cells. Firstly, released metabolites may either diffuse freely or diffuse 
attached to carrier proteins for uptake by the inner segment compartment. Secondly, 
the intimate relationship between the RPE cytoplasmic extensions (microvilli) and the 
distal part of the outer segment may promote rapid uptake by minimising the 
diffusional distance.   
 The mechanism for delivery of lipids is poorly understood. Fatty acids could 
be transported in the IPM bound to albumin. But the possible synthesis and release 
of lipoprotein-type molecules as delivery vehicles by the RPE needs investigation. A 
recent study has detected apo B and apo B mRNA in human RPE but its role in the 
inner loop recycling of lipids and/or in the deposition of lipids beneath the RPE 
requires clarification (Malek et al., 2003). 
 
1.1.1.1 Size selectivity of transported molecules 
 The spacing between the collagenous fibres in the resistance barrier provides 
a rough estimation of 10-14nm as the maximum diameter of traversing 
macromolecules. A more quantitative study has been undertaken by investigating 
the diffusional flux of FITC-labelled dextran molecules in the molecular weight range 
4.2-500 kDa (Hussain et al., 2010). As the molecular weight of the dextran species 
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increases, its diffusional constant D decreases. Thus a plot of diffusional flux versus 
molecular weight of species would be expected to show a decreasing relationship 
whether or not there was any interaction of the diffusing species with the structural 
elements of the matrix of Bruch’s membrane. Normalisation of these experimental 
fluxes with respect to their free diffusion coefficients (D/Do) would be expected to 
produce horizontal lines on the D/Do vs. MW plots (Michel et al., 1999; 
Pappenheimer et al., 1951; Renkin et al., 1988). However, if the dextran molecules 
were large enough to interact with the fibre-matrix of the membrane, then downward 
deviations would be expected on the plots. 
 As shown in Figure 1.3, the D/Do plots for transport across Bruch’s 
membrane deviated downwards, providing evidence for dextran-membrane 
interactions. The relationship was biphasic, with a rapid decrease between 4.4 and 
77 kDa followed by a much shallower change between 77 and 500 kDa dextrans. 
The latter region may well represent ‘reptation’ behaviour whereby a much larger 
linear molecule can get through a smaller opening by ‘snaking’ through it (Pluen et 
al., 1999). Thus the larger dextran molecules (because of the nature of their long 
flexible chains) could traverse membranes by the process of ‘reptation’ whereas 
similarly sized globular proteins would be restricted. The ‘reptation’ behaviour is 
displayed by mRNA molecules as they ‘snake’ their way through the small openings 















Figure 1.3 Dextran diffusion across macular regions in six donors aged 77-87 
years over a large molecular weight range of 4.4 – 500 kD. 
The plot shows normalised D/Do ratios as a function of dextran molecular weight. 
Continuous line is the non-linear regression fits to the equation y=a*MWb.  
 
 If the region between 4.4 and 77 kDa dextran (non-reptation behaviour) is 
extrapolated, the exclusion limit for dextran molecules can be calculated as 71 kDa. 
This limit approximates to a Stokes-Einstein radius of about 6.0nm. However, 
(Refojo, 1982) has highlighted the inaccuracy of this conversion since the normally 
determined Stokes radius (rs ,from diffusional work) does not reflect the effective 
radius of the hydrated molecule but rather that of a hard sphere that diffuses at the 
same rate as the molecule. This is particularly important in the case of dextran 




study of Hussain et al., 2010. An alternative method for determining molecular radius 
is by calibration with protein standards using size exclusion chromatography (rsec) 
and this determination is thought to reflect the functional size of dextrans (Williams et 
al., 1998). Using this conversion, the radius of a traversing molecule at the exclusion 
limit would be 5.6nm. Thus proteins such as catalase (radius 5.2nm & MW 240kDa), 
and ferritin (radius 5.5nm & MW 440-500kDa) would be expected to diffuse across 
Bruch’s membrane. Plasma proteins ranging in size of 40-200 kDa have been shown 
to cross Bruch’s membrane (Moore et al., 2001). However, it is difficult to explain 
how the much larger lipoprotein complexes comprising LDL (radius 11.5nm) can also 
cross Bruch’s membrane (Gordiyenko et al., 2004; Tserentsoodol et al., 2006). They 
can certainly enter Bruch’s because of the larger open spaces outside the resistance 
barrier and therefore it is very likely that they may undergo some processing prior to 
transfer of the core across Bruch’s. 
 
1.1.1.2 Mechanism of transport:  Metals and retinoids (vitamin A) 
 Carrier proteins are often used in the transport of important metabolites. Often, 
hydrophobic regions within the carrier allow binding of hydrophobic substrates 
thereby effectively increasing the ‘solubility’ of these compounds in the aqueous 
environment of blood. Binding and stabilisation also tends to prolong the half-lives of 
many unstable compounds. The carrier protein can also be used to regulate delivery 
to target tissues that express specific receptors for the protein. More importantly, 
binding of potentially harmful entities protects tissues from cytotoxicity due to high 
local concentrations of these substances. These principles are explained in detail for 




1.1.1.2.1 Divalent metals  
Heavy metals are essential cofactors for metabolic, physiological, antioxidant, 
and drug detoxification processes. In the retina, they further participate in the highly 
specialised processes of visual function. The fatty acid desaturase is an iron-
containing enzyme that provides unsaturated fatty acids for the continuous synthesis 
of outer segment disc membranes (Shichi, 1969). Photoreceptor specific guanylate 
cyclase is an iron-containing enzyme that plays a pivotal role in the 
phototransduction cascade of vision (Yau et al., 1989). RPE65 is also an iron-
dependent isomerohydrolase catalyzing the conversion of all-trans-retinyl ester to 
11-cis-retinol in the visual cycle and essential for normal vision (Moiseyev et al., 
2005). Zinc, another heavy metal, is also widely distributed in biological systems. It is 
an essential constituent of about 300 enzymes (including the anti-oxidant enzymes 
catalase and superoxide dismutase) and plays a structural role in over 400 nuclear 
regulatory elements and has specific roles in vision associated with both the turnover 
of Bruch’s membrane and in the operation of the visual cycle (Berg et al., 1996; 
Grahn et al., 2001; Kimura et al., 2000; Ugarte et al., 2001). 
 Free iron (Fe2+) is toxic and is therefore incorporated into haem or non-haem 
proteins. It can react with hydrogen peroxide in the Fenton reaction to generate 
hydroxyl radicals that are extremely damaging to cellular elements (Chevion, 1988). 
Rapid sequestration of free iron is essential to protect against free-radical damage. 
Thus, extracellular iron overload from sub-retinal haemorrhages can cause 
photoreceptor degeneration if not treated urgently by metal chelation therapy(Glatt et 
al., 1982).  
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 Because of its toxicity, iron is transported in the bloodstream in its ferric state 
((Fe3+) bound to the transport protein, transferrin. Since delivery to photoreceptors 
requires the crossing of several barriers, many transport proteins are involved in the 












Figure 1.4 Iron mobilisation pathways in the outer retina. 
Circulating transferrin (Tf) is released from the choriocapillaris (CC), traverses Bruch’s membrane (BM) 
and is taken up by the RPE. Intracellular ferrous iron (Fe2+) is bound to ferriportin (FP), converted to 
the ferric form by either ceruloplasmin (Cp)/hephaestin (Heph) and loaded onto transferrin for 
subsequent release and either intercompartmental mobilisation or export via the choroidal circulation. 
Some of this iron is stored as ferritin (F). Mitochondrial ferritin (Mtf) binds the toxic Fe2+, converts it to 
Fe3+ and is then stored. M, Muller cell; RIS & ROS, rod inner and outer segment; DMT-1, divalent 
metal transporter. The above scheme was constructed from references (Chowers et al., 2006; 
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 Transferrin mRNA levels in the retina are 6-fold higher than those in the liver 
or brain indicating high rates of retinal iron transport (Farkas et al., 2004; Yefimova et 
al., 2000). Transferrin released from the choriocapillaries diffuses across Bruch’s 
membrane and is endocytosed by RPE following binding to the cell surface 
transferrin receptor (Hunt et al., 1989). The low pH in the endosome leads to 
disassociation of iron from ferritin.  Divalent metal transporter 1 (DMT1) transports 
iron from the endosome into the cytoplasm (He et al., 2007) . 
 Iron export from the RPE is mediated by ferroportin (Fp) that binds free 
ferrous iron preferentially (Donovan et al., 2000). Free ferrous iron (Fe2+) must be 
oxidised to its inert ferric form (Fe3+) before it can be loaded onto transferrin. This 
can be achieved by the ferroxidases ceruloplasmin (Cp) and hephaestin (Heph). Cp 
facilitates iron export by oxidizing iron from Fe2+ to Fe3+. Fp is localized on the 
basolateral surface of RPE cells suggesting cooperation of Fp with the Cp/Heph 
system to release iron from the RPE (Hahn et al., 2004a).  
 Iron storage is mediated by cytoplasmic ferritin, each ferritin molecule can 
hold 4,500 iron molecules in the ferric state. Most of the metabolically active iron is 
processed in the mitochondria, which has own iron storage protein, mitochondrial 
ferritin (MtF) (Levi et al., 2001). MtF displays ferroxidase activity such that released 
toxic ferrous iron can be converted into the inert ferric state and stored. In the rat 
retina, highest iron levels were found to be in the RPE, choroid, and the inner 
segments of photoreceptor cells (Yefimova et al., 2000).  
 Zinc is another important divalent metal ion with a deficiency being linked to 
ageing, changes in dark adaptation, and night blindness (Evans, 1986; Grahn et al., 
2001). Lack of zinc can affect important antioxidants such as catalase and 
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superoxide dismutase, retinol dehydrogenase in the visual cycle, and matrix 
metalloproteinases which play a central role in the turnover and remodelling of 
Bruch’s membrane (Ugarte et al., 2001). Zinc is transported across Bruch’s bound to 
specific protein carriers (Leung et al., 2008; Redenti et al., 2004). 
 
1.1.1.2.2 Vitamin A transport 
 Photoisomerisation of 11-cis retinal in the rhodopsin molecule leads to its 
release as all-trans retinal. This is then reduced to retinol and transported to the RPE 
cell where in a series of enzymatic reactions, it is reconverted to 11-cis-retinal and 
transported back to the photoreceptor cell culminating in the vitamin A cycle shown 
schematically in Figure 1.5. Retinoids have a very low solubility in aqueous media, 
high susceptibility for oxidation and are toxic in high concentrations. They are 
therefore always bound to carrier molecules. In the extracellular environment, they 
are bound to retinol binding protein (RBP), albumin and interphotoreceptor retinol 
binding protein (IRBP).  Intracellularly, they are bound to cellular retinol and retinal 
binding proteins (CRBP, CRALBP). Although retinol is recycled between the 
photoreceptor and the RPE, losses occur due to oxidative damage of the 
chromophore and thus a continuous supply is required from the choroidal circulation. 
 In the blood, retinol is carried bound to a 21kDa carrier, the retinol binding 
protein (RBP) (Cowan et al., 1990).  This 1:1 retinol-RBP complex is in turn bound in 
1:1 ratio to transthyretin (TTR), a homotetramer composed of 14-kDa subunits 
(Bellovino et al., 1996; Melhus et al., 1991). The combined molecular weight of the 















Figure 1.5 The vitamin A cycle and blood-borne delivery of retinol. 
A: The vitamin A cycle. Photoisomerised all-trans retinal is recycled by the RPE 
and transported back to the photoreceptor cell for incorporation into rhodopsin. 
Endogenous stores of the retinoid are supplemented by supply from the choroidal 
circulation via Bruch’s membrane. 
B:  Blood-borne delivery of retinol. The retinol-retinol binding protein-transthyretin 
complex (R-RBP-TTR) crosses Bruch’s and following interaction with the RBP 
receptor on the basal surfaces of the RPE, the retinol is internalised and RBP and 

























































































































 The retinol-RBP-TTR complex crosses Bruch’s membrane to interact with the 
RBP receptor on the basolateral surface of the RPE. The subsequent mechanism 
that delivers retinol to the RPE is not clear. The RBP does not appear to enter the 
RPE cell (Heller et al., 1976). Current data suggests that retinol bound RBP has a 
higher affinity for the receptor than free RBP (Heller, 1975). Thus free RBP, having 
released its load is easily displaced by retinol bound RBP. It is suggested that the 
interaction of RBP with its receptor on the RPE leads to the dissociation of RBP and 
TTR leading to the release of retinol for uptake (Paci et al., 2005). Released RBP 
and TTR then diffuse out across Bruch’s membrane into the choroidal circulation. 
 
1.1.2  Outward transport: waste disposal  
 The waste disposal pathway, operating in the opposite direction to nutritional 
transport serves to remove metabolic waste, degradation products of phagocytosed 
outer segment material, and fluids (Figure 1.6). Metabolic waste products are 
generally small soluble species that can diffuse freely down their concentration 
gradients across the RPE and Bruch’s membrane for final removal into the 
choriocapillary network.  The bulk of the fluid originating in the retina is actively 























Figure 1.6 Transport pathways for removal of waste products. 
[a] Fluid transport. Fluid arising from the inner retina [1], and from photoreceptor metabolism [2] is 
presented at the apical surface of the RPE. In a healthy RPE, the major proportion (about 70%) is 
removed by an active process mediated by solute-coupled water transport [3]. The remaining 30% is 
transported by hydrostatic and osmotic processes (3a and 3b respectively). 
[b] Waste transport. Metabolic waste products (including urea and carbon dioxide) are removed by 
simple diffusion down their concentration gradients. Phagocytosis [1] and phagolysosomal 
degradation of outer segment portions [2] constitutes the major source of waste material. The fate of 
the phagolysosomal contents [3] is dependent on the degree of degradation. Fatty acids, retinoids, 
essential metals and vitamins for example can be recycled to the photoreceptor by the inner loop of 
transport [4]. Small soluble/insoluble products are voided onto Bruch’s membrane [5] for clearance 
into the choroidal circulation [6]. Particulate matter is also voided onto Bruch’s [7]. Some of this 
material will enter the inner layer of Bruch’s where it may become trapped [8] or if sufficiently small, 
traverse the membrane [9]. The larger fragments will be deposited on the surface of Bruch’s 
membrane [10] and may become focal centres for generalised lipid or drusen formation. The complex, 
non-degradable macromolecular complexes within the phagolysosome give rise to lipofuscin which is 






























1.1.2.1 Fluid transport 
 Fluid originating in the retina (from inner retinal capillary bed and retinal 
metabolism) is transported out by the RPE. Net outward fluid movement has been 
demonstrated both in-vivo (Frambach et al., 1982; Marmor et al., 1980; Negi et al., 
1986b) and in-vitro (Tsuboi, 1987; Tsuboi et al., 1988).  
 Nearly 70% of outward fluid movement by the RPE is mediated by an active 
process, driven by transport of ions from apical to basal compartments (Negi et al., 
1986b; Quinn et al., 1992). Excellent work in several laboratories has elucidated the 
ionic mechanism for fluid transport across the RPE (Adorante et al., 1990; Bialek et 
al., 1994; Joseph et al., 1991; Quinn et al., 1992).  Briefly, the Na+,K+,2Cl- co-
transporter on the apical surface mediates the entry of ions into the RPE cell and the 
increase in intracellular osmolarity in the locality will allow passive entry of water at 
that site. Extrusion of K+ and Cl- at the basal surface leads to outward water flow 
and the coupling in these ionic movements at the two surfaces provides the basis for 
net fluid transport across the RPE. The other 30% is thought to be due to passive 
means, driven mainly by the hydrostatic and osmotic gradients between the 
subretinal space and the extravascular choroid. Osmotic gradients arise from the 
high molecular weight species that are normally excluded from Bruch’s membrane 
(see earlier). In addition, it has been estimated that albumin is present in the 
extravascular compartment at a concentration of about 10% of plasma and this will 
additionally contribute a small osmotic gradient pulling water out of Bruch’s 
membrane (Toris et al., 1990). 
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 Quantitative measurements of fluid transport by the human RPE are few and 
have often been derived from pathological situations and therefore may be open to 
over-estimation.  In one study, fluid transport for the entire RPE area of 
approximately 10 cm2 was estimated to be between 1-2mls per day (0.04-0.08 l / 
hour / mm2) (Pederson, 1994).  Another clinical study examined the rate of 
regression of a retinal bleb in a non-rhegamatous detachment using B-scan 
ultrasonography and assuming that fluid was cleared by the RPE calculated the rate 
of transport to be of the order of 0.11 l / hour / mm2 (Chihara et al., 1985). 
 Several animal studies incorporating both induced retinal blebs and in-vitro 
Ussing chambers have determined the rate of fluid transport by the RPE to be about 
0.1248 0.11 l / hour / mm2, a value similar to that in the human studies given 
above (Frambach et al., 1982; Hughes et al., 1984; Negi et al., 1986a; Negi et al., 
1986b; Tsuboi, 1987; Tsuboi et al., 1988).  
 Fluid pumped out by the RPE is then transported across Bruch’s due to a 
hydrostatic pressure head. The hydraulic conductivity (HC) of Bruch’s membrane 
required to transport the output from the RPE can be calculated from: 
HC = flow / pressure 
 However, the hydrostatic pressure differential across human Bruch’s has not 
been determined due primarily to technical difficulties. In monkeys, the pressure 
differential across the vitreous and suprachoroidal space was estimated to be about 
4 mm Hg (equivalent to 534 Pa) (Emi et al., 1989). Since a pressure differential was 
not detected across the neural retina (Maurice et al., 1971), the 4mm Hg gradient 
must fall across the RPE-Bruch’s complex. There is no doubt that some of this 
pressure head must fall across the RPE. Thus, at best, the driving pressure gradient 
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across Bruch’s can be no more than 4mmHg but in all probability would be expected 
to be lower. Using a value of 4mmHg, the hydraulic conductivity of Bruch’s required 
to transport fluid deposited onto its surface by the RPE (0.13 l / hour / mm2) can 
therefore be calculated as 0.65 x 10 -10 m/sec/Pa.   
 
1.1.2.2 Transport of phagocytic by-products 
 Retinal photoreceptors maintain one of the highest rates of oxidative 
metabolism of any cell type in the body and it has been estimated that during normal 
metabolism, the mitochondrial electron transport chain converts 1-5% of consumed 
oxygen to reactive oxygen species (ROS: superoxide, °O
-
2 and hydrogen peroxide, 
H2O2) (Ahmed et al., 1993; Bui et al., 2003; Korshunov et al., 1997). Furthermore, 
these receptors operate in an environment rich in highly unsaturated fatty acids, high 
oxygen tension and light, an ‘explosive’ mixture for generation and propagation of 
free-radical mediated damage pathways (Bicknell et al., 2002; Boulton et al., 2001). 
This highly oxidative environment of the retina leads to oxidation of outer segment 
lipids such as docosahexonoic acid (Esterbauer et al., 1991; Miceli et al., 1994). 
Free radical mediated attack will lead to chain propagation reactions and despite the 
presence of blockers of this ravagenous process (e.g., vitamin E, superoxide 
dismutase, catalase), considerable damage is sustained. Such oxidative reactions 
lead to the formation of reactive aldehydes that can cross-link proteins leading to the 
formation of large macromolecular complexes (Witz, 1989).  
 The sustained photoreceptor damage, noticeably in the lipid rich membrane 
discs of outer segments, is transferred en masse to the RPE cells by the process of 
daily disc shedding and phagocytosis by the RPE (Bok et al., 1979; Young, 1976). It 
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has been estimated that in humans, each RPE cell ingests about 6000-8000 discs 
daily (Bok, 1994; Feeney-Burns, 1980; Young, 1982). Complete digestion within the 
RPE cell reduces the complex structures to their basic building blocks of fatty acids, 
amino acids, vitamins including the retinoids and essential metals. These are 
normally recycled back to the photoreceptor using the pathways described earlier 
and assist in the re-synthesis of new discs (Bok, 1990). This short pathway is often 
termed the inner loop of nutrient transport compared to the outer loop involving 
transport of blood-borne nutrients.  
 Phagosomes containing discs with minimal damage can fuse with lysosomes and 
the major degradation products can be recycled with the minor small non-degradable 
material being voided out of the cell for clearance by Bruch’s membrane.  
 
1.2 Ageing of transport systems 
1.2.1 Structural and compositional alterations of ageing Bruch’s 
membrane 
 Bruch’s membrane undergoes age-related morphological and compositional 
alterations with its thickness increasing 2-3 fold over the life-span of an individual 
(Newsome et al., 1987; Okubo et al., 1999; Ramrattan et al., 1994; Sarks, 1976; van 
der Schaft et al., 1992). Despite the overall increase in thickness, the elastin layer of 
the membrane at both macular and peripheral locations was not observed to thicken 
to any significant level (Chong et al., 2005). Compositional alterations include the 
deposition of lipids (Curcio et al., 2001; Holz et al., 1994; Pauleikhoff et al., 1990; 
Sheraidah et al., 1993), proteins (Hageman et al., 1999; Kliffen et al., 1995) and 
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carbohydrate associated moieties such as glycolipids, glycoproteins and 
proteoglycans (Farkas et al., 1971; Mullins et al., 1997).  
 
1.2.1.1 Lipid accumulation 
 Very early histochemical studies showed an age-related accumulation of lipids 
in Bruch’s membrane leading to the concept of a ‘lipid barrier’ that was postulated to 
undermine metabolic exchange processes between the choroidal blood supply and 
the light sensitive receptor cells (Bird et al., 1986; Grindle et al., 1978). This concept 
was particularly useful in explaining the occurrence of RPE detachments in patients 
with AMD where the ‘hydrophobicity’ of ageing Bruch’s blocked the exit pathways for 
fluids and the continuing pumping by RPE cells led to fluid accumulation and 
eventual detachment (Bird et al., 1986). 
  Subsequent quantitative studies showed little or no deposition of lipids prior to 
the age of 40-50 years followed by an exponential increase thereafter (Holz et al., 
1994; Sheraidah et al., 1993). More recent studies have examined filipin 
fluorescence due to the presence of free and esterified cholesterol and suggest an 
earlier onset of accumulation of these species (Curcio et al., 2001; Ruberti et al., 
2003). In samples from aged donors (>60 years), 80-100nm particles enriched in 
esterified and free cholesterol were observed to occupy a third of the inner 
collagenous layer and to exist as a discreet sublayer in between the RPE basal 
lamina and Bruch’s membrane. All of the above studies confirm the greater 




1.2.1.2 Collagen content and age 
 The collagen content of Bruch’s increases throughout life and two forms can 
be recognised morphologically (Bird et al., 1986; Loffler et al., 1986; Sarks, 1976; 
van der Schaft et al., 1992). Collagen with a 64nm periodicity is intrinsic to the 
membrane and accumulates throughout life. Another form with a banding periodicity 
of 100-140nm, termed long spaced collagen (LSC) becomes prominent after the age 
of 40 years. The presence of LSC in the outer collagenous layer of most young eyes 
suggests it to be a normal feature of collagen turnover. Its increased presence in the 
basal laminar deposits (between the plasma and basement membrane of the RPE) 
and in the outer collagenous layer of Bruch’s is thought to be a response of 
distressed cells (Guymer et al., 1999; Marshall et al., 1994; Sarks, 1976; van der 
Schaft et al., 1991).   
 Ageing also results in a change in the properties of the collagen molecule. 
The insoluble collagen content of Bruch’s membrane was shown to increase linearly 
with age (Karwatowski et al., 1995) and over a 10-decade period accounted for 
nearly 50% of membrane collagen. The insolubility is indicative of denaturation and 
subsequent chemical modification including greater cross-linking and formation of 
advanced glycation end-products (AGE’s).  
 
1.2.1.3 Advanced glycosylation and lipid end-products (AGEs and ALEs) 
 Pentosidine and carboxymethyllysine (CML), two of the most studied collagen 
AGE products were shown to be present in ageing Bruch’s membrane, basal laminar 
and linear deposits and in soft macular drusen (Handa et al., 1999; Ishibashi et al., 
1998).  Quantitative studies have shown an age-dependent increase in the level of 
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pentosidine in Bruch’s membrane (Handa et al., 1999). AGE’s are strong promoters 
of protein cross-linking (Krishnamurti et al., 1997; Tian et al., 1996) and can thus 
reduce the porosity of an ECM with dire consequence for transport pathways. More 
importantly, AGE’s reduce protein susceptibility to enzymatic proteolysis and will 
uncouple the tightly regulated matrix metalloproteinase (MMP) synthetic/degradation 
system for normal membrane rejuvenation leading to increased deposition of matrix 
components (Haas et al., 1998; Howard et al., 1996; Rittie et al., 1999; Scott et al., 
1998), a situation present in ageing Bruch’s membrane. Interestingly, ARPE-19 cells 
grown on AGE modified matrigel showed altered expression of plasminogen-
activator-inhibitor-1 (PAI-1) leading to decreased plasmin activation resulting in 
reduced MMP activation (Bobbink et al., 1997; Corcoran et al., 1996; Honda et al., 
2001). Other workers have previously observed a marked absence of active MMPs 
2&9 in macular regions of human Bruch’s membrane whereas their presence in the 
periphery was routinely demonstrated (Guo et al., 1999). This AGE mediated 
alteration could therefore contribute to the expansion of ageing human Bruch’s 
membrane in the macular region.  
 
1.2.1.4 Accumulation of phagocytic debris 
 As indicated earlier, the highly oxidative environment of the retina leads to 
free-radical mediated damage of outer segment lipids such as docosahexonoic acid 
and formation of reactive aldehydes that can cross-link proteins leading to the 
formation of large macromolecular complexes (Esterbauer et al., 1991; Sayre et al., 
1996; Witz, 1989). Phagocytosis of outer segment tips simply transfers this reactive 
system to the interior of the RPE, which like the retina, is situated in a highly 
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oxidative environment. This material can therefore undergo further oxidative damage 
whilst in the RPE cell. The reactive species within the engulfed disc material may 
damage the phagosomal membrane leading to problems of fusion with lysosomes so 
that further processing is inhibited (Hoppe et al., 2001).   
 Phagolysosomes containing damaged outer segment material could 
theoretically degrade the accessible material with the remainder being packaged as 
lipofuscin granules. However, current evidence suggests this to be unlikely. A major 
fluorophore of lipofuscin has been shown to be a bis-retinoid called N-retinylidene-N-
retinylethanolamine (A2-E) (Reinboth et al., 1997; Sakai et al., 1996).  Although the 
mechanism remains unknown, A2-E has been shown to inhibit lysosomal proteolysis 
in RPE cells (Holz et al., 1999; Sundelin et al., 1998). A2-E also inhibits the 
phagolysosomal degradation of phospholipids and may therefore influence the 
natural history of lipid deposits of Bruch’s membrane (Finnemann et al., 2002). The 
toxic environment within the phagolysosomes containing such damaged material is 
expected to result in incomplete degradation of contents. Furthermore, the 
phagolysosomal membrane may itself undergo damage with the possibility of 
leakage of destructive contents into the cytoplasm. Products of incomplete digestion 
will include soluble components that are likely to be recycled, ‘normal’ membraneous 
aggregates, and insoluble particulate material containing lipofuscin. 
 Lipofuscin granules are discernable by the age of 10 years and occupy nearly 
20% of cytoplasmic volume by the age of 80 years (Feeney-Burns et al., 1984). 
Decreased cytoplasmic volume may have ramifications for the storage potential for 
diffusible metabolites. Furthermore, increasing levels of melanolipofuscin complexes 
result in removal of an important free-radical scavenger from the anti-oxidant 
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machinery of RPE cells (Feeney-Burns et al., 1984; Schmidt et al., 1986). There is 
also some evidence that increased lipofuscin can compromise the phagocytic 
degradation potential of the cell resulting in increased levels of partially digested 
material that must be removed from the cell. Several reports have now demonstrated 
an age-related decline in the activity of lysosomal enzymes and this will result in 
greater accumulation of lipofuscin (Boulton et al., 1989; Kennedy et al., 1995; Liles et 
al., 1991; Wilcox, 1988).  
 Increased lipofuscin within the RPE is an indicator of increased production of 
‘undigested’ debris. Thus ageing results in greater amounts of membraneous derived 
waste products being extruded onto Bruch’s membrane. The smaller fraction may 
pass through Bruch’s membrane or coalesce to produce larger species that may be 
trapped in the membrane. Peroxidised PUFA’s have been demonstrated in Bruch’s 
membrane and particles containing these species may cross-link with proteins to 
become trapped in the membrane (Hicks et al., 1989; Kikugawa et al., 1987; 
Wiegand et al., 1983). Larger particles may only penetrate the inner collagenous 
layer whereas even larger species may be deposited onto the surface of Bruch’s 
membrane progressing to the formation of drusen (Feeney-Burns et al., 1985; 
Ishibashi et al., 1986).   
 It is also likely that free lipids could aggregate leading to ‘free-energy’ driven 
growth, stabilisation and deposition. High resolution morphometric studies have 
shown the presence of 100 nm particles enriched in esterified and free cholesterol 
(Curcio et al., 2001; Ruberti et al., 2003). The latter studies showed these particles to 
occupy >30% of the inner collagenous layer in eyes from donors aged over 60 years.  
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Further incorporation is likely to lead to fusion of these particles resulting in sheets of 
soft drusen. 
 The deposition and growth of this lipid rich component under the basal 
aspects of the RPE is expected to considerably increase the diffusional distance for 
transport of nutrients.  
 
1.2.2 Hydrodynamics and ageing of Bruch’s membrane 
 Previously (section: 1.1.2.1) the hydraulic conductivity of Bruch’s required to 
deal with fluid output from the RPE was calculated as 0.65 x 10 -10 m/sec/Pa. This 
threshold value may be appropriate at peripheral locations but at macular sites, high 
photoreceptor densities would be expected to produce higher fluid output. Thus, for 
comparative purposes, threshold values in the macular region should be higher than 
calculated.  
 Several studies have now documented on the hydraulic conductivity of ageing 
human Bruch’s membrane. (Fisher, 1987) showed the hydraulic conductivity of 
Bruch’s to halve between the ages of 22 and 71 years. Subsequent and more 
detailed studies showed an exponential reduction in hydraulic conductivity at both 
macular and peripheral locations (Moore et al., 1995; Starita et al., 1996). A more 
extensive analysis of transport across Bruch’s, including samples from donors with 
age-related macular degeneration (AMD) is presented in Figure 1.7 and Figure 1.8 












Figure 1.7 Age-dependent variation in the hydraulic conductivity of human 
Bruch’s membrane: macular region. 
The semi-logarithmic plot shows an exponential decay in the hydraulic conductivity of Bruch’s 
membrane.The failure threshold for fluid transport was calculated from the minimum hydraulic 
conductivity of Bruch’s required to transport fluid pumped out by human and animal RPE as described 
in the text. In this control donor population, the likelihood of the decay curve meeting the failure 
threshold lies outside the normal human life span.  Data from 56 donors, age range 1-91 years. 
Modified from Hussain et al., 2004. 
 
 
 In macular regions, hydraulic conductivity was observed to decrease 
exponentially (linear line in the log transform of Figure 1.7). The rate of change in 
hydraulic conductivity with age remains unaltered throughout the life of an individual 
and is depicted by the linear regression fit on the logarithmic plots.  In an exponential 
relationship, the rate of decay is often characterised by the half-life of the process 




non-linear regression fit to the data. In macular regions, the half-life for the age-
related decline in hydraulic conductivity was calculated as 16 years, i.e., the capacity 
for transport of fluids is halved for every 16 years of life. The regression line of Figure 
1.7 can be extrapolated to cut the failure threshold and this would represent a finite 
period of viable function for transport of fluids through Bruch’s membrane. In the 
case of the macular data, the age at which Bruch’s would be expected to fail is about 
127 years, well outside the normal human life span. In a given individual, 
environmental factors, smoking habits or genetics may influence the rate of decline 
and this secondary modulation may be reflected in the scatter of Figure 1.7. Since 
the data of Figure 1.7 was accrued from a ‘control’ donor population, it might be 
argued that although the demise in hydraulic conductivity is rather precipitous, it 
nevertheless has very little effect on the underlying physiology. Thus Bruch’s has 
rather an excess capacity for dealing with fluid output from the RPE. On the other 
hand, the declining exponential curves may be indicative of the increasing risk in the 
elderly of developing transport problems that may progress to pathology.  
 Hydraulic conductivity at peripheral locations also showed an exponential 
decrease with age but the decay constant was lower with a half-life of 23 years 
(Figure 1.8). Thus ageing in non-macular regions occurs at a much slower rate. 
Extrapolating the non-linear regression transform to meet the failure threshold 
provided a shelf-life of Bruch’s in the periphery of about 174 years, again the 
capacity for transport across Bruch’s appears to be far in excess of that required for 
routine daily transport of fluids. The similarities in the exponential graphs between 
macular and peripheral regions suggests that in the normal eye, measurement of 
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hydraulic conductivity in one region can provide a good estimate of the situation in 












Figure 1.8 Age-dependent variation in the hydraulic conductivity of human 
Bruch’s membrane: peripheral region. 
A similar exponential decay in hydraulic conductivity was also observed in the 
peripheral region of the human fundus but with a slower half-life of 23 years (open 
circles, n=90; age range 1-90 years). Hydraulic conductivities of AMD donors (n=12; 
age range 64-95 years, filled circles) were all below the mean regression line of the 
control samples and showed a drift towards failure thresholds. 






 In AMD, the ultrastructural changes in Bruch’s membrane are best described 
as advanced ageing (Green et al., 1993; Green et al., 1977; Sarks, 1976). Since 
eyes from aged AMD donors often show the very late stage of the disease, macular 
scarring prevents isolation of this region but peripheral regions were examined and 
resulting hydraulic conductivities are presented in Figure 1.8. 
Interestingly, all twelve AMD samples showed conductivities that fell beneath the 
regression line for control donors. Of these twelve samples, two (16.7%) were on or 
below the demarcation line of minimum hydraulic conductivity. If a parallel can be 
drawn between hydraulic conductivities of macular and peripheral regions in control 
with those in AMD, then it can be predicted that in the latter, the fluid transportation 
system of Bruch’s must be under severe strain and more likely to fail leading to 
accumulation of fluid under the RPE.  It is therefore not surprising that 12-20% of 
AMD sufferers show RPE detachments as the continued pumping by the RPE leads 
to fluid accumulation and subsequent detachment (Bird et al., 1986). 
 
1.2.3 Macromolecular transport and ageing of Bruch’s membrane 
 Carrier mediated delivery of metabolites across Bruch’s is essential for both 
RPE and photoreceptor survival. Their payload includes important ligands such as 
vitamin A (retinol binding protein), the heavy metals iron and copper (transferrin, 
ceruloplasmin), and lipids (lipoproteins). Albumin can also carry a variety of 
metabolites including fatty acids. 
 Some evidence already exists to suggest that this transportation function may 
be impaired in elderly patients with ageing changes in Bruch’s membrane (Chen et 
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al., 1992; Pauleikhoff et al., 1990; Steinmetz et al., 1993; Sunness et al., 1988).  
These patients displayed good visual acuity but on fluorescein angiography there 
was evidence of delayed choroidal perfusion in other areas of the fundus.  Functional 
analysis of these regions showed elevated dark adaptation thresholds similar to 
changes observed in vitamin A deficiency.  Similar changes were observed in 
Sorsby’s fundus dystrophy (SFD), a disease with many clinical associations with 
AMD together with the presence of a 30 m thick lipid rich deposit in Bruch’s 
membrane (Steinmetz et al., 1992). The conclusion has been that ageing changes in 
Bruch’s membrane lead to a diminution in the transport of macromolecules such as 
vitamin A-RBP.  
 Traversing protein carriers such as albumin, transferrin, and ceruloplasmin 
display Stokes-Einstein radii of 3.58nm, 4.3nm and 4.68nm respectively. The 
diffusional status of ageing Bruch’s was previously assessed using a quasi-spherical 
FITC-labelled dextran of molecular weight 21.2 kDa and Stokes-Einstein radius of 
3.28nm (Hussain et al., 2010). The diffusional studies for macular and peripheral 
Bruch’s are presented in Figure 1.9: Diffusional transport of the FITC-labelled test 
probe declined linearly with ageing at both macular and peripheral locations. As with 
hydraulic conductivity, the decline in the non-macular fundus was much slower. At 
macular locations, there was a nearly 80% reduction in diffusional transport between 
the first and ninth decade of life. 
 Another study, using serum proteins as markers showed a 10-fold decline in 
diffusion rate between the first and ninth decade of life in macular regions of the 
human fundus (Moore et al., 2001). Thus macromolecular traffic through macular 
Bruch’s membrane undergoes considerable attenuation with ageing of donor and 
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supports the earlier conclusions derived from clinical studies of elevated dark 









Figure 1.9 Age related variation in the diffusional flux of a 21.2 kDa dextran 
through Bruch’s membrane from macular (A) and peripheral (B) locations. 
Diffusional fluxes were measured (over a period of 12 hours) in response to a 0.412mM concentration 
gradient of the FITC-dextran across the preparation. Ageing of the donor was associated with a highly 
significant decline in the rate of diffusion across Bruch’s membrane, p < 0.001. In (B), the 99% 
confidence limits for the normal donor population are shown as dotted lines. Diffusional levels in 
Bruch’s membrane from peripheral samples of AMD donors (filled circles) were much lower lying 




 As with hydraulic conductivity, the diffusional pathways appear to maintain a 
capacity that is far in excess of that required for supplying the neural retina. However, 
some elderly patients do show signs of reduced supply of vitamin A and thus in 





rates of supply for retinal maintenance. Nonetheless, the capacity to withstand an 
additional insult may be compromised. Thus in four AMD donors, peripheral rates of 
diffusion of the test probe were considerably reduced (Figure 1.9B) with values lying 
outside the 95% confidence limits of the control population. As with hydraulic 
conductivity, the diffusional situation at macular locations is likely to be much more 
severe in these patients. The reduction in the diffusional transport of this test probe 
means that all carriers transporting essential vitamins, lipids, and heavy metals that 
are of vital importance to both metabolic and enzymic protection systems (such as 
catalase and superoxide dismutase) will be severely compromised. The initial impact 
of a reduction in macromolecular transport may place the homeostatic protective 
systems (both in the RPE and photoreceptors) under considerable stress increasing 
the likelihood of a pathological insult. 
 
1.2.4 Advanced changes in age-related macular degeneration 
 The ageing changes in structure and composition of Bruch’s membrane have 
already been discussed. Associated changes in functional parameters of transport 
were also shown to decline and in the control aged, problems associated with carrier 
proteins for vitamin A were apparent. The morphologically advanced ageing in AMD 
is therefore expected to exacerbate the functional decline in transport properties 
(Hammes et al., 1999). Although macular regions have not yet been assessed, 
peripheral locations in donor AMD eyes showed considerable compromise in fluid 
and macromolecular transport (Hussain et al., 2010; Hussain et al., 2004). 
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 Restricted transport of carrier proteins not only reduces the delivery of 
retinoids, vitamins and metals to overlying RPE and retina, it can also lead to the 
deposition of these materials in the matrix of Bruch’s membrane. For example, the 
increased thickness of Bruch’s, cross-linking of collagen fibres, increased rigidity of 
the membrane and reduced porosity can considerably increase the ‘dwell’ times for 
traversing molecules. Increased dwell times can increase the risk of oxidative 
damage and entrapment of carrier proteins within Bruch’s. Released payloads such 
as iron, zinc, copper can then complex with the debris leading to increased levels in 
the membrane. The presence of toxic levels of these metals poses further risk of 
damage to the membrane. 
 Iron levels are higher in aged control subjects, but AMD donors display much 
elevated levels in the retina, RPE, and Bruch’s-choroid (Dentchev et al., 2005; 
Dunaief, 2006). If the entry of iron via transferrin and ferritin is curtailed, the raised 
levels in RPE and retina must occur via additional pathways such as the inner retinal 
circulation and possibly the vitreous. It is also likely that with reduced capability of 
exit pathways, iron storage of ferritin becomes more important leading to its 
accumulation in the retina and RPE.  Elevated levels of iron in Bruch’s could also be 
due to entrapment and stabilisation of plasma-derived transferrin and ferritin within 
the reduced porosity of aging Bruch’s and by complexation of divalent metals to 
amorphous debris within the membrane.  
 Increased levels of iron in photoreceptors, RPE and Bruch’s risk additional 
damage from released free iron (Fe2+) since the free radical pathway in the presence 
of high levels of unsaturated lipids, light, and oxygen will exacerbate the underlying 
pathological mechanism (Organisciak et al., 1998). 
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 Metabolic insufficiency leads to a highly stressed RPE cell that may undergo 
apoptosis discharging its contents onto Bruch’s membrane. Histopathological 
investigations have often underlined the presence of such a ‘stressed’ situation in the 
RPE-Bruch’s complex of donor AMD eyes (Sarks et al., 1999). Complement 
activation and local inflammatory processes have been implicated in the formation of 
drusen as these deposits contain both cascade proteins and immune system 
components and terminal immune complexes (Donoso et al., 2006; Hageman et al., 
2001; Johnson et al., 2001; Mullins et al., 2001). Since extensive druse formation is 
a hallmark of AMD, inappropriate complement activation due to the CFH 
polymorphisms may well contribute to the development of AMD. 
 Several single nucleotide polymorphisms have been identified in the 
complement factor H (CFH) gene that were strongly associated with AMD (Edwards 
et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005). Some of 
these polymorphisms were located in the functional domains of the CFH gene and 
immunohistochemical analyses have shown increased presence of CFH expression 
in macular areas of AMD donors compared to controls (Hageman et al., 2005). Other 
single nucleotide polymorphisms with even greater association with AMD have been 
found in both coding and non-coding flanking regions of the CFH gene (Li et al., 
2006; Maller et al., 2006). The list of AMD-associative sites in members of the 
complement system is further enlarged by the presence of polymorphisms in the 
complement factor B (CFB) and complement C2 cascades (Gold et al., 2006; Maller 
et al., 2006). 
 Release of vascular endothelial growth factor (VEGF) is an early event in the 
angiogenic process. It is thought that AGEs and ALEs stimulate the AGE-receptor 
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(RAGE) on RPE cells that culminates in the release of VEGF from highly stressed 
cells. Although neovascular episodes occur in only about 10%-20% of all AMD cases, 
they are nevertheless responsible for nearly 90% of cases of visual loss. 
 Anatomical variations in the elastin layer of Bruch’s between macular and 
extra-macular regions are thought to underlie the greater susceptibility of the former 
region to choroidal neovascularisation (Chong et al., 2005). This study showed that 
the elastin layer in the macular region was three to six times thinner and two to five 
times more porous than at peripheral locations, changes that are more likely to 
compromise barrier function against potential neovascularisation at the macula. The 
elastin layer in the macular region of AMD donors was shown to be much thinner 
and more porous compared to age-matched controls. Furthermore, endogenous 
inhibitors of angiogenesis such as endostatin, pigment epithelium-derived factor and 
thrombospondin 1, normally present in Bruch’s membrane, were shown to be 
significantly lowered in AMD thereby increasing the vulnerability for choroidal 
neovascularisation (Bhutto et al., 2008).  
 The advanced ageing changes in Bruch's membrane associated with AMD 
and the potential for inflicting degenerative insults are shown in schematic form in 







Figure 1.10 Summary of advanced ageing changes in the RPE-Bruch's 
complex and the potential for transition to pathology. 
In AMD, an exaggeration of the various ageing mechanisms described in the text 
leads to severe structural and functional compromise of Bruch’s membrane. The 
resulting diminished metabolic support increases ‘stress’ on the RPE cell that may 
then proceed to pathological alterations via apoptosis or the recruitment of additional 
































1.3 Extracellular matrix turnover and Bruch’s membrane 
1.3.1 Structural elements of Bruch’s membrane 
 In addition to acting as a scaffold for adhesion of RPE cells, the matrix of 
Bruch’s also serves as a reservoir of factors that promote cell proliferation, activation, 
and migration (Aumailley et al., 1998; Labat-Robert et al., 1990; Vaday et al., 2000). 
In common with other ECMs, Bruch’s contains four major classes of structural 
components: (i) collagens, (ii) elastin(s), (iii) proteoglycans and (iv) structural 
glycoproteins (Labat-Robert et al., 1990).   
 The collagen molecule contains high levels of proline and glycine and exists 
as a triple helix by the inter-twining of three -chains to form a rope-like structure. 
Nineteen types of collagen molecules have been identified and it is the relative mix 
of these that determines the physical characteristics of a given matrix (Aumailley et 
al., 1998). The fibrillar collagens (types I, II, III, V and XI) are relatively inextensible 
and therefore determine the rigidity of a matrix (Scott, 1995). Types IX and XII can 
cross-link with other collagen fibres and to non-collagenous components of the 
matrix. Network-forming collagens are represented by types IV and VII and of these 
type IV spontaneously aggregates into meshworks to form the major skeletal 
backbone of basement membranes (Grant et al., 1981). Type VII molecules form 
dimers that assemble into specialized structures called anchoring fibrils and function 
to attach epithelium cells to their basement membrane (Aumailley et al., 1998). 
 The elastin protein is also rich in proline and glycine but unlike collagen, it is 
not glycosylated. Elastin molecules assemble into elastic fibres that become highly 
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cross-linked to form extensive networks of fibres and sheets. Hydrophobic regions 
within the molecule are thought to impart elastic properties with an alanine-lysine rich 
 helical segment being responsible for cross-linking adjacent molecules (Robert et 
al., 1980). These elastic fibres are enmeshed with microfibrils comprising 
glycoproteins and can interact directly with cellular membranes (Hornebeck et al., 
1986; Robert et al., 1986). 
 Proteoglycans (PGs) consist of glycosaminoglycan (GAG) chains covalently 
linked normally to a core glycoprotein. The presence of GAGs allows proteoglycans 
to form gels of varying ‘pore’ size and therefore can serve as size and charge sieves 
regulating molecular traffic through the matrix (Wight et al., 1987). Proteoglycans 
bind growth factors and by shifting the equilibrium between bound and free, can 
regulate cell proliferation (Schmidt et al., 1987). They also bind proteolytic enzymes 
and their inhibitors and therefore by immobilising the enzymes at local sites can 
regulate enzymic activity (Alberts et al., 1994).  
 Fibronectin is a disulfide-bonded dimer and multiple forms exist due to 
variations in the nature of the side chains. Soluble plasma fibronectin plays a role in 
enhancing blood clotting, wound healing and phagocytosis. Highly insoluble 
fibronectin molecules are found assembled at cell surfaces and within extracellular 
matrices and can interact with integrin cell membrane receptors to play a role in cell 
adhesion (Birdwell et al., 1978).  Other glycoproteins include the laminin family of 
ECM components. 
 The molecular composition of Bruch’s membrane has been shown to be 
similar to that of most extracellular matrices and includes collagens of type I, III, IV, V 
and VI, proteoglycans such as heparan and chondroitin sulphate, and glycoproteins 
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such as laminin and fibronectin (Campochiaro et al., 1986; Das et al., 1990; Lin, 
1989; Marshall et al., 1994; Newsome et al., 1987). However, the distribution of the 
individual components varies between layers of Bruch’s membrane and is shown 






Figure 11. Schematic representation of Bruch’s membrane with location of its 
ultrastructural components.  
Abbreviations: BM, basement membrane; ICL, inner collageous layer; EL, elastin layer; OCL, outer 
collagenous layer; CC, choriocapillaris; C, collagen, HS, heparan sulphate; CS, chondroitin sulphate; 
DS, dermatan sulphate. 
Figure 1.11 Schematic representation of Bruch’s membrane with location of its 
ultrastructural components. 
Abbreviations: BM, basement membrane; ICL, inner collageous layer; EL, elastin layer; OCL, outer 
collagenous layer; CC, choriocapillaris; C, collagen, HS, heparan sulphate; CS, chondroitin sulphate; 
DS, dermatan sulphate. After (Campochiaro et al., 1986; Das et al., 1990; Marshall et al., 1993; 
Marshall et al., 1994; Marshall et al., 1992).  
 
 
1.3.2  Homeostatic turnover of Bruch’s membrane 
 To maintain the structural and functional properties of Bruch’s, homeostatic 




of coupled synthesis and degradation processes regulate the turnover of Bruch’s. 
The degradation pathway is mediated by a family of proteolytic enzymes called the 
matrix metalloproteinases (MMPs) (Birkedal-Hansen et al., 1993; Woessner, 1991). 
Secretion of MMPs 1, 2, 3 and 9 by the RPE and choroidal endothelium cells has 
been shown and their presence in Bruch’s has been demonstrated (Alexander et al., 
1990; Guo et al., 1999; Hunt et al., 1993; Vranka et al., 1997).  The proteolytic 
activity of MMPs is controlled by the presence of tissue inhibitors of MMPs (TIMPs), 
which are represented by four gene products. TIMP2 and TIMP3 has been localised 
in Bruch’s membrane. Among the TIMPs, TIMP3 is unique in that that it exists bound 
to the matrix of Bruch’s membrane (Fariss et al., 1997; Vranka et al., 1997). A 
disturbance of the synthesis and degradation pathways for matrix turnover and 
renewal can cause severe dysfunction in Bruch’s membrane. Mutations in the TIMP-
3 gene leads to an early-onset form of macular degeneration called Sorsby’s fundus 
dystrophy, characterised by a thick (~30μm) deposition of lipid-rich material on top of 
Bruch’s (Fariss et al., 1998; Weber et al., 1994). Although mutations in the TIMP3 
gene are not associated with AMD (De La Paz et al., 1997), strong associations for 
higher risk of AMD have been reported near the TIMP3 locus (Chen et al., 2010; 
Neale et al., 2010). Mutations in molecules that normally interact with the MMP 
system can also lead to abnormal ECM turnover (Klenotic et al., 2004). Thus a 
mutation in the TIMP-3 binding epidermal fibulin-like extracellular matrix protein 1 
(EFEMP1) is responsible for the hereditary macular degenerative disease, Malattia 




1.3.3 The matrix metalloproteinase family 
1.3.3.1 Structure of MMPs 
 The first member of MMP family, collagenase, was identified in 1962 in 
tadpole tails and could degrade fibrillar collagen. A family of structurally related 
collagenases, 23 members in humans (24 members in mice) has now been 
documented and referred to as the MMP family. MMPs belong to the metzincin 
superfamily of proteases, named after the presence of a zinc ion and a methionine 
residue at the active site.  
 Other high molecular weight gelatinases (representing dimers and polymers) 
have been identified. In human and dog brain, a 280 kDa gelatinase species that 
reacted with antibodies to MMP9 has been documented (Lim et al., 1997). Similarly, 
in human Bruch’s membrane, two high molecular weight forms (130 and 225 kDa) 
were identified and suggested to be mono- and hetero-dimers of MMPs 2&9 (Guo et 
al., 1999).  
 Most MMPs share conserved domain structure containing an invariant Cys 
residue at the active site, the catalytic domain with active site zinc ion, a hinge region, 
and a C-terminal hemopexin-like domain which attaches to the catalytic domain by a 
















Figure 1.12 Protein structure of MMPs. 
Panel A, domain structure of majority of members of MMP family including MMP-1 and MMP-3. Four 
domains are signal peptide, propeptide, catalytic domain with Zn++ binding site, and C-terminal 
hemopexin domain. Panel B, MMP-2 domain structure, the catalytic domain is separated by the 
‘fibronectin’ domain. Panel C, MMP-9 domain structure, a ‘collagen V’ is inserted between catalytic 




Most of the MMPs are released as inactive zymogens with a pro-peptide domain that 
needs to be cleaved for activation of the enzyme, referred to as the “cysteine switch” 
activation mechanism (Van Wart et al., 1990). The pro-peptide domain contains an 
invariant Cys residue that ligates the active site zinc ion to prevent catalysis, keeping 



















The catalytic domain 
The active site of MMPs is formed in the catalytic domain, and the catalytically 
important Zn2+ ion is bound to three histidine residues in the HEXGHXXGXXH zinc-
binding motif. The gelatinases (MMP2 and MMP9) have three fibronectin type 
repeats (which mediate binding to collagens) encoded in their catalytic domain.  
The hinge region 
The catalytic domain links to C-terminal domain by a hinge region.  
The hemopexin-like C-terminal domain 
The hemopexin domain has a four bladed β propeller structure that provides a flat 
surface and mediates protein-protein interaction such as substrate recognition, 
enzyme activation, and protease localization (Overall, 2002). This domain interacts 
with tissue inhibitors of matrix metalloproteinases (TIMPs).   
 The gelatinases (MMP2 and MMP9) contain an additional fibronectin-like 
domain that is believed to facilitate binding to their gelatin substrates. The ‘collagen 
V’ domain has homology to type V collagen and is found only in MMP9 (Matrisian, 
1992; Matrisian, 1990; Woessner, 1991).  
 The five members of the MT-MMP family have three additional insertions. The 
first one is inserted in the pro and catalytic domains, the second in the catalytic 





1.3.3.2 Substrate specificity of MMPs 
 The members of the MMP family are divided into several groups. The three 
major groups, based on substrate preferences comprise collagenases, gelatinases 
and the stromelysins (Murphy et al., 1991). Another group comprises the membrane-
type MMPs (MT-MMPs) and these are not secreted but are an integral part of the 
plasma membrane (Sato et al., 1994). The substrate specificity of these various 
MMPs is given in Table 1.1. From the composition of structural elements and the 
broad substrate specificities of the proteolytic enzymes, it is clearly discernable that 
activated MMPs can degrade nearly all components of the matrix of Bruch’s 
membrane. 
 The members of the MMP family are listed in Table 2. However, additional 
species also occur from dimerization and polymerisation processes (Guo et al., 1999; 
Lim et al., 1997). MMP9 can also exist in dimeric or polymeric latent and active forms 
but the biological significance of these transitions is not known (Goldberg et al., 
1992). However, dimerization is known to significantly reduce the rate of activation of 
pro-MMP9 by MMP3 (Olson et al., 2000). Since dimerization/polymerisation is 
sensitive to thiol reduction, the interaction is thought to be disulphide mediated but 
the origin of the participating cysteines is not known (Goldberg et al., 1992; Olson et 
al., 2000). Interestingly, deletion mutants of MMP9 lacking the O-glycosylation (OG) 
domain were only observed as monomers (Van den Steen et al., 2006). There is 
evidence that the hemopexin domain in MMP9 can participate in 
dimerization/polymerization via non-covalent and mainly hydrophobic interactions 
(Bjorklund et al., 2004; Cha et al., 2002) 
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TGF=transforming growth factor ; TNF=tunor necrosis factor ; IL-1=interleukin-1; LPS=lipopolysaccharide; EGF=epithelial growth factor;  PDGF=platelet derived 
growth factor; LIF=leukemia inhibitory factor; WBC=white blood cell; 
# 
Reduced 
Ref.  1. Woessner, 1991;    2. Matrisian, 1992 ;    3. Dollery et al., 1995;   4. Sato et al, 1997;   5. Li et al, 2000;   6. Sethi et al, 2000  














MMP-1 55 52 









MMP-8 75 58 Collagen I, II, III, proteoglycans MMP-3, -7, -10 TNFα, IL-1β. 
Collagenase 3 MMP-13 65 55 






Gelatinase A MMP-2 65/72# 58/66# 
Gelatin, laminin, Collagen I, IV, V, 
VII, XI, fibronectin, elastin 
MT-MMP TGFβ 
Gelatinase B MMP-9 92 84 






Stromelysin 1 MMP-3 57 46 
Collagen II, III, IV, V, IX, X, XI, 
laminin, fibronectin, elastin, gelatin, 





Stromelysin 2 MMP-10 57 46 Similar to stromelysin 1   
Stromelysin 3 MMP-11 51 44 
Gelatin, fibronectin, proteoglycans, 




MMP-7 28 19 
Gelatin, fibronectin, laminin, 




MT1-MMP MMP-14 64 54 
ProMMP-2, proMMP-13, collagens, 





MT2-MMP MMP-15 72 61 Similar to  MT1-MMP   
MT3-MMP MMP-16 66 55 ProMMP-2   
MT4-MMP MMP-17 ? 54 ProMMP-2   
MT5-MMP MMP-24 63 62 ProMMP2   
Others Matrilysin MMP-7 28 20 
Collagen IV, PCP, fibronectin, 
gelatin 
  




1.3.3.3 Control and regulation of MMP activity 
 Regulatory control of MMP function is complex and occurs at three levels of 
transcription, activation of latent proenzymes, and inhibition of proteolytic activity. A 
number of cytokines and growth factors have been shown to stimulate the synthesis 
of MMPs including interleukin-1 (IL-1), platelet-derived growth factor (PDGF), and 
tumor necrosis factor- (TNF-), whereas others, such as transforming growth 
factor- (TGF-), heparin, and corticosteroids, have an inhibitory effect  (Table 1.1) 
(Nagase, 1996; Sethi et al., 2000). In addition, cell-matrix and cell-cell interactions 
are also involved in MMP gene expression (Biswas et al., 1995; Malik et al., 1996; 
Tremble et al., 1994).  
 
1.3.3.3.1 General activation of MMPs 
 MMPs are secreted as latent pro-enzymes and are activated by the loss of a 
N-terminal pro-peptide sequence of about 80 amino acids (Bode et al., 2003). A 
cysteine in the pro-domain coordinates with the zinc ion at the catalytic site and 
thereby occludes the active site (Elkins et al., 2002; Morgunova et al., 1999). The 
catalytic zinc is situated in a shallow cleft and accessibility (after removal of the pro-
peptide) will determine substrate specificity for proteolysis (Solomon et al., 2007).   
 Pro-MMPs are normally activated in vivo by other proteases such as tissue 
kallikrein, trypsin, and other MMPs (Ra et al., 2007). As stated earlier, activation 
involves the dissociation of the cystein from the active site zinc ion followed by 
sequential removal of the pro-peptide. Pro-MMPs can also be activated in-vitro by 
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aminophenyl mercuric acetate (APMA) and other S-reactive reagents and with 
reactive oxygen species and detergents.  In the case of APMA, activation proceeds 
to the removal of the pro-peptide whereas sodium dodecyl sulphate (SDS) exposure 
leads to enhanced proteolytic activity without loss of the pro-peptide. 
 Latent pro-MMPs can be activated by plasmin in the urokinase-plasminogen 
cascade (Murphy et al., 1992; Nagase et al., 1990; Sperti et al., 1992). The role of 
urokinase plasminogen activator (uPA) and its specific receptor (uPA-r) and 
inhibitors (PAI) has been studied in relation to tissue invasion and cell surface 
proteolysis (Liotta et al., 1991). The binding and activation of uPA on its receptor 
appears to provide a mechanism for localizing proteolytic activity at the leading edge 
of the invading cell (Kirchheimer et al., 1989). Urokinase converts plasminogen, a 
component of plasma and interstitial fluids, into the active enzyme plasmin. Plasmin 
can recognize and cleave basic resides in the ‘pro’ domain of both collagenase and 
stromelysin enzymes resulting in activation of the enzymes. Activated stromelysin is 
autoproteolytic and cleaves itself at the phenylalanine residue at position 98, 
removing the entire ‘pro’ domain and resulting in a permanently active, low molecular 
weight form of the enzyme. Plasmin activation of collagenase makes this enzyme 
more susceptible to proteolytic cleavage by stromelysin (Nagase et al., 1991).   
 
1.3.3.3.2 Allosteric control of MMP activity 
 The activity of MMPs can also be regulated by allosteric control. Allosteric 
control means the ability to modify the activity of an enzyme by protein and ligand 
interactions at sites away from the catalytic site. The modular construction of pro-
MMPs appears to be ideal for exercising such control. In pro-MMP9, the molecule is 
73 
 
thought to possess an elongated structure consisting of two globular domains 
separated by an unstructured and flexible 3nm long O-glycosylated (OG) domain 
(Rosenblum et al., 2010). This flexibility allows varied conformational states that may 
be important in its activation and proteolytic function. The flexibility of the OG region 
means that the terminal domains have independent movement allowing protein-
substrate interactions such as enzyme translocation on collagen fibrils (Overall et al., 
2007; Rosenblum et al., 2010). The allosteric control is also thought to underlie the 
dimerization of MMP9 via the hemopexin and linker domains (Van den Steen et al., 
2006). 
 In the proteolytic cleavage of pro-MMP9 by kallikrein, the binding of kallikrein 
results in the disruption of the cystein mediated complexation of the active site zinc 
ion followed by proteolysis (Rosenblum et al., 2010). Similarly, allosteric interaction 
by β-hematin with the hemopexin region of MMP9 destabilises the enzyme through 
conformational changes progressing to autocatalysis (Geurts et al., 2008).  
 
1.3.3.3.3 Activation of pro-MMP2 
 Triple helical collagens are resistant to proteolysis by most proteases but 
MMP2 is one of five collagenases capable of attacking such structures. Triple helices 
are generally broken into 3/4 and 1/4 fragments that can then be degraded by other 
MMPs. MMP2 contains a fibronectin repeat domain (FRD) for binding to collagen 
and gelatin and results in unwinding of the triple helix (Gioia et al., 2007; Tam et al., 
2004). The catalytic and hemopexin domains work together to unwind triple-helical 




 The activation mechanism of pro-MMP2 on the basolateral surface of the RPE 
has been investigated. Activation requires, in addition to membrane bound MT14, 
free and mobile levels of TIMP2 and pro-MMP2 (Butler et al., 1998; Strongin et al., 
1995). The mechanism requires two molecules of MMP14; the first MMP14 molecule 
binds TIMP2 and this enables the formation of the ternary complex with pro-MMP2. 
A second MMP14 molecule then cleaves the pro-form to release active MMP2. Thus, 
efficient activation requires the presence of MMPs and TIMPs in optimum 
concentrations near the basolateral surface of the RPE. Age related alterations that 
reduce the free level of MMPs are therefore likely to compromise the activation of the 
MMP degradation system. 
 
1.3.3.3.4 Tissue inhibitors of matrix metalloproteinases (TIMPs) 
 The proteolytic activity of MMPs can be inhibited by a 1:1 noncovalent binding 
to a family of protein inhibitors called TIMPs. TIMPS inhibit MMPs by inserting a 
conserved anchor into the active site of the target MMP. It should be noted that in 
plasma, inhibition of MMPs can also occur on binding to several proteins such as a2-
macroglobulin (Birkedal-Hansen et al., 1993; Woessner, 1991). TIMP1, TIMP2, and 
TIMP4 are present in soluble forms, but TIMP3 is unique in that it is insoluble and 
bound to the extracellular matrix (Leco et al., 1994). 
 Members of the TIMP family show about 40% sequence homology (Murate et 
al., 1999; Murphy et al., 1995). All TIMP’s possess 12 cysteine residues in 
conserved regions of the molecule, forming six disulfide bonds that are essential for 
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maintaining the correct tertiary structure of the molecule. They also contain an amino 
terminal group that is responsible for inhibiting MMP activity and a C-terminal that 
controls autocatalytic activation (DeClerck et al., 1993; Gomez et al., 1997; Murphy 
et al., 1991). TIMPs consist of between 184 (TIMP1, MW 25-36 kDa) and 194 amino 
acid residues (TIMP2) and apart from TIMP1 that is heavily glycosylated, the other 
members have been isolated in unglycosylated forms (TIMPs 2, -3; MW 21 kDa) (De 
Clerck et al., 1989; Goldberg et al., 1989; Pavloff et al., 1992; Stricklin et al., 1983).  
 TIMPs can also be regulated at the transcriptional level. For example, 
interleukin-1ß (IL-1 ß ) and phorbol esters (PMA) stimulate TIMP-1 expression in 
cultured human fibroblasts (Overall, 1994), whereas TGF-1ß  and retinoids 
downregulate the expression of TIMP1 (Clark et al., 1987; Overall et al., 1991). In 
RPE cells, expression of MMP’s and TIMP’s is upregulated by phorbol (Alexander et 
al., 1990).  
 The TIMP1 gene has a TATA-less promoter which contains multiple 
responsive elements that respond to cytokines and many other agents (Campbell et 
al., 1991; Edwards et al., 1992). In contrast to the highly stimulus-responsive TIMP1 
promoter, the TIMP2 promoter is unresponsive to cytokines (Shapiro et al., 1992). 
Like TIMP1, TIMP3 can be regulated in vitro by an array of stimuli that influence 
ECM remodelling, including a tumor promoter, growth factors, cytokines and anti-
inflammatory agents, and show that the on/off transcription kinetics are faster for 
TIMP3 than for TIMP1 (Leco et al., 1994).  
 In summary, there are three situations where the regulation of MMPs is 
required. Firstly, MMPs are required at the leading edge of an invasive cell so that 
the ECM in front can be disassembled allowing the transit of the cell. Localised 
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transcriptional activation can then furnish large quantities of activated MMPs at the 
site of required action. Excessive MMPs at the locality can thus overcome the low 
endogenous presence of TIMPs. The potential for damage from the leakage of active 
MMPs away from the site of action is then combated by presence of TIMPs and 
other plasma inhibitory factors such as a2-macroglobulin (Birkedal-Hansen et al., 
1993; Woessner, 1991). Secondly, activated MMPs may be released continuously to 
maintain a tightly coupled cycle of synthesis and degradation in order to continually 
renew the ECM despite the presence/absence of damaged elements. The basal 
release and activation of MMP2 has often been thought of contributing to this 
constitutive process in Bruch’s membrane. Thirdly, MMPs may be released in 
response to damaging stimuli generated from the ageing process but very little is 
known of the mechanisms involved.     
 
1.3.4 MMPs and TIMPs in ageing and retinal degeneration 
 In vitro serial subcultivation (mimicking ageing) of human fibroblasts has 
shown that basal levels of mRNAs encoding collagenase and stromelysin enzymes 
increase (Millis et al., 1992). Similarly, synthesis and secretion rates of pro-
collagenase and pro-stromelysin proteins are elevated in the late-passage 
(senescent) compared to early-passage (young) cells (Bauer et al., 1985; Bauer et 
al., 1986; Millis et al., 1992). However, the expression of TIMP1 mRNA was lower in 
aged compared to younger cells. Interestingly, the changes in MMPs and TIMP1 
associated with ageing cells were also observed in Werner syndrome, a condition of 
premature senescence (Millis et al., 1992; Sottile et al., 1989). In contrast to TIMP1, 
TIMP2 mRNA and protein levels increased in aging fibroblast cells and were 
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accompanied by an increase in levels of newly synthesized MMP2-TIMP2 
complexes (Zeng et al., 1994). Cultured human RPE cells also exhibit an age-related 
increase of MMP2 in late-passage (Padgett et al., 1997). 
 Ageing of Bruch’s membrane was associated with an increase in the level of 
proMMPs 2&9 (Guo et al., 1999). Levels of active MMP2 were frequently observed in 
the periphery but rarely at macular locations. This may reflect slower ageing in the 
periphery similar to the slower decline in transport functions mentioned earlier. 
 Both levels of TIMP3 protein and MMP-inhibitory activity showed an age-
dependent increase in the human RPE-choroid complex (Kamei et al., 1999). In 
addition, immunoreactivity for TIMP3 was intense across Bruch’s membrane in AMD 
and other retinal degenerative diseases such as retinitis pigmentosa and Sorsby’s 
fundus dystrophy (SFD) (Fariss et al., 1998; Kamei et al., 1999). 
 
1.3.4.1 Altered expression of TIMP3 in Sorsby’s 
 Sorsby’s fundus dystrophy (SFD) is an early-onset, inherited retinal 
degeneration. The clinical features are similar to AMD but with earlier onset of 
symptoms leading to loss of central vision. Mutations in the TIMP3 gene of patients 
with this rare disorder associated with accumulation of lipid-rich extracellular 
deposits and characterized by thickening of Bruch’s membrane (Fariss et al., 1998; 
Weber et al., 1994). TIMP3 is synthesized and secreted by the RPE and is present in 
normal Bruch’s membrane. Sorsby’s patients showed extensive accumulation of 
TIMP3 in thickened Bruch’s (Fariss et al., 1998). Overexpression of TIMP3 may 
affect degradative processes for matrix turnover and cause lipid-rich deposition in 
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SFD. This rare hereditary disorder demonstrates the importance of tightly regulated 
homeostatic turnover of the ECM for maintaining the integrity of Bruch’s membrane.  
 
1.3.4.2 MMP9 polymorphisms in AMD 
 Previous reports have shown reduced levels of active MMP2 and MMP9 in 
macular regions of human Bruch’s membrane in comparison to peripheral regions 
(Guo et al., 1999). Pro-MMP enzymes need activation for catalytic function and 
reduction of active forms in aging Bruch’s implies dysfunctional turnover of the 
membrane. Although active MMPs were reduced, their pro-forms showed an age-
dependent increase (Guo et al., 1999).  
 Transcriptional levels of MMP9 are regulated by polymorphisms in the 
promoter region of the MMP9 gene (Peters et al., 1999; Shimajiri et al., 1999; Ye, 
2000). The polymorphisms are in the microsatellite region with variations in the 
number of Cytosine-Adenine (CA) repeats. In animal models, the number of CA 
repeats correlates with level of gene expression. MMP9 activities were reduced to 50% 
when the number of CA repeats was shortened from 21 to 14 (Shimajiri et al., 1999). 
Furthermore, in mesangial cells, MMP promoter carrying 24 CA repeats showed 
more than 20 times higher expression compared to 20 repeats (Fornoni et al., 2002). 
An association between exudative AMD and number of CA repeats in the MMP9 
promoter region has been reported. Longer microsatellites with 22 repeats or more 
CA repeats were associated with exudative AMD patients (Fiotti et al., 2005). This 
association between the higher CA repeats and AMD could explain the raised levels 
of plasma MMP9 in these patients (Chau et al., 2008).   
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1.4 Problems prior to the commencement of this thesis 
 Although previous studies had identified the importance of two MMP species 
in the age-related modulation of the structure of Bruch's membrane, an 
understanding of age related changes in such molecules and consequences for 
transport mechanisms were effectively unknown. Specifically the following problems 
required empirical studies in order to elucidate their relative importance.   
 
1. Previous work had shown the presence of high molecular weight species 
(HMW1&2) in human Bruch's but their monomeric composition and physiological 
significance to the remodeling process of the membrane was not known.  
 
2. The existence of a dynamic equilibrium between free and bound MMP species, 
crucial in determining the level of pro-MMPs available for activation was unknown. 
Therefore the likely impact of age-related alterations in these compartments on the 
operation of the MMP system could not be ascertained. 
 
3. Despite the presence of micro-satellite polymorphisms in the promoter region of 
the MMP9 gene and elevated levels of plasma pro-MMP9 levels in AMD patients, 
corresponding alterations in and likely effects on the MMP system of Bruch’s 




4. The inter-relationships between the various gelatinase species in normal and AMD 
Bruch’s were unknown. 
 
5. The relevance of excessive deposition of divalent metals in Bruch’s and choroid of 
elderly and AMD donors on the structural and functional characteristics of the 
membrane was unclear. A better understanding is a prerequisite for contemplating 















1.5 AIMS of the thesis 
 The overall aim of this thesis was to explore the major enzymatic frame work 
involved in the processes that maintain Bruch's membrane as a functional entity over 
a human life span. In order to facilitate such an understanding, it was deemed 
important to identify age-related changes in the level of individual MMP species and 
their inter-compartmental distribution together with the degree of sequestration that 
would be expected to impact on the activation of MMPs and therefore on the 
transportation properties of Bruch’s membrane. An understanding of the MMP 
pathway and its alteration due to the advanced ageing process in AMD is an 
essential prerequisite for developing strategies for therapeutic intervention. Specific 
aims were as follows:  
 
To understand the gelatinase system of Bruch's so as to allow therapeutic 
modulation to address the age-related failure in the transport properties of the 
membrane. 
 To quantify age-related changes in the spectrum of gelatinases within human 
Bruch’s membrane by utilising gelatin zymography 
 To determine the equilibrium between bound and free level of individual 
gelatinase species using perfusion techniques 
 To determine the gelatinase composition of the high molecular weight (HMW1 
and HMW2) species by fragment analyses 
 To determine the gelatinase composition of the high molecular weight (HMW1 




To quantify changes in the gelatinase system of Bruch’s in both normal ageing 
and in AMD. 
 Using the above, to construct the gelatinase pathway of Bruch’s membrane to 
describe the age-related changes in individual components of the MMP 
system 
 To evaluate the role of the gelatinase pathway, if any, in the pathophysiology 
of age-related macular degeneration (AMD) 
 
To assess the potential for modulating the gelatinase system of Bruch's 
membrane in an effort to delay the ageing process. 
 To assess the possibility of disturbing the free-bound equilibrium to cause the 
release of monomeric (pro and active) MMP species using a divalent metal 
chelator in order to improve transport through the membrane 
 To assess the potential of enhancing the hydraulic conductivity of Bruch’s 















































 The matrix metalloproteinase (MMP) system plays an important role as the 
degradation arm of a continuously remodelling process that renews the extracellular 
matrix of Bruch’s membrane. The gelatinase component of the MMP system, 
comprising pro-MMPs 2 & 9, has been shown to be secreted by both RPE and 
choroidal endothelium cells and its presence in Bruch’s has been demonstrated 
(Alexander et al., 1990; Guo et al., 1999; Hunt et al., 1993; Vranka et al., 1997). 
 The pro-MMPs are inactive or latent enzymes that are normally activated 
physiologically by removal of an inhibitory pro-peptide of about 10 kDa (Ahir et al., 
2002; Matrisian, 1992; Murphy et al., 1997). However, on exposure to sodium 
dodecyl sulphate (SDS), the enzymes undergo conformational changes leading to 
partial activation without loss of the inhibitory pro-peptide. Thus on gelatin 
zymography, these pro-MMPs 2 & 9 can be detected by their proteolytic action on 
the gelatin substrate and display molecular weights of 92 and 65 kDa respectively 
(Guo et al., 1999). In the laboratory, the pro-peptide can also be removed with thiol 
reacting agents such as aminophenyl mercuric acetate (APMA) leading to full 
activation (Brown et al., 1994; Woessner, 1991).  
 Transition to activated forms occurs via a series of intermediate structures. 
Thus for pro-MMP9 (MW 92 kDa), a transitory 88 kDa active form is observed 
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followed by its conversion to the fully activated 84 kDa enzyme. The 65 kDa pro-
MMP2 enzyme is converted to the fully activated 58 kDa form, with the occasional 
presence of the partially activated 61kDa species (Ahir et al., 2002; Guo et al., 1999). 
 In aqueous solutions, MMPs can undergo dimerisation and polymerisation by 
non-covalent interactions but the physiological significance of this conversion is not 
known (Goldberg et al., 1992; Guo et al., 1999; Lim et al., 1997). There is some 
evidence that dimerisation can significantly reduce the rate of activation of pro-
MMP9 by MMP3 (Olson et al., 2000). Because of the non-covalent nature of the 
interaction, such polymeric species are reduced to their monomeric states during 
preparation and processing for zymography. Thus these loosely associated 
polymeric forms cannot be detected as intact complexes by zymography. 
 Presence of additional gelatinase species, of much higher molecular weight 
than the pro-MMPs 2 & 9, have been shown on zymographic gels. Their existence in 
zymographic gels shows that the dimeric or polymeric forms must be stabilised by 
covalent bonding. In canine brain specimens, an additional gelatinase was 
characterised by a molecular weight 280 kDa. In human brain specimens from 
donors with Alzheimers disease, the presence of two high molecular weight species, 
130 and 280 kDa has also been documented. The 280 kDa species was shown to 
react positively to MMP9 antibodies but the likelihood of the additional presence of 
MMP2 was not investigated. Interestingly, APMA activation resulted in reduction of 
molecular weight to 270 kDa (Lim et al., 1997). Thus it would appear that only one 
MMP9 or MMP2 molecule in this complex was accessible to activation. This result 
suggests that the other molecules in this complex were protected from activation and 
may have implications for physiological activation. 
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 Human Bruch’s-choroid has also been shown to house two high molecular 
weight MMP species running at 225 and 130 kDa (Guo et al., 1999). APMA 
activation resulted in a reduction in molecular weight in both species. The 
combination of APMA activation and reduction and alkylation resulted in loss of high 
molecular weight species with an increase in the amount of activated MMP9 
indicating the presence of this monomer in the intact complex. 
 The gelatinase system has been implicated in the structural and functional 
demise of ageing human Bruch’s membrane. This largely arose from the 
demonstration of accumulation of altered and denatured collagen in ageing Bruch’s 
suggestive of a dysfunctional MMP system (Karwatowski et al., 1995). The concept 
was further supported by the observation that active forms of MMP2 were frequently 
present in peripheral locations but only occasionally in macular regions (Guo et al., 
1999). Similarly, levels of TIMP3 and AGEs were elevated in ageing Bruch’s, the 
former being a natural inhibitor and the latter known to compromise the proteolytic 
activity of MMPs (Haas et al., 1998; Kamei et al., 1999; Rittie et al., 1999; Scott et al., 
1998). 
 An understanding of the mechanisms that compromise the activity of the 
gelatinase system requires a knowledge of the participating species, their 
interactions such as monomer to polymer formation (and hence sequestration of 
activity), and their compartmentalisation between bound and free states since this 
will control the amount of pro-enzyme available for activation. A previous study has 
reported that the levels of both pro-MMPs 2&9 increased with age. But in this study, 
only MMPs that could be extracted with Tris-HCl buffer containing 0.25% Triton X-
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100 were quantified without any evaluation of the amount in the bound form (Guo et 
al., 1999). 
 The present study was designed to characterise all the gelatinase species in 
human Bruch’s-choroid with respect to their molecular weights, to determine the 
level of bound and free enzymes as a function of age, and to analyze the 
composition of the high molecular weight species with respect to their monomeric 
constitution. 
 ELISA techniques are normally used to quantify the level of specific proteins 
in a tissue extract but these are not applicable for the determination of gelatinase 
species for the following reasons. Firstly, the antibodies often cross-react and 
secondly they cannot differentiate between pro- and active forms of the gelatinases. 
Thirdly, antibodies specific to the high molecular weight forms have not yet been 
manufactured. Quantitative zymography is the only technique currently available that 
can separate all the gelatinase species. Complications that can arise from instability 
of MMPs under SDS denaturing conditions, and from variations in background 
staining and gel-to-gel variation were first addressed followed by quantification of 









2.2.1 Tissue preparation 
 Human donor eyes were obtained from Bristol Eye Bank (Bristol, UK). Eyes 
with corneas removed for transplantation surgery were delivered in saline filled 
containers packed in ice, within 72 hours post-mortem time. Previous studies had 
shown structural and functional integrity of Bruch’s and RPE for a period of up to 72 
hours post-mortem (Hussain et al., 1985; Moore et al., 1995). Of the 29 donor eyes 
used in the ageing study (age range 21-99 years), post-mortem times were 36 hours 
for two donors, 57 hours for one donor, and the remainder were within the 37 to 50 
hours.  
 A circumferential incision was made to remove the remaining anterior portion 
of the globe. The fundus was examined with a dissecting microscope to ensure that 
it was free from gross handling artefacts. An eight millimetre full thickness trephine, 
centred on the fovea, was removed for other on-going studies. A similar full 
thickness trephine was obtained from the peripheral region along an imaginary line 
lying on the meridian joining the fovea, optic disc, and the cut edges of the globe and 
used in the ageing study. 
 The isolated tissue discs were transferred to a Petri dish containing PBS with 
an antibiotic / antimycotic mixture (Sigma-Aldrich, Poole, UK). Retinal tissue was 
removed from the tissue button with fine forceps and the RPE cells were gently 
brushed away with a camel’s hair brush. The Bruch’s-choroid preparation was gently 
isolated from the underlying sclera with blunt forceps. The remaining globe was cut 
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into quadrants and peripheral Bruch’s choroid isolated in a similar fashion and stored 
at –70ºC.  
 
2.2.2 Zymographic analyses 
 The zymographic gels used in this study were 10 % SDS PAGE (1mm thick) 
containing a 4 % stacking layer and 0.1 % gelatin in the separating layer. Samples 
prepared in non-reducing SDS sample buffer were applied to the gel lanes together 
with prestained protein molecular weight markers (Invitrogen, Paisley, UK) and 20 % 
fetal calf serum (FCS, Sigma-Aldrich) acting as an internal standard to correct for 
gel-to-gel variation in background staining. Electrophoresis was performed with the 
X-Cell SureLock Mini-Cell system (Invitrogen, UK).  
 After electrophoresis (150 V, 1 hour), gel cassettes were removed from the 
electrophoretic apparatus, gels carefully removed and following a quick rinse in 
distilled water, incubated for two half hour periods in 2.5 % Triton X-100 solution to 
remove SDS and re-nature the enzymes. Gels were then transferred to reaction 
buffer (50 mM Tris-HCL, 10 mM CaCl2, 75 mM NaCl, and 0.02 % NaN3, pH 7.4) and 
incubated at 37 ºC for 18 hours to allow digestion of the gelatin substrate. After 
incubation, gels were rinsed in distilled water and stained with SimplyBlue SafeStain 
(Invitrogen, UK) containing Coomassie G-250 for three hours. Destaining was 
carried out in distilled water for 1.5 hours.  
 Proteolytic activity of gelatinases was observed as clear bands on a blue 
background. The gels were scanned at a resolution of 2400 dpi (Epsom 3490 
scanner; Surrey, UK) and stored in JPEG format. The scanned colour files were 
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uploaded into the gel analysis software package in greyscale format (Quantiscan, 
version 3.0; Biosoft, Cambridge, UK). Before analysis, colours were inverted and 
MMPs were then visualised as dark bands against a whitish background. Following 
software mediated background subtraction, the area under individual gelatinase 
bands was quantified. The pro-MMP9 band of the foetal calf serum sample was used 
as a reference for normalization, because the MMP2 band was often distorted and 
skewed. Areas representing individual gelatinase bands were normalized with 
respect to the area of the control FCS pro-MMP9 band and further corrected for 
dilution, and MMP activities calculated as densitometric area per 8-mm disc of tissue.  
 
2.2.2.1 Variable parameters in quantitative zymography 
 Key parameters influencing the observed activity of gelatinases in 
zymographic gels are (i) stability of enzyme in the presence of SDS buffers, (ii) 
incubation time for hydrolysis of gel-embedded gelatin, (iii) variation in gel-to-gel 
running times during electrophoresis and (iv) variations in background and band 
staining between gels.  
 Tissue samples used for the assessment of these variables utilised quadrants 
from one or several eyes. Pooled tissue samples were macerated using a pestle and 
mortar in Tris-HCl buffer (100mM Tris, 0.15M NaCl, 10mM CaCl2, 0.02% sodium 
azide, pH 7.5). The extract was centrifuged at 10,000g for five minutes and the 
supernatant removed for analysis. Depending on the number of eyes used, the 




2.2.2.1.1 Stability of MMP activity in SDS buffers 
 MMP extracts mixed with SDS sample buffer and left overnight (at 4ºC) were 
found to have lost all proteolytic activity (data not shown). Thus time-dependency of 
exposure to SDS is a factor that should be considered during zymographic runs. 
Generally, extracts mixed with non-reducing SDS sample buffers are loaded onto 
zymographic gels immediately or within 5-10 minutes. With a large number of 
samples for analysis and the need for loading several gels, this period could vary up 
to 30 minutes. Furthermore, the electrophoretic run itself would take about 1 hour 
during which time the enzymes would also be exposed to SDS. 
 Thus stability of MMPs was assessed covering an exposure period to SDS 
sample buffer of 0-2 hours. For this study, the MMP extract was obtained from one 
eye (donor aged 67 years). After the relevant incubation period, samples were 
loaded into gel lanes for zymography. 
 
2.2.2.1.2 Use of foetal calf serum to control for gel-to-gel variation 
 Gel-to-gel variation in expressed proteolytic activity can be controlled by 
incorporating known amounts of purified enzyme on each gel. However, 
commercially available gelatinases show variable ratios for active/inactive species 
and activities deteriorate considerably on storage. Foetal calf serum (FCS) on the 
other hand only contains inactive pro-MMPs 2&9 and has therefore been utilised as 
an internal control in zymographic runs. FCS also deteriorates on storage with aged 
samples showing broadening and skewing of pro-MMP2 bands and the emergence 
of high molecular weight species. There is also batch-to-batch variation. Once 
thawed and aliquotted, a new FCS batch nevertheless maintains the band intensity 
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for pro-MMP9 for about a month. Thus, FCS working solutions need to be renewed 
each month. 
 For standard zymographic estimations, gels after electrophoresis are 
incubated for 18 hours to allow proteolytic digestion of gelatin. Slight variations in the 
thickness of the gels, temperature fluctuations over the 18-hour incubation period, 
and variations in destaining time resulting in background alterations all lead to 
complications in quantitative zymography.  
 To assess the effectiveness of incorporating an internal FCS control to 
normalise for these variations, four identical gels were prepared incorporating FCS 
and tissue extracts but each gel was incubated for different times and staining and 
destaining periods were also varied randomly. Extracts were obtained from three 
donor eyes (age range 56 – 67 years), mixed with an equal volume of SDS sample 
buffer, and after electrophoresis, individual gels were incubated for 13, 16, 18 and 22 
hours. The stained gels were scanned and the Quantiscan software used to subtract 
background and calculate the areas under individual gelatinase bands. The 
effectiveness of using FCS as an internal standard to correct for variations in gel 
band intensities was assessed. 
   
2.2.2.1.3 Linearity between enzyme activity and band area 
 For quantitative work it is important to establish a relationship between 
amount of enzyme and corresponding area under the gelatinase band. A linear 
relationship is ideal but a non-linear relationship can also be used for quantitative 
purposes. Serial dilutions of both FCS and a tissue extract were run on zymographic 
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gels and the relationship between the amount of enzyme within each lane and the 
resulting area under individual gelatinase bands investigated. 
 
2.2.3 Gelatinase species of human Bruch’s-choroid 
 A tissue extract was obtained from two pairs of donor eyes (ages 75 & 83) 
and after mixing with an equal volume of SDS sample buffer, 10, 15, and 20ul 
aliquots were applied to lanes. A high range multicoloured molecular weight standard 
(71-500 kDa, Invitrogen) was also incorporated. After electrophoresis, the gel was 
photographed to obtain a record of the positions of the molecular weight standards. 
The gel was then developed in incubation buffer and after staining and scanning, the 
migratory distances of individual gelatinase species were obtained. Migratory 
distances of the standard molecular weights were also obtained. Logarithmic plots 
were then constructed to calculate the molecular weights of the individual gelatinase 
species. 
 
2.2.4 Fragment analyses of high molecular weight gelatinase species 
 Previous studies had shown that the high molecular weight species 
disappeared from the zymographic gels when samples were pre-treated with APMA 
alone or in combination with reduction and alkylation (Guo et al., 1999; Lim et al., 
1997). This procedure was repeated to confirm that the high molecular weight 
species could be fragmented. Next, an attempt was made to break up these species 





2.2.4.1 Activation of gelatinase species 
 Altogether, Bruch’s-choroid preparations from 11 human donor eyes (age 
range 58-91 years) were macerated in a pestle and mortar and the suspension 
centrifuged at 10000g for 5 minutes to yield a MMP extract of 3.5 mls.  
 The following solutions were prepared for APMA activation, reduction and 
alkylation. A 20 mM solution of APMA was made by dissolving 0.07g in 0.1 ml 
DMSO and making up the volume to 10.0 mls with 0.1 N NaOH. Dithiothreitol (DTT, 
20mM) was made by dissolving 0.03 g in 10.0 mls of Tris-HCl buffer. A 50 mM 
solution of iodoacetate (IAA) was made by dissolving 0.093 g in 10.0 mls of Tris-HCl 
buffer. 
 Two test tubes, each containing 0.75mls of tissue extract were pre-incubated 
at 37oC for 15 minutes. 0.25 mls of Tris-HCl buffer was added to one of the tubes to 
act as control. APMA activation was initiated in the other tube by the addition of 
0.05mls of 20mM APMA solution (final concentration 1mM). Following an incubation 
period of 1 hour, 0.1ml DTT solution was added to reduce the sample giving a final 
concentration of 2.0mM. After an incubation period of 30 minutes, 0.1 ml IAA (final 
concentration, 5mM) was added with a further incubation of 30 minutes.  
 At the end of the incubation period, both tubes were placed in an ice-bath for 
further processing. Each sample (40µl) was added to 40µl of SDS sample buffer and 





2.2.4.2 Fragment analysis using double electrophoretic separation 
 Activation by APMA results in the dissolution of the high molecular weight 
species as observed by gelatin zymography. If these complexes break up into their 
respective monomeric species, then it should be possible to identify the resulting 
species. 
 A single lane zymographic gel was prepared and 200µl of tissue extract was 
mixed with 200µl of non-reducing SDS sample buffer and the whole mixture layered 
into the single lane. Electrophoresis was carried out and the MMP enzymes re-
natured by incubation in 2.5% Triton X-100 for 1 hour. The gel was then cut in two, 
one-half acting as control and the other half activated/reduced/alkylated as described 
in section 2.2.4.1. Thus the control half should have intact high molecular weight 
complexes whilst in the other half, the regions normally occupied by high molecular 
weight species should now contain the constituent monomeric species. 
 Thin slithers of the gel (40mm x 5mm) containing all the gelatinase species 
were cut out and mixed with non-reducing SDS buffer for 10 minutes (Figure 2.1). 
These were loaded onto a gelatin zymography gel containing only the separating 
layer. Electrophoresis was performed a second time and the gel processed for 





Figure 2.1 Schematic representation of the double electrophoretic procedure. 
 
2.2.5 Subunit characterisation of high molecular weight species by 
Western blots 
 Four 8 mm peripheral trephines from each eye were pooled and homogenized 
in Tris-HCl buffer. They were centrifuged at 10,000 rpm for 30 minutes at 4 °C and 
supernatant was collected for analysis. The samples were subjected to SDS-PAGE. 
10 % SDS-PAGE gels (1 mm thick) containing a 4 % stacking layer were prepared. 
Samples were loaded into lanes with ColorBurst Markers (Invitrogen, UK). 
Electrophoresis was performed for 1 hour at 150 V using the X Cell SureLock mini-
Cell system (Invitrogen). Following electrophoresis, the gels were removed from their 
cassettes and rinsed in distilled water.  
 Proteins within the gel were transferred to nitrocellulose sheets by the iBlot 
Dry blotting system (Invitrogen, UK). The iBlot Anode Stack was placed in the bottom 
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and the pre-run gel was put on the transfer membrane of the anode stack. A water 
soaked iBlot sheet of filter paper was placed on top of the gel. Air bubbles present 
between the membrane and gel were removed by the Blotting Roller. The iBlot 
Cathode Stack was placed on top of the filter paper with the copper electrode sheet 
facing uppermost. Good electrical contact was again achieved by use of the roller. 
To remove extra solution during the performance, an iBlot disposable sponge was 
placed on the inner side of the lid.  
 Pilot experiments with transfer of FCS proteins carried out at 20 V running 
voltage had shown the time required for efficient transfer was about 6-8 minutes. 
Thus for extracts of Bruch’s-choroid, a time of 7 minutes was chosen to carry out the 
transfer.  
 After the electrophoretic transfer, sponge and cathode stacks were discarded 
and the gel and filter paper carefully removed. The underlying nitrocellulose 
membrane was carefully removed and used for immunodetection or staining of 
proteins.  
 
2.2.6 Ageing changes in the gelatinase system of Bruch’s membrane 
 Free and bound pools of gelatinases of peripheral Bruch’s-choroid were 
obtained as follows. The 8mm diameter sample of Bruch’s-choroid was placed in an 
Eppendorf tube and 100 µl PBS added. The tube was vortexed every 5 minutes five 
times for a period of one minute. Tubes were then centrifuged for 5 minutes at 
10,000 g and the supernatant removed. Twenty microliters of the supernatant 
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representing the free pool of MMPs was mixed with 40 µl of non reducing SDS 
sample buffer and 20 µl of this mixture was loaded onto zymographic gels.  
 The remaining tissue button was washed several times with 1.0 ml aliquots of 
PBS and pilot analysis (not reported) did not show any further release of MMPs. 
After washing and a final centrifugation procedure, the pellet of tissue was 
reconstituted with 20 µl water and 40 µl non-reducing SDS sample buffer. Then 
samples were vortexed for five minutes and centrifuged as described above. Finally, 
20 µl of the supernatant, representing the bound or SDS-extracted fraction, was 
loaded onto zymographic gels. After controlling for gel-to-gel variation, the band 
areas for individual gelatinase species were plotted against the age of the 
corresponding donor. 
 
2.2.7 Statistical analysis 
 Standard linear and non-linear regression analysis was applied using a 
commercial statistical package (Fig-Sys, Biosoft, Cambridge, UK) that utilised the 
Marquardt-Levenberg algorithm. Statistical significance of the Pearson’s correlation 









2.3.1 Gelatinase species of human Bruch’s membrane 
 A zymogram of the releasable pool of gelatinase species extracted from 
Bruch’s-choroid preparations from two donors aged 75 and 83 years is shown in 
Figure 2.2. Altogether, six gelatinase species were discernable. Logarithmic plots of 
migratory distance versus molecular weight were used to characterise individual 
species (Figure 2.2B). As shown in several other studies, pro- and active forms of 
MMP9 were characterised by molecular weights of 92 and 84 kDa respectively. 
Active MMP9 was just about discernable in the releasable pool of MMPs in these 
donors. This releasable species was found to be absent in most donors assessed. 
Pro and active forms of MMP2 were characterised by molecular weights of 65 and 
58 kDa respectively. In addition, two high molecular weight species were routinely 
observed, running in these preparations with molecular weights of 150 and 348 kDa 
and now termed HMW1 and HMW2 respectively. A more comprehensive analysis of 
molecular weights determined individually and in pooled samples from several 
donors has provided molecular weights for HMW1 & 2 of 122 ± 9kDa and 344 ± 







Figure 2.2 The releasable pool of gelatinase species of Bruch's membrane. 
Bruch's-choroid was isolated from two pair of eyes (donor ages 75 & 83 years). After mixing with an equal volume of SDS 
sample buffer, 10, 15 and 20 ul were loaded into lanes 1, 2 &3 respectively. Altogether five gelatinase species were clearly 
identifiable. Log plots were used to calculate the molecular weights of HMW1 and HMW2 as 150 and 348 kDa respectively.  
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 The characteristic feature of matrix metalloproteinase is that they are Mn2+ 
containing, Ca2+ dependent proteases. Thus the removal of divalent ions results in 
inhibition of MMP activity. Incubation of gels in 10mM EDTA, to remove metal ions, 
confirmed that the high molecular weight species identified on zymographic gels of 








Figure 2.3 Effect of 10mM EDTA on the proteolytic activity of extracts of 
Bruch’s-choroid.  
A tissue extract of Bruch’s-choroid was prepared from two eyes of a donor aged 72 
years. The normal zymogram in (A) showed the presence of high molecular weight 
species, HMW1 &2. Incubation in the absence of divalent ions (B) resulted in loss of 
all gelatinolytic activity confirming the high molecular weight species as belonging to 












2.3.2 Parameters of quantitative zymography 
 The stability of MMP activity in SDS containing buffers, the relationship 
between enzyme activity and area under corresponding zymographic bands and the 
importance of including an internal standard to normalise for gel-to-gel variation has 
been addressed. 
 
2.3.2.1 MMP stability in SDS buffers 
 An MMP extract was obtained from frozen quadrants of Bruch’s-choroid from 
21 donors (age range 51-87 years). Aliquots were incubated with non-reducing SDS 
sample buffer for various periods in the range 0-2 hours. Triplicate zymographic gels 
were then run to assess the effect of exposure to SDS on enzyme activity (Figure 
2.4). The results show that the activity of all six gelatinase species was not altered 



























Figure 2.4 Effect of exposure period to SDS buffers on the proteolytic activity 
of MMPs extracted from human Bruch’s-choroid.  
(A) All six gelatinase species are clearly delineated on the zymograms. (B) 
Quantitative analysis of data obtained from three gels showing little (if any) variation 
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2.3.2.2 Relationship between enzyme levels and band areas on 
zymography 
 
 Demonstrating a relationship (linear or non-linear) between the amount of 
enzyme and the resulting densitometric area under the zymographic band is an 
essential requirement prior to use of the technique for quantitative zymography. It is 
also necessary to define the limits of enzyme activity over which a quantitative 
approach can be entertained. In the present study, FCS pro-MMP 2 & 9 enzymes 
were used as test probes. Pilot work varying the amount of FCS applied had shown 
that amounts greater than 1.5µl resulted in gross distortion and streaking of the pro-
MMP2 band. For quantitative purposes therefore, the amount of FCS applied was 
varied between 0 and 1.5 µl. A representative zymogram and quantitative analysis is 
depicted in Figure 2.5. The results show the potential for the use of zymography for 
quantitative applications. In all subsequent analyses, quantification was only 























Figure 2.5 Quantitative relationship between the amount of enzyme applied 
and the resulting band area on densitometric analysis for MMPs in FCS.  
(A) Zymogram showing progressive darkening of the pro-MMP9 band whereas the 
high levels of pro-MMP2 lead to considerable distortion. (B) Within the FCS range of 
0-1.5µl, a linear relationship was observed between enzyme level and corresponding 












2.3.2.3 FCS as internal standard to correct for gel-to-gel variation 
 The use of commercially available (and therefore standardized) ready-made 
gels and staining solutions minimizes the likelihood of gel-to-gel variation in staining 
of background and gel bands. Nevertheless, variations in incubation solutions, 
temperature fluctuations, extent of SDS removal during incubation with 2.5% Triton 
X-100, etc., can lead to gel-to-gel variations and must be taken into account if data 
from several gels is to be compared.  The use of an internal standard to cater for 
such fluctuations is always recommended.  
 FCS, incorporating pro-MMPs 2&9 is often used because of the stability and 
reproducibility of its MMP bands. To assess its usefulness, four gels were prepared 
each containing the same amount of FCS and a tissue extract (from 11 eyes, age 
range 67-82 years). After electrophoresis, gels were developed in zymographic 
buffer for periods of 13, 16, 18 and 22 hours and destained for various times to 
induce variability in both background and gel band staining intensity. The resulting 
zymograms are depicted in Figure 2.6. The zymogram labelled number 5 is identical 
to zymogram number 4 but has been scanned on a different scanner (Biorad). 
 As expected, band intensities have varied considerably because of the 
different incubation times. Within a given gel, the variation in intensity of MMP2 or 
MMP9 bands (run in triplicate lanes) in the FCS solutions was observed to be about 
4.7 ± 1.7%. In tissue samples, this variability was 6.6 ± 2%. 
 Development of zymograms is normally carried with an incubation period of 
18 hours. Thus, gel 3 (incubation time 18 hours) was selected as standard for 
comparison with the other gels. The raw data for levels of pro-MMPs 2&9 (after 
subtracting for background staining intensity) in the various gels is represented in 
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Figure 2.7A and as expected shows much variation between gels. Note also that the 
gel scanned on a different scanner (Biorad) showed abnormally low values.  
 The average area under the FCS MMP9 band (Astd) in gel 3 was taken as 
standard and the area under the gelanolytic bands in the other gels corrected as 
follows: 
Acorrected =[(Astd) / Atest) x (area under gel band)] 
where Atest  represents the area under the FCS  pro-MMP9 band in the test gel. The 
resulting corrections have been applied and are represented in Figure 2.7B. 
Following the corrections, the level of pro-MMP 2&9 activity is found to be similar in 
all the gels. Thus, despite variations in staining intensity/incubation conditions, the 
inclusion of FCS can assist in controlling gel variability. After correction, the gel to gel 
variability in the level of pro-MMP9 was determined to be 2.4%, due likely to the 
higher level and therefore accuracy in determining its area under the bands. With the 
low levels of pro-MMP2, errors increase in the accurate determination of areas, and 





Figure 2.6 Zymograms of FCS and Bruch’s-choroid tissue extracts developed 
for various times to induce variability in background and gel band staining. 





















Figure 2.7 Raw and corrected data for pro-MMP2&9. 
(A) Areas under the pro-MMP 2&9 bands were determined by Quantiscan analysis 
software (correcting for background intensity) for gels 1-5 of Figure 2.6. 
(B) Using the pro-MMP9 band of the FCS sample of Gel 3 as standard, all other 











2.3.3 HMW1 and HMW2 fragment analyses 
2.3.3.1 Activation of gelatinase species 
 A tissue extract was prepared from 11 donor eyes (age range 58-91 years) 
and aliquots were APMA activated, reduced and alkylated. The resulting zymograms 
and densitometric scans of individual lanes are depicted in Figure 2.8. Activation 
resulted in the complete loss of the HMW1 band and considerable loss of the HMW2 
band. These changes were associated with increases in the level of active MMPs 
2&9.  
 The increased levels of active enzymes could be due to conversion of 
endogenous pro-MMPs and from released monomers arising from the breakdown of 
HMW1 & 2. It could also be argued that these active forms arise from endogenous 
monomeric MMPS without much contribution from HMW1 & 2. Since activated forms 
should display increased gelatinase activity, the increased banding intensity may 
simply be a reflection of this process. Activation of a sample that does not contain 
much HMW1 & 2 would indicate how the monomeric species behave after activation.  
 Thus a sample of FCS was activated with APMA and the resulting zymogram 
is displayed in Figure 2.9. Although activation did not lead to the complete removal of 
pro-enzymes, partial conversion to activated forms is clearly discernable. In the case 
of pro-MMP2, loss of activity in the latent form does not appear to be fully translated 
into the activated form. Thus the large increase in activated MMPs 2 & 9 in Figure 
2.8 may well reflect a contribution from the loss of HMW1 & 2. 
 Further work to identify the components of the high molecular weight species 




Figure 2.8 Activation of gelatinase species. 
A concentrated extract was obtained from 11 eyes (donor age range 58-91 years) and on zymography showed the ample presence 
of all gelatinase species except active MMP9 (Con lanes). Activation resulted in the complete loss of HMW1 with a major reduction in 
the intensity of the HMW2 band. These changes were accompanied with an increase in the levels of activated MMPs2&9.  
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Figure 8. Activation of gelatinase species. A concentrated extract was obtained from 11 eyes (donor age range 58-91 
years) and on zymography showed the ample presence of all gelatinase species except active MMP9 (Con lanes). 
Activation resulted in the complete loss of HMW1 with a major reduction in the intensity of the HMW2 band. These 

















































































































Figure 2.9 APMA activation of FCS pro-MMPs 2 & 9.  
The (-) and (+) symbols represent samples as controls or APMA activated 
respectively. The procedure resulted in partial activation since some pro-MMP 
activity remained after the incubation. Nevertheless, the increased banding intensity 
of the activated forms was lower than the intensity loss of the pro-MMP bands. 
 
 
2.3.3.2 HMW fragment analysis using double electrophoretic 
separations  
 In the previous section, APMA activation resulted in the removal of the HMW 
species with an increase in the level of active MMPs 2&9. However, it was not 
certain how much of this increase was due to activation of HMW derived MMP 
species and how much due to activation of endogenous free pro-MMPs.  
 An alternate method to assess the contribution would be to separate the 
individual gelatinases species in a single lane gel by electrophoretic means. Then 
activating the HMW species whilst within the gel would be expected to release the 
monomeric species in the locality of the HMW regions within the gel. Removing a 









dimension shown, should separate the individual components released on activating 
the HMW species. 
 Tissue extract from 11 donor eyes (section 2.3.3.1) was utilised in these 
studies. Initially, the gelatinase extract was separated by standard SDS-PAGE (i.e., 
without gelatin substrate) and following activation/reduction/alkylation, a slither of the 
gel containing all of the MMP species was loaded for zymographic analysis (Figure 
2.10A).  
 In the control half of the gel (with a slither that was not activated), the lengthy 
electrophoretic procedure resulted in partial breakdown of both HMW2 to yield pro-
MMP9 and in the case of HMW1, yielded both pro- and active MMP9 species. In 
addition, both pro-MMPs 2 & 9 were also activated. In the activated portion of the gel, 
gelanolytic activity was considerably subdued. However, HMW1 & 2 were removed 
leading to the presence of activated MMP9 in both cases. 
 Subsequently, the primary separation of the gelatinases was undertaken in 
the presence of gelatin substrate (Figure 2.10B).  Under these conditions, APMA 
activation resulted in more stable preservation of activated MMP9 monomers. The 
presence of MMP9 in the HMW species was therefore confirmed. Activity of pro and 
active MMP2 was better preserved when the primary separation was undertaken in 
the presence of gelatin substrate (Figure 2.10B). Nevertheless, activation resulted in 
considerable loss of this species and in the activated portion of the gel, some active 
conversion of endogenous pro-MMP2 can just be discerned. Because of the labile 
nature of active MMP2 under the conditions employed, the likelihood of detecting 




Figure 2.10 Compositional analysis of the breakdown products of HMW1&2 
following activation. 
Gel A: The initial separation of the various gelatinase was performed by standard 
SDS-PAGE under on-reducing conditions. Gel slithers were obtained from control 
and activated gels and place on top of a gelatin separating gel, electrophoresed and 
subjected to standard zymography. In the control portion, there is evidence of partial 
breakdown of HMW1&HMW2 and activation of MMPs 2&9. Activation in the absence 
of gelatin (and under the conditions utilised) resulted in marked loss of gelatinase 
activity. Nonetheless, activation resulted in the release of MMP9 species from both 
HMW1& HMW2.  
Gel:B The initial separation was performed on a gelatin zymography gel and resulted 
in better preservation of gelatinase activities (control section). Activation resulted in 
breakdown of HMW1&2 giving rise to activated MMP9 species.  
P9 & A9, pro- and active MMP9 respectively.  





























Compositional analysis of the breakdown products
Of HMW1&2 following activation. 
Gel A: The initial separation of the various gelatinases
was performed by standard SDS-PAGE under
on-reducing conditions. Gel slithers were obtained from
control and activated gels and placed on top of a gelati
separating gel, electrophoresed and subjected to
standard zymography. In the control portion, there is
evidence of partial breakdown of HMW1 & HMW2 and
activation of MMPs 2 & 9. Activation in the absence of
gelatin (and under the conditions utilised) resulted in
marked loss of gelatinase activity. Nonetheless,
activation resulted in the release of MMP9 species from
both HMW1&HMW2.
Gel B: The initial separation was performed on a gelatin
zymography gel and resulted in better preservation of
gelatinase activities (control section). Activation resulted
in breakdown of HMW1&2 giving rise to activated MMP9
species.
P9 & A9, pro- and active MMP9 respectively.




2.3.4 Component analysis of HMW species by Western blots 
 Pilot experiments were carried out to ensure that the Western transfer 
procedure was sufficiently optimised to ensure the transfer of the high molecular 
weight species to the nitrocellulose membranes. Several batches of antibodies to 
MMPs 2 & 9 were obtained but nearly all showed some degree of cross-reactivity 
between the species.  
 Probing the nitrocellulose membranes with antibodies directed towards MMP9 
showed positive reactivity against pro-MMP9, HMW1 and HMW2 (Figure 2.11). 
These results showing the presence of pro-MMP9 in the high molecular weight 
complexes corroborates the evidence from zymographic studies described earlier. 
 Antibodies raised against MMP2 were positive towards pro-MMP2 and active 
forms of the enzyme, as expected. But they also reacted against pro-MMP9. This 
cross-reactivity against pro-MMP9 should have also resulted in cross-reactivity 
against HMW1 & 2 since pro-MMP9 has been localised to these species. However, 
only HMW1 was occasionally picked up but reactivity towards HMW2 was never 






























































2.3.5 Age related changes in the gelatinase system of human Bruch’s 
membrane 
 The effect of ageing on the gelatinase components of Bruch’s membrane was 
investigated in 29 donor eyes in the age range 21 to 99 years. Vigorous agitation of 
8mm disc samples in PBS was used to obtain the free pool of gelatinases with 
subsequent extraction of the washed sample with non-reducing SDS sample buffer 
to provide the bound pool.  
 Zymographic gels of the free and bound fractions for a donor subset in the 
age range 22-87 years are shown in Figure 2.13. Visual inspection of gels clearly 
shows the variation in level of individual gelatinase species between donors.  
 The free pool of gelatinases was dominated by the presence of pro-MMP9 but 
its activated form (active MMP9) was not observed in any of the samples analysed. 
Active MMP2, on the other hand was observed in the soluble fraction in 48% of 
donor samples. High molecular weight species were also observed in the soluble 
fraction but with very much diminished levels compared to pro-MMP9. 
 The bound pool was dominated by HMW2 and pro-MMP9 and active MMP9 
was observed to be present in 45% of the donors examined. Active MMP2 was 
present in the bound fraction of all donors.  
 For normalisation of data between gels, densitometric scans with software 
assisted background subtraction and corrections for gel-to-gel variation with FCS as 
internal standard were undertaken. Further calculations were made to take into 
account the volumes of the extracted samples and gelatinase activity of bands was 
expressed as densitometric area per 8 mm disc of tissue. The resulting activities for 
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the various gelatinase species of Bruch’s membrane are presented as function of 
donor age in Figure 2.14-Figure 2.16. 
 Aging of Bruch’s membrane was associated with an increase in the amount of 
bound pro-MMP9 (p<0.05) but with a decrease in the free pool (p<0.05). In 
comparison to pro-MMP9, levels of activated MMP9 were very low or absent. Given 
the very low level of this species, the validity of attempting a correlation with age 
must remain questionable.  Bound and free levels of pro-MMP2 did not appear to 
change with age of donor. Levels of active MMP2 were higher in the bound pool 
compared to the free pool but an ageing relationship was not observed for this 
species.       
 Aging of Bruch’s membrane resulted in increased levels of total and bound 
HMW2 (P < 0.005). Level of HMW1 showed considerable variation between donors 
and ageing was associated with an increase in both total and bound levels (P < 0.05 
and P < 0.01, respectively). Most of the HMW1 and HMW2 species was found in the 
bound fraction of the membrane and constituted 87 % ± 10 % and 80 % ± 20 % 
(mean ± SD) of individual levels respectively. The combined gelatinase activity of 
HMW1 and HMW2 was responsible for 23 % ± 20% of overall gelatinase activity in 





Figure 2.13 Zymograms for quantification of free and bound gelatinase activity of Bruch's membrane. 
A: Eight millimeter tissue discs were vortexed in PBS for 5 minutes, spun at 10,000 g and supernatant containing released 
enzymes removed and processed for zymography.  
B: Remaining tissue disc was washed several times with PBS and then extracted with non-reducing SDS extraction buffer to 
obtain the extracted fraction.  
MW, molecular weight standards; FCS, foetal calf serum. 
 
 



















Figure 12. Zymograms for quantification of free and bound gelatinase activity of Bruch’s membrane. A: Eight millimetre
tissue discs were vortexed in PBS for 5 minutes, spun at 10,000g  and supernatant containing released enzymes
removed and process d for zymography. B: Rem ining tissue disc was washed several times with PBS and then
extracted with non-reducing SDS extraction buffer to obtain the extracted fraction. MW, molecular weight standards;





Figure 2.14 Age-related variation in variation in bound and free levels of the 
MMP9 species in Bruch's membrane. 
The peripheral fundus was sampled in 29 donor eyes, age range 21-99 years and 
gelatinase activity is expressed as the area under the corresponding zymographic 
bands. Ageing was associated with an increase in the amount of bound pro-MMP9 
(p<0.05) but a decrease in the level of free (p<0.05). Active MMP9 was only present 
in the bound fraction.  
Pro MMP9-Bound Pro MMP9-Free
Active MMP9-Bound
Figure 13. Age-related variation in bound and free le els of the MMP-9 species in Bruch’ membrane.The peripheral
fundus was sampled in 29 donor eyes, age range 21-99 years and gelatinase activity is expressed as the area
under the corresponding zymographic bands. Ageing was associated with an increase in the amount of bound 




Figure 2.15 Age-related variation in bound and free levels of the MMP2 species 
in Bruch's membrane. 
Ageing did not result in any significant alterations in the levels of latent or active 
MMP species.  
  
Pro MMP2-Bound Pro MMP2-Free
Active MMP2-Bound Active MMP2-Free
Figure 14. Age-related variation in bound and free levels of the MMP-2 species in Bruch’s membrane. Ageing did




Figure 2.16 Age-related variation in the total and bound level of high molecular 
weight gelatinase species of Bruch's membrane. 
Total and bound levels of HMW2 species were observed to increase linearly with 
age of (p<0.005). Despite the large scatter in the data, total and bound levels of 





 The age related variations between bound and free compartments were 




Figure 15. Age-related variation in the tot l a d bound level of high molecular we t gelatinase species of Bruch’s
membrane. Total and bound levels of HMW2 species were observed to increase linearly with age (p<0.005).Despite










 Of all the gelatinase species, pro-MMP9 was the only one that showed a 
significant increase in binding to the matrix with age (p<0.05). In the absence of 
statistical significance, the data for the other gelatinases has been grouped to 
provide an average value for the percentage bound to the matrix of Bruch’s 
membrane (Table 2.1). 
 
Gelatinase species Percentage bound 
HMW1 80 ± 21 
HMW2 87 ± 10 
Pro-MMP9 ** 
Pro-MMP2 62 ± 29 
Active MMP9 100 ± 0 
Active MMP2 87 ± 17 
 
Table 2.1 The percentage of total gelatinase species found in the bound 
compartment of Bruch’s membrane. 















 The importance of the MMP system lies in its ability to degrade extracellular 
matrices so as to allow the migration of phagocytic and endothelial cells in the 
processes of inflammatory response and new blood vessel growth. Their 
involvement in tumour cell invasion and in choroidal neovascularisation has been 
well documented. 
 Proteolytic activity of MMPs is also required for the normal maintenance of 
extracellular matrices. The tightly coupled processes of degradation and synthesis 
provide a mechanism for continual rejuvenation of matrices throughout life. This is 
particularly important for Bruch’s membrane for several reasons. Firstly, it houses 
high-traffic transport pathways for exchange of nutrients and waste products to and 
from a photoreceptor layer that maintains one of the highest rates of oxidative 
metabolism of any cell type in the body. Secondly, it is situated at a location with an 
elevated risk of oxidative and free-radical mediated damage. Thirdly, it has to deal 
with highly damaged and potentially damaging phagocytic ‘debris’ that has been 
extruded onto its surface by the overlying RPE. Hence Bruch’s requires efficient 
regenerative mechanisms to maintain its structural and functional characteristics. 
 Ageing of Bruch’s suggests that these regenerative mechanisms are not fully 
operational in that nearly 50% of the collagen content in aged specimens was shown 
to exist in an oxidatively damaged state (Karwatowski et al., 1995). The presence 
within a tissue of active forms of MMPs is an indicator of an attempt at proteolysis. 
Active forms of gelatinases MMPs 2&9 have previously been demonstrated in aged 
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human Bruch’s membrane (Ahir et al., 2002; Guo et al., 1999). It is possible that the 
MMP system remains at an operational state but that the highly damaged and cross-
linked nature of the collagen molecule prevents effective degradation. The level of 
active MMPs is another consideration that will dictate the degree of degradation. 
Interestingly, Guo et al., 1999 showed that active MMPs were frequently present in 
the more slowly ageing peripheral region and only occasionally in the faster ageing 
macular region. 
 Preliminary assessment of the gelatinase system of ageing Bruch’s 
membrane requires identification and characterisation of individual species and their 
associated age-related changes (if any). In the present study, identification of 
gelatinases species was based on the technique of substrate gelatin zymography 
and the limitations imposed by this approach require some clarification. 
 The use of SDS buffers for preparing samples for SDS-PAGE (for Western 
blots) or zymography leads to the disassociation of dimers, trimers, tetramers or 
polymers if the monomeric units were initially held together by non-covalent bonds. 
Such complexes cannot be detected by zymography and the quantification of 
monomers would artificially elevate the levels found physiologically. With this caveat 
in mind, the analysis of Bruch’s-choroid preparations showed the presence of six 
distinct gelatinase species on the zymograms: latent Pro- forms of MMPs 2 &9 of 
molecular weights 95 and 65 kDa respectively, their activated counter parts of 
molecular weights 84 and 58 kDa, and two additional high molecular weight species 




 Most publications only show the regions of zymograms housing the 
monomeric MMPs 2 &9, ignoring the high molecular weight components. Others 
have noted the presence of these species on their zymograms (Guo et al., 1999; Lim 
et al., 1997). In the present study, nearly 23% of the gelatinase activity found in the 
free compartment of the membrane was due to the presence of HMW1 and HMW2. 
Even greater amounts of these species (43%) were present in the bound fraction of 
the membrane. Previous studies have suggested that these high molecular weight 
species are most likely to be homo- and hetero polymers of pro-MMPs 2&9. If this 
were the case, then these HMW species would be responsible for sequestrating 
latent forms of MMPs 2&9, thereby diminishing the monomeric pool for activation. 
Moreover, the age related increase in HMW1 & 2 would serve to further sequester 
monomeric species in the elderly. 
 Activation of tissue extracts with APMA resulted in the disintegration of the 
HMW complexes with a concomitant increase in the level of activated MMPs 2 & 9. 
Although this result suggests that the HMW species contain both MMPs 2 & 9, the 
relative contribution from endogenous monomeric MMPs 2 & 9 complicates the 
analysis. APMA activation of FCS, that contains very little (if any) HMW species, 
resulted in the movement of the gelatinase bands towards lower molecular weights 
without an increase in staining intensity. Based on this result, the analysis shown in 
Figure 2.8 certainly supports the inclusion of MMPs 2&9 in the HMW complex. The 
double electrophoretic separations clearly demonstrated the presence of MMP9 in 
the HMW complexes and this was also supported by the Western blots. The age 
related increase in HMW1 & 2 would therefore imply greater sequestration of pro-
MMPs 2&9 in ageing donors. 
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 The high level of pro-MMP9 present in Bruch’s samples allowed for greater 
accuracy in their quantification by gelatin zymography.  The amount of pro-MMP9 in 
the bound compartment increased with ageing of donor (p<0.05) whilst that in the 
free compartment showed a decrease (p<0.05). Thus, greater binding to the 
membrane and incorporation into the HMW complexes would appear to result in 
decreased levels of free pro-MMP9. Active MMP9 was only found in the bound 
compartment of Bruch’s membrane with levels very small compared to pro-MMP9. 
This species was present in 45% of the donors examined. Because levels were so 
low, and often near the detection limit, the scatter in the age-dependency analysis 
was considerably higher. The fact that all the active MMP species was bound to the 
matrix is perhaps not surprising. Pro-MMP9 binds to the damaged and hence 
uncoiled strands of the triple helix chain of the collagen molecule (Rosenblum et al., 
2010). This binding results in conformational changes that lead to activation and 
auto-catalytic removal of the inhibitory pro-peptide. Once activated, the activated 
MMP9 remains bound to the uncoiled chain and has translational capability along the 
collagen molecule. Thus, activated molecules of MMP9 would be expected to be 
bound to the matrix. 
 Levels of pro-MMP2 were somewhat evenly distributed between bound and 
free compartments and did not show alterations with age. Active MMP2 was present 
in the bound fraction of all donors examined. It was also present in the free 
compartment in 48% of donors. Again, the presence of active MMP2 in the free 
compartment is not surprising. Pro-MMP2 is activated on the basolateral surface of 
the RPE cell (section 1.3.3.3.3) and the activated form must then diffuse through the 
matrix of the membrane to interact with its substrate. Unlike active MMP9, levels of 
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active MMP2 were found to be very high, about 50% of the level of pro-MMP2. This 
high level is in keeping with its role as a constitutive MMP in the homeostatic 
regulation of matrix maintenance.  
 In the case of MMP9, the age related increase in binding and incorporation 
into the HMW species explains the observed lower level of pro-MMP9 in the free 
pool. A lowered free pool of pro-MMP9 would be expected to impact on the pool of 
activated MMP9 but this analysis is hampered by the low sensitivity of the 
zymographic technique for such quantification. This ageing process has been shown 
as a pathway in Figure 2.18. Similar considerations should also apply to the pools of 
MMP2 but the present results clearly show that the free levels of pro-MMP2 are not 
reduced. One possible explanation for this anomaly may be that the free pool of pro-
MMPs 2&9 has been overestimated. This could arise if the tissue housed polymeric 
forms that were non-covalently bound leading to their dissolution in SDS buffers, 
resulting in artificially elevating the free pool of pro-MMPs. This aspect is addressed 
in the following chapter. 
 
















STRUCTURAL CONFIGURATION OF GELATINASE SPECIES  









 The technique of substrate zymography has been used extensively in the 
analysis MMPs. Gelatin and the milk protein casein have been used as substrates 
for the detection of MMPs 2&9 and MMPs 1&3 respectively (Guo et al., 1999). Pro-
MMPs are latent enzymes that require the removal of an inhibitory pro-peptide for 
activation. Thus under normal circumstances and in the presence of substrate, these 
latent enzymic forms would not show any proteolytic activity. However, during 
preparation of samples for electrophoresis, an anionic detergent, sodium dodecyl 
sulphate (SDS) is used to solubilise the proteins. The binding of SDS with the latent 
MMPs causes conformational alterations that lead to partial activation without 
cleavage of the inhibitory pro-peptide. Hence, the process of zymography allows the 
detection of ‘latent’ forms of MMPs. Since physiological activation of MMPs results in 
species of lower molecular weight, both latent and activated MMPs can be identified 
and quantified by zymography. 
 There is one major drawback to zymography. The SDS used to solubilise 
proteins (and to partially activate latent MMPs) also disassociates macromolecular 
complexes that are held together by hydrophobic and/or electrostatic interactions. 
Thus, zymographic analyses only allow the detection and quantification of 
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monomeric or covalently bounded multi-meric MMP species. Physiologically, the 
presence of loosely or non-covalently bound multi-meric species may be more 
important in the assessment of biological activity. 
 Techniques that do not break up the non-covalently bonded macromolecular 
complex are required to verify and characterise such species. Size-exclusion gel 
filtration chromatography can separate such macromolecular complexes in an intact 
configuration. The availability of different grades of gel material means that a suitable 
preparation can be chosen to fractionate complexes within a certain molecular 
weight range. 
 As shown previously (Chapter 2), the gelatinase species of human Bruch’s 
membrane exist in bound and free compartments. Since SDS buffers can extract 
most of the bound form, the interaction that keeps the gelatinase species bound 
must entail hydrophobic and/or electrostatic bonding. In the present analysis, only 
the soluble pool of gelatinases has been examined for the presence of high 
molecular weight complexes. 
 Gel filtration chromatography has been used to fractionate the free pool of 
gelatinase species of human Bruch’s membrane according to size and molecular 
weight of individual species. The presence of gelatinase activity in each of the elution 
fractions of the chromatographic run was determined by gelatin zymography. 
Column calibration with proteins of known molecular weight allowed the assignment 
of specific molecular weights to the gelatinase species identified. The fractionation 
scheme also provided elution fractions that were predominantly enriched in HMW2 
species. Thus it was possible to fragment this complex (free of contaminating pro-
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MMP2 that is normally present in crude extracts) with APMA and assess its 




3.2.1 Sample preparation 
 Gel filtration chromatography requires much larger samples than zymography 
because of the inherent dilution due to the elution process. Thus tissue samples from 
several eyes were combined for a given preparation. Altogether eight preparations 
were obtained from a total of 29 donor eyes (age range 65-90 years). 
 The anterior portion of the globe was removed followed by the vitreous and 
retina. The remaining globe was ‘opened’ in the shape of a Maltese cross and each 
of the quadrants transferred to phosphate buffered saline (PBS, Sigma-Aldrich, UK). 
RPE layer was removed by gently brushing away with a Camel hair brush. The 
Bruch’s-choroid layer was removed from the sclera by blunt dissection. Following a 
quick rinse in PBS, samples were either used immediately or stored at –70ºC for 
future use. Pooled samples from several eyes were macerated with a pestle and 
mortar in Tris-HCl buffer (100 mM Tris, 0.15 M NaCl, 10 mM CaCl2, 0.02 % sodium 
azide, pH 7.5) and centrifuged at 10,000 rpm for five minutes. Supernatant volumes 




3.2.2 Gel filtration chromatography 
 Sepharose CL-6B separating media (delivered as a suspension in distilled 
water) was obtained from Sigma-Aldrich, UK. The distilled water was decanted and 
replaced with Tris-HCl buffer and mixed on a magnetic stirrer for about 1 hour. The 
process was repeated a further six times. Finally, the mixture was degassed and the 
Sepharose CL-6B packed into a filtration column (30 cm x 1.5 cm i.d). A reservoir of 
Tris-HCl buffer was attached to the top of the column and flow maintained overnight 
to allow tight packing of the gel material. Flow rate through the column was adjusted 
to 0.6-1.0mls per minute. 
 
3.2.2.1 Determination of column void volume, vo 
 The void volume of the column (vo) was determined using Blue dextran of 
molecular weight 2000 kDa. A solution of blue dextran (prepared in Tris-HCl buffer) 
was run on the chromatography column and the absorbance of the resulting fractions 
was read at 610nm. A plot of the absorbance against cumulative fraction volume 
allowed the determination of the void volume of the column. This void volume was 
determined regularly to ensure stability of the column. 
 
3.2.2.2 Molecular weight calibration 
 All proteins used for calibrating the column were obtained from Sigma-Aldrich 
(UK). These included: Carbonic anhydrase MW 29 kDa; albumin, MW 66 kDa; 
alcohol dehydrogenase MW 150 kDa; β-amylase, MW 200 kDa; apoferritin, MW 443 
kDa; and thyroglobulin, MW 669 kDa. All protein samples were prepared in Tris-HCl 
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buffer and run individually on the column. The absorbance of the fractions was read 
at 280nm. A plot of absorbance versus the ve/vo ratio was used to determine the 
ve/vo of the peak of the individual protein. Peak ve/vo (volume eluant /volume void volume) 
ratios for individual proteins were plotted against their respective logarithmic 
molecular weights to obtain the calibration curve. 
 
3.2.2.3 Gel filtration chromatography of gelatinases 
 Supernatants from the tissue extracts (volume 0.6mls) were applied to the 
column and the chromatographic run instigated. Eluant aliquots were collected every 
1.5 to 2.0 minutes using a LKB (Sweden) fraction collector. The protein profile of the 
chromatography run was obtained by measuring the absorbance of the fractions at a 
wavelength of 280nm. The gelatinase components in each fraction were determined 
by gelatin zymography as previously described (section 2.2.2). Areas under 
individual gelatinase species were plotted as a function of gel fraction. The intensity 
of the bands with proteolytic activities of gelatinases was plotted as a function of 
fraction number to determine their mobility on the column.  
 
3.2.3 Fragment analysis of HMW2 
 In the previous studies of chapter 2, uncertainties remained as to the inclusion 
of pro-MMP2 in the HMW2 polymeric species. Clarification could be obtained if a 
purer source of HMW2 was available without any contaminating pro-MMP2 in the 
sample. On gel filtration chromatography, such a sample with trace amounts of 
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HMW1 and pro-MMP9 was available and was therefore fragmented by APMA 




3.3.1 Gel filtration chromatography of gelatinase species 
 The analysis was undertaken with the free gelatinase extracts from pooled 
donor eyes. Following gel filtration chromatography, individual fractions were 
subjected to gelatin zymography to identify the presence of various gelatinase 
species. Representative gels showing the distribution of MMPs in the 
chromatographic run for two extracts are shown in Figure 3.1. Figure 3.1A was 
obtained from an extract from 3 eyes, donor ages 71, 73 & 84 years and Figure 3.1B 
from 8 eyes, donor age range 69-84 years. In gel filtration chromatography, larger 
species are eluted early followed by species of progressively decreasing molecular 
weight. 
 These zymograms show that fractions could be categorised into four groups. 
The first group collected at early stage (fraction numbers 15-20) contained high 
levels of HMW2 and lesser amounts of HMW1 and MMP9 and traces of MMP2. 
Group 2 contained traces of HMW2. All the major species of gelatinases were 
present in Group 3 with Group 4 containing primarily MMP2 and MMP9.  
 The Group 1 region of the chromatographic run represents the elution of very 
large complexes that could not enter the spaces within the gel beads and have been 
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‘voided’ from the column. Thus the presence of HMW2, HMW1, pro-MMP9 together 
with trace amounts of pro-MMP2 in this region implies that all these species must 
have run as one large macromolecular weight MMP complex, now termed ‘LMMC’.  
 All four of the above mentioned gelatinase species were also present in 
Group 3 fractions but they could not have run as a complex since this would have 
shifted their elution to the void volume region (Group 1). It seems odd that despite 
the different molecular weights (as determined by zymographic methods), HMW1, 
HMW2 and pro-MMP9 appear to be present in the same elution fractions. It is likely 
that under gel filtration conditions, the individual species may be migrating as loosely 
bound polymers and therefore the molecular weights assigned by zymography would 
not be valid. The situation can be resolved by determining the molecular weight of 
the eluting species and will be addressed later. Another possibility that must be 
entertained to explain this anomaly is that following elution, pro-MMP9 may have 
polymerised to the high molecular weight forms during the time between elution 
collection and the zymographic runs. This is perhaps not surprising since working 





Figure 3.1 Gel filtration chromatography of the free gelatinase pool of Bruch's membrane. 
After gel filtration individual fractions were subjected to gelatin zymography. Highest levels of HMW2 were present in the early 
fractions together with the presence of HMW1 and MMP9. This was followed by fractions containing very little gelatinase activity 
except for traces of HMW2. MMP9 together with some HMW1/HMW2 was then released accompanied in later fractions with 
MMP2.  
A: Extract from three eyes (5mls), donor ages 71, 73, and 84 years; applied 0.6ml to column 




 The gels were subjected to densitometry and the distribution of individual 
gelatinases in the chromatographic fractions is shown for four preparations in Figure 
3.2. In every preparation examined, the earliest group of gelatinases eluted 
contained a mixture of HMW2, HMW1, high levels of pro-MMP9 together with the 
trace amounts of pro-MMP2. The peak of these MMP species corresponded to 
fractions 17-20 with an elution volume of about 17-18 mls i.e., at the void volume of 
the column (described later). Thus these four MMP species at the forefront of the 
elution profile must have moved as a single macromolecular MMP complex 
(designated earlier as LMMC). 
 Pro-MMP9 was present in two discreet peaks along the chromatographic run. 
The first peak corresponded to the species complexed in the LMMC particle whilst 
the later eluted species corresponded to the free form. It should also be pointed out 
that in preparations 2, 3 & 4, peaks for non-LMMC derived HMW1 & 2 corresponded 
to the peaks of pro-MMP9, i.e., they appeared to run in the same fractions but not as 
a complex since this would have shifted their elution profiles towards the void volume 
of the run. Running together would suggest that under the conditions of the gel 








Figure 3.2 Gel filtration chromatography of the free gelatinase pool of Bruch’s 
membrane. 
Band intensities corresponding to the various gelatinase species have been plotted 
as a function of fraction number. In every preparation examined, the earliest fractions 
corresponding to the highest molecular weight species always contained a mixture of 
HMW2, HMW1 and MMP9 indicative of the fact that these species moved as one 
complexed macromolecular entity. Three of the four preparations displayed also 
showed that the free MMP9 fractions were also associated with some degree of 
HMW1 & HMW2. MMP2, being the smallest species, was eluted last but with 
considerable overlap with the slightly larger MMP9 species. 
Prep 1: extract from two eyes (donor ages 72&79 years); Prep 2: extract from 3 eyes 
(donor ages 71, 73 & 84 years, Gel A of Fig.1); Prep 3: extract from two donor eyes 
(ages 67 & 81 years); Prep 4: extract from 8 eyes (donor age range 69-84 years; Gel 




3.3.2 Molecular weights of gelatinase species by gel filtration 
 
3.3.2.1 Determination of void volume of column 
 The void volume (vo) is the elution volume of molecules that are excluded 
from the gel filtration medium because they are larger than the largest pores in the 
matrix and pass straight through the gel bed. In the case of Sepharose CL-6B, Blue 
dextran of MW 2000 kDa is too large and will be completely excluded from the matrix. 
This dextran was therefore run on the column to determine the void volume. Any 
gelatinase species appearing close to this void volume would have also been 
excluded because of its very large size. 
 Two separate runs with Blue dextran are shown in Figure 3.3 allowing the 
determination of void volume of the column as 17.25 mls. Void volumes for different 







Figure 3.3  Determination of the void volume of the column. 
 
 
Vo = 17.25mls Vo = 17.25mls
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3.3.2.2 Protein calibration curve for determination of molecular weights 
 Proteins of various molecular weights in the range 29 – 669 kDa were run 
individually and the ve/vo ratios of the elution peaks were determined (Figure 3.4). 
Elution profiles for carbonic anhydrase, albumin and beta-amylase were 
characterised by a single peak. However, the commercial samples of alcohol 
dehydrogenase and apoferritin showed two peaks with the smaller molecular 
component being a breakdown product. In the case of thyroglobulin, polymerisation 
was noted with one of the peaks coinciding with the void volume. 
 The ve/vo ratios for the various protein markers were plotted against their 
respective logMW to obtain a calibration plot (Figure 3.5). The relationship between 
ve/vo and logMW was described by the equation: 




Figure 3.4 Elution profiles of protein molecular weight standards used in the 










Figure 3.5 Calibration curve for determination of molecular weights of MMP 
species by gel filtration chromatography. 
 
3.3.3 Molecular weights of gelatinase species of Bruch’s membrane 
 The elution profiles of MMP extracts of Bruch’s membrane were normalised 
with respect to ve/vo ratios and a representative plot is given in Figure 3.6. The peak 
ve/vo for individual species was determined and with reference to the calibration plot 














Figure 3.6 Gel filtration chromatography and 
analysis of various gelatinase species in the 
eluant fractions. 
The extract was obtained from four eyes of 
donors aged 86-95 years. The cumulative fraction 
volumes were converted to ve/vo ratios by 
dividing by the void volume of the column, 
determined in this run as 17.25mls. The elution 
profiles show the presence of HMW1, HMW2, 
and Pro-MMP9 in the void volume region of the 
run. Pro-MMP2 was also visibly present as a faint 
band in this region but levels were below the 
detection limits of densitometry. These 
gelatinases represent the contribution of the 
LMMC complex. The later fractions constitute the 
free, uncomplexed gelatinase species. In this 
particular run, the HMW1 fraction showed a broad 
profile. From the peak ve/vo ratios and with 
reference to the protein calibration plot (Figure 
3.5), the molecular weights of HMW2, HMW1, 
Pro-MMP9, and Pro-MMP2 were calculated as 







 The molecular weights of individual gelatinase species obtained from 6-8 
fractionations have been tabulated in Table 3.1. Also shown are the molecular 
weights derived from zymography. Molecular weights derived from gel filtration 
represent the ‘true’ configuration of the gelatinase species whereas those derived 
from zymography represent the monomers in the loosely bound complex. 
 The data shows that in the free pool of Bruch’s membrane, pro-MMP2 and 
HMW2 exist as monomers, and pro-MMP9 and HMW1 exist as dimers. Since in this 
configuration, the molecular weights of pro-MMP9, HMW1 and HMW2 are similar, 
their elution profiles were also similar giving rise to the distribution observed in Group 









State in tissue 
Pro-MMP2 65 ± 1 kDa* 88 ± 14 kDa 1.3 Monomer 
Pro-MMP9 95 ± 2 kDa* 191 ± 35 kDa 2.0 Dimer 
HMW1 122 ± 9 kDa 208 ± 19 kDa 1.7 Dimer 
HMW2 344 ± 22 kDa 307 ± 17 kDa 0.9 Monomer 
  
Table 3.1 Comparison of molecular weights of gelatinase species determined 
by gel filtration and zymography.  
The ratio of molecular weights by the two techniques was also calculated (GF/Z) and 
rounding up to whole numbers allowed for designation of species in the free pool as 
either monomer or dimer. Data has been presented as Mean ± SD (n) where n= 6-8. 




3.3.4 Fragment analysis of HMW2. 
 An eluant fraction (fraction 20, preparation 3, Figure 3.2) containing 
predominantly HMW2 species with some contamination with pro-MMP9 but with no 
pro-MMP2 was activated/reduced/alkylated to obtain fragments for analysis of 
released MMPs (Figure 3.7). Fragmentation of HMW2 resulted in the release of the 





Figure 3.7 Activation of gelatinases in the HMW2 enriched fraction. 
Fraction 20 of Preparation 3 (Figure 3.2) that contained predominately HMW2 and some MMP9 was activated and the resulting 
zymogram is shown in A. The HMW2 band was lost with a concomitant increase in levels of activated MMP2. The underlying 
changes are made more clear in the scans of B and C. Scan B shows the presence of HMW2 and MMP9 but no HMW1 or 
MMP2 species. Activation (Scan C) shows loss of HMW2, increase in the region of active and inactive MMP9 and a prominent 
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Figure 8. Activation of gelatinases in the HMW2 enriched fraction. Fraction 20 of Preparation 3 (Fig.2) that
contained predominantly HMW2 and some MMP9 was activated and the resulting zymogram is shown in A.
The HMW2 band was lost with a concomitant increase in levels of activated MMP2. The underlying changes
are made more clear in the scans of B and C. Scan B shows the presence of HMW2 and MMP9 but no HMW1
or MMP2 species. Activation (Scan C) shows loss of HMW2, increase in the region of active and inactive





























 Previous studies using zymography have identified the presence of pro-and 
active forms of MMP9 (MW 95 & 84 kDa respectively) and MMP2 (MW 65 & 58 kDa 
respectively) in human Bruch’s membrane (Ahir et al., 2002; Guo et al., 1999). The 
present study has confirmed the existence of two further MMP species, termed 
HMW1 & 2 of molecular weights 122 ± 9 and 344 ± 22 kDa respectively (Chapter 2, 
(Kumar et al., 2010). Thus six gelatinase species have now been identified in human 
Bruch’s membrane. 
  Fragment and Western blot analyses have demonstrated the presence of pro-
MMP9 in HMW1 & 2 and therefore these high molecular weight species are most 
likely to be homo or hetero polymers of MMPs 2 & 9. Confirming the presence of pro-
MMP2 within these complexes has proved difficult. However, the present gel filtration 
analysis allowed the isolation of a fraction enriched in HMW2 without contamination 
from pro-MMP2. Fragment analysis of such a preparation showed that the HMW2 
species also contained MMP2. Thus the HMW2 complex must be a co-polymer of 
pro-MMPs 2 & 9.  
  The zymographic techniques have successfully demonstrated the unitary 
presence of various components of the MMP system in Bruch’s. However our 
knowledge of higher order structures formed through non-covalent interactions 
between monomeric units has been rudimentary. Gel filtration chromatography has 
allowed the analysis of MMP species in their native configuration. Thus, pro-MMP2 
and HMW2 species were observed to exist as monomers whilst pro-MMP9 and 
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HMW1 circulated within Bruch’s as dimers. The relative equivalence of molecular 
weights of Pro-MMP9, HMW1 and HMW2 in their native configurations meant that 
they were eluted roughly within the same fractions of the chromatographic run. 
  The most reproducible finding in the gel filtration profile was the presence of 
HMW2, HMW1 and high levels of pro-MMP9 at the elution front in the void volume. 
Such a grouping travelling at the elution front can only occur if the components were 
bound together in a complex, now termed the large macromolecular MMP complex 
(LMMC). Pro-MMP2 was just detectable in the LMMC region of the fractionation 
regime.  
  The HMW2 species sequesters pro-MMPs 2 & 9 and the LMMC complex 
sequesters HMW2, HMW1 and a lot of pro-MMP9. Such sequestration is expected to 
reduce the level of free pro-MMPs for activation and may impact on the MMP-
mediated turnover of Bruch’s membrane. The inter-relationships between the six 
gelatinase species and the LMMC complex can be used to construct a working 
model of the MMP pathway that can be used to predict the effect of age and age-







Figure 3.8 The MMP pathway in human Bruch’s membrane. 
 
 The level of MMPs 2 & 9 in the free pool will regulate the rate of activation of 
these enzymes. In the case of pro-MMP2, previous studies have already 
demonstrated the rate of activation being dependent on optimum levels of both pro-
MMP2 and TIMP2 near the basolateral surfaces of the RPE (Butler et al., 1998; 
Strongin et al., 1995). Little is known of the activation mechanism of pro-MMP9 in an 
extracellular compartment, but as suggested by several reports, if activation is 
dependent on binding of the molecule to damaged portions of the collagen molecule, 
then the amount of activated MMP9 will depend on the available pool of pro-MMP9 
for activation. 
 Ageing of Bruch’s is associated with an increase in the levels of HMW1 & 2 
and therefore increased sequestration of pro-MMPs 2&9. Such an increase will be 
expected to lead to greater formation of the LMMC complex further sequestrating 
pro-MMP9. A reduction in the level of free pro-MMPs will impact on the conversion to 
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activated form of MMPs. This may explain the reported scarcity of active forms at 
macular locations compared to peripheral locations in ageing human donor eyes 
(Guo et al., 1999).  
 Experimental verification of the free levels of pro-MMPs 2&9 has not yet been 
undertaken. Measurements that utilise zymographic techniques are doomed to 
failure because the use of SDS buffers will release the large pool of pro-MMP9 from 
the LMMC complex leading to the artefactual elevation of pro-MMP9 levels. It may 
be possible to undertake such an analysis using high performance liquid 
chromatographic (HPLC) techniques using gel permeation columns.  
 The development of the above scheme for the MMP pathway was dependent 
on identifying and characterising the individual members of the gelatinase system in 
human Bruch’s membrane and evaluating the age related changes in its components. 
In age-related macular degeneration (AMD), the advanced nature of the ageing 
changes would suggest that the MMP pathway may have been shifted far to the left. 















THE GELATINASE SYSTEM  










 Age-related macular degeneration (AMD) remains the single largest cause of 
untreatable blindness in the elderly population (Klein et al., 1992). The prevalence of 
the disease is age dependent with levels of 1.3%-3% in the young (<55 years) 
increasing to 28%-30% in those aged 75 years and older (Friedman et al., 2004; 
Klein et al., 1992). Clinically, AMD is divided into early and late forms. Early AMD is 
characterised by the presence of drusen and retinal pigmentary abnormalities such 
as hypo- or hyperpigmentation (Nowak, 2006). Drusen are dome shaped deposits 
lying between the basal lamina of the retinal pigment epithelium (RPE) and inner 
collagenous layer of Bruch’s membrane. Although the presence of drusen remains a 
hallmark of AMD, they are also present in normal advanced ageing. It is the size, 
number and degree of confluency of druse that determines the risk of AMD 
(Pauleikhoff et al., 1990; Ambati et al., 2003). Early AMD progression to the late type 
is associated with two specific phenotypes; the ‘dry’ form, present in about 13% of all 
AMD patients showing geographic atrophy of the RPE and photoreceptors whilst the 
‘wet’ form (comprising 10-20%) is associated with additional neovascular 
complications (Friedman et al., 2004).  
 The aetiological mechanisms underlying the development and progression of 
AMD remain uncertain. Epidemiological studies have shown AMD to be a highly 
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complex, multi-factorial disease that has both a genetic disposition and considerable 
gene-environmental interactions (Hawkins et al., 1999; VanNewkirk et al., 2000). A 
genetic predisposition has been indicated from studies of familial aggregation, twin 
studies and classical linkage analysis (Klaver et al., 1998; Majewski et al., 2003). 
The diverse genetic associations with AMD best reflect the complex nature of the 
disease process. These genetic variations associated with AMD include several 
members of the complement pathway, components in lipid metabolism 
(cholesterylester transfer protein (CETP), hepatic lipase (LIPC), apolipoprotein E), 
heat shock serine protease (Htra1) and polymorphisms in the satellite promoter 
region of the matrix metalloproteinase-9 gene (MMP9) (Cameron et al., 2007; Chen 
et al., 2010; Edwards et al., 2005; Fiotti et al., 2005; Neale et al., 2010; Thakkinstian 
et al., 2006) 
 Despite the complexities of the mechanisms involved, the underlying changes 
in Bruch’s membrane of AMD donors show clear signs of advanced ageing (Dorey et 
al., 1989; Sarks et al., 1999).  Thus normal ageing changes such as increased 
thickness of Bruch’s (Okubo et al., 1999; Ramrattan et al., 1994), deposition of 
normal and abnormal ECM material (Karwatowski et al., 1995), increased cross-link 
formation (oxidative and non-enzymic glycosylation leading to advanced glycation 
end-products, AGEs and ALEs) (Handa et al., 1999) and the accumulation of lipid-
rich debris (Holz et al., 1994; Pauleikhoff et al., 1990) are further exaggerated in 
AMD. 
 The gross structural changes in AMD impact on the functional competence of 
Bruch’s membrane. Transport functions such as movement of fluids and diffusional 
delivery of macromolecules across the membrane are further reduced (Hussain et al., 
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2010; Hussain et al., 2004). Clinically, reduced transport status is often indicated by 
reduced scotopic thresholds in the elderly and in those with early maculopathy due 
to reduced efficiency in the transport of vitamin A (Chen et al., 1992; Owsley et al., 
2001; Owsley et al., 2006; Steinmetz et al., 1993). In AMD, diminished metabolic 
support may therefore be the initial insult that progresses to the death of RPE and 
photoreceptors, recruiting additional inflammatory or neovascular episodes. 
 The important role of the MMP degradation system in maintaining the 
structural and functional characteristics of normal ageing Bruch’s membrane has 
previously been stressed. It would appear to be even more important in the case of 
AMD where gross abnormalities have been identified. Thus not surprisingly, the 
MMP system has begun to attract attention. TIMP3 levels of Bruch’s membrane were 
considerably elevated in AMD donors compared to age-matched controls with the 
consensus being that elevated TIMP3/MMP ratios may underlie the increased 
thickening of Bruch’s in this condition (Fariss et al., 1998; Kamei et al., 1999). 
Involvement of the MMP system in the aetiology of AMD has also been inferred from 
the raised levels of plasma pro-MMP9 in these patients (Chau et al., 2008). This 
increased expression of pro-MMP9 may be related to polymorphisms in the promoter 
region of the MMP9 gene since this appears to dictate the transcription activity for 
this enzyme (Peters et al., 1999; Shimajiri et al., 1999; Ye, 2000). Thus in mesanglial 
cells of mice, 24 repeats of the cytosine-adenine (CA) sequence in the promoter 
region was associated with 20 times higher expression of pro-MMP9 compared to 
strains with 20 CA repeats (Fornoni et al., 2002). An association between the length 
of the MMP9 promoter microsatellites and choroidal neovascularisation has been 
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documented and alleles with 22 or more CA repeats were more often found in AMD 
patients (Fiotti et al., 2005). 
 The present investigation was therefore designed to ‘screen’ donor tissue and 
clarify any disturbance (if present) in the gelatinase component of the MMP 
degradation system of Bruch’s membrane from donors with AMD. It would have 
been ideal to examine macular regions but tissue samples were only available from 
aged donors and the highly degenerative state and scar formation meant that 
isolation of intact samples was very difficult. Previous studies have shown that 
similar ageing changes occur across the entire fundus but that the macular region 
ages at a faster rate. With this in mind, peripheral samples of Bruch’s-choroid were 
obtained from six AMD (age range 71-95 years) and thirteen control donors (age 
range 71-99 years) and the level of the different gelatinase species in the free and 













4.2.1 Tissue preparation 
 Human donor eyes, with consent granted for research, (13 pairs, age range, 
71-99 years and post-mortem times 24-48 hours) were obtained from the Bristol Eye 
Bank, U.K. In addition, six AMD donor eyes (ages 71, 79, 81, 83, 87 and 95 years) 
were obtained through the Macular Disease Society Eye Donor Scheme, UK. Clinical 
data sheets accompanied AMD donor eyes and their status was confirmed by fundus 
examination during the dissection procedure. The corneas were removed for use in 
transplantation surgery and the remaining globes were transported to the laboratory 
on saline moistened pads in an icebox.  
 The methodology for obtaining peripheral samples was identical to that 
described previously (section 2.2.1). Briefly, the tissue sample (8mm disc) was taken 
from the peripheral region of the fundus along an imaginary line joining the optic disc, 
fovea and the cut edge of the anterior globe. 
 
4.2.2 Sample preparation for zymography 
 Methodology was as described in the ageing study described previously 
(section 2.2.6). Briefly, for extraction of free and bound pools of gelatinase species, 
100μl of PBS was added to each sample and the tubes voxtexed five times for 
periods of one minute each. Samples were then centrifuged for 5 minutes at 10,000g 
and the supernatant, representing the free pool of MMPs removed. Twenty micro-
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litres of the supernatant was mixed with 40μl of non-reducing SDS sample buffer 
(Invitrogen, UK) and 20μl of this mixture applied to zymographic gels. 
 The pellet from the above centrifugation was washed several times with 
1.0mls aliquots of PBS and reconstituted with 20μl water and 40μl non-reducing SDS 
sample buffer. Samples were vortexed as before, spun at 10,000g for five minutes 
and 20μl of the supernatant representing the bound or SDS-extracted fraction 
applied to zymographic gels. 
 
4.2.3 Zymography 
 Zymographic analysis was identical to that previously described (section 
2.2.2). Protein molecular weight standards were included in each gel to allow 
determination of the molecular weights of individual gelatinase species. For each gel, 
log plots of migratory distance versus molecular weight were constructed. 
 
4.2.4 Statistical analysis 
 Data has been presented as Mean ± 1 SD. The Mann-Whitney test was 
employed to assess significant differences (p<0.05; p<0.01 or p<0.005) between 







 Several zymographic gels were required to undertake this screening analysis 
and therefore special care was taken to ensure that all procedures remained 
identical. Thus times for incubation, staining and de-staining were strictly controlled 
to minimise variations between gels. 
 The resulting zymograms were scanned, grey scaled with colours inverted, 
and aligned with respect to the position of the molecular weight markers included in 
each gel. They were then collated from the different gels and have been presented in 
Figure 4.1. All gelatinase species normally present in control samples were also 
present in AMD donor samples. 
 The free pool of gelatinases released was marked by the absence of active 
MMP9 from both AMD and control donors (Figure 4.1A). A visual inspection of the 
gels showed levels of pro-MMP9 to be elevated in AMD donors whereas levels of 
pro-MMP2 were reduced. The migratory distances of HMW2, HMW1, Pro- and active 
MMP2 were virtually the same within and between donor subsets. However, the 
migratory distances of pro-MMP9 showed a detectable variation within each donor 
set. 
 In the bound pool, levels of HMW2, HMW1 and pro-MMP9 were greater in the 
AMD donor group in comparison to controls (Figure 4.1B). On the other hand, levels 
of pro- and active MMP2 species were generally lower in the AMD group.   
 The variability in the migratory distances of pro-MMP9 observed in the free 
pool was much clearer in the bound samples due to the higher level of enzymatic 
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activity present on these zymograms. Comparing the positions of the pro-MMP9 
bands in AMD donors aged 71 and 83 years suggests the possible presence of two 
adjacent bands in the latter. The presence of two proteins running close to each 
other is also indicated on gels for the 87 year old AMD donor, and control donors 
aged 94, 80a and 71 years. The likelihood of two adjacent protein bands can also be 
inferred by comparing the 98-year-old control band with neighbouring lanes for the 
80a and 99-year-old samples. In the present study, no attempt was made to 
separate these bands and the mid-point was used in determining molecular weights. 
 Furthermore, active MMP9 in the control bound pool was observed as a 
narrow distinct band but in AMD samples, such specific banding was less frequently 
encountered and replaced by a broader smear (Figure 4.1B). Representative 
densitometric gel scans of control samples show clearly identifiable active MMP9 
peaks (Figure 4.2 a, b). Scans of AMD samples were generally dominated by a 
gradation of activated species that appeared as smears on the zymograms (Figure 
4.2 c, d).  
 In the 95 year-old AMD donor, the gel scan of the bound fraction (Figure 4.2c) 
suggests that the pro-MMP9 band may actually house two gelatinase species since 
the scan profile for this species was not symmetric about the expected position for 
pro-MMP9 depicted in Figure 4.2a. The presence of a lower molecular weight pro-
MMP9 species may also be responsible for the shift in the polymeric HMW1 form 
(compare Figure 4.2(c) with (a)). In other samples (Figure 4.2 (b) and (d)) the 
presence of a single pro-MMP9 species can be discerned since the scan profile 











Figure 4.2 Densitometric scans of zymographic lanes in the bound fraction analysis of Panel B, Figure 4.1. 
Scans (a) and (b) were from control donors (96 and 74 years old respectively).  




 The molecular weight of individual gelatinase species was compared between 
controls and AMD donors. Each gel had its own molecular weight standards and 
logarithmic plots of relative migratory distance vs. molecular weight were used to 
calculate respective weights. The plot of Figure 4.3 was constructed by combining 
the molecular weight calibration standards from eight gels superimposing the mean 
molecular weights of the various gelatinase species found in the control bound 
fraction. Statistical analysis showed that there was no significant difference in the 
molecular weights of the various gelatinase species in the free and bound fractions 














Figure 4.3 Calibration curve to measure the molecular weights of gelatinase 
species in Bruch’s membrane.  
The molecular weight standards were in the range of 31 to 500 kDa and their 
migration is given as Mean ± SD of data taken from eight gels. The molecular 











 MMP Molecular weights (kDa) 





322 ± 40 162 ± 8 95 ± 2 - 65 ± 1 58 ± 1 





323 ± 52 161 ± 7 92 ± 3 82 ± 2 65 ± 1 58 ± 1 
327 ± 14 162 ± 5 94 ± 3 84 ± 2 65 ± 1 58 ± 1 






 A quantitative analysis of the level of individual gelatinase species of Bruch’s-
choroid preparations in terms of the free, bound and total pools is given in Table 4.2. 
There was considerable variation in levels within each donor group and this was 
reflected in the large standard deviations for a given species. A better representation 
of the variability in the data is provided by the Box and Whisker plots shown in Figure 
4.4.  
 





Figure 4.4 Box and Whisker plots of gelatinases in control and AMD Bruch's-choroid preparations. 
Median, quartiles and inter-quartile ranges (IQR) were determined from the data of Table 2. The ends of the whiskers were set at 1.5 x IQR above the third 
quartile (Q3) and 1.5 x IQR below the first quartile (Q1). The maximum and minimum values, if outside the whisker range, are shown as crosses. * p<0.05; 




 The total level of high molecular weight gelatinases, HMW1 & HMW2, was 
significantly raised in donors with AMD (p<0.05). In the absence of a statistically 
significant increase in bound levels, the observed increase in total levels was due 
primarily to an increase in free levels of HMW1 and HMW2 (p<0.01 and p<0.05 
respectively). The free level of HMW1 & 2 in AMD donors was about 4.8-fold higher 
than in controls. The percentage of total HMW1 & 2 that was in the bound fraction in 
controls was 82 and 90% respectively, whereas in AMD this was reduced to 62 and 
69% respectively.  
 Levels of free pro-MMP9 were significantly raised in AMD donor tissue 
(p<0.005) doubling the total content of this MMP compared to controls (p<0.05). 
Despite this increase in the pro-form, bound and total active MMP9 levels were 
reduced (p<0.05). 
 The free and total levels of pro-MMP2 were reduced in AMD (p<0.05). 
Comparing means, the reduction in free and total amounted to 4- and 3-fold 
respectively.  Also apparent in AMD samples was the reduction in bound and total 
levels of active MMP2 (p<0.005 and p<0.05 respectively). 
  
 In summary, in AMD donor samples of Bruch’s membrane, levels of HMW1, 
HMW2 and pro-MMP9 were considerably raised. Levels of pro-MMP2, and active 






 The zymographic analysis has demonstrated a disturbance in the gelatinase 
machinery of Bruch’s-choroid preparations from donors with AMD. More specifically, 
the total levels of active MMP2 and 9, enzymic forms responsible for proteolysis, 
were significantly reduced, diminishing the degradative capacity that is essential for 
maintaining the structural and functional characteristics of Bruch’s membrane. 
 Lowered levels of active MMP2 may be a reflection of the lowered levels of 
the precursor, pro-MMP2. The activation mechanism for pro-MMP2 has been studied 
and is mediated by another metalloproteinase, a trans-membrane enzyme MMP14, 
in combination with TIMP2 (Alcazar et al., 2007; Smine et al., 1997; Strongin et al., 
1995). The activation takes place on the basolateral surface of the RPE and requires 
two molecules of MMP14. The first MMP14 molecule binds TIMP2 and this enables 
the formation of the ternary complex with pro-MMP2. A second MMP14 molecule 
then cleaves the pro-form to release active MMP2 (Butler et al., 1998; Smine et al., 
1997; Strongin et al., 1995). Thus, efficient activation requires the presence of MMPs 
and TIMPs in optimum concentrations near the basolateral surface of the RPE. The 
lowered levels of free pro-MMP2 (p<0.05) observed for donors with AMD would 
therefore reduce the rate of activation leading to a reduction in total active MMP2. 
Lowered levels of pro-MMP2 may be the consequence of greater sequestration by 
the increased levels of HMW1 & 2. These results support the proposal that 
decreased levels of active MMP2 contribute to the thickening of Bruch’s membrane 




 Regulatory mechanisms for the synthesis of pro-MMP9 and its activation are 
poorly understood. Current evidence suggests that the level of MMPs is dependent 
on transcriptional regulation since most MMP genes are expressed in response to 
active physiological or pathological tissue modelling (Fini et al., 1995; Matrisian, 
1992). In addition, basal levels of pro-MMP9 are determined by polymorphisms in 
the sequence of cytosine-adenine (CA) repeats in the promoter microsatellite region 
of the MMP9 gene (Shimajiri et al., 1999). Increased CA repeats are associated with 
greater expression of pro-MMP9. Thus the higher number of CA repeats observed in 
AMD patients may explain both the higher levels of pro-MMP9 found in Bruch’s 
membrane in the present study and the raised levels of plasma pro-MMP9 in 
patients with AMD (Chau et al., 2008; Fiotti et al., 2005). 
 The total amount (i.e., free + bound) of pro-MMP9 in Bruch’s of donors with 
AMD was elevated nearly 2.2-fold compared to controls (p<0.05). But this only refers 
to the un-complexed pro-MMP9. The HMW1 and HMW2 species represent 
polymeric forms of pro-MMPs 2&9 (Kumar et al., 2010) and since these levels were 
also elevated in AMD donors (p<0.05), the overall increase in pro-MMP9 must be 
much higher.  
 Despite the considerably elevated levels of pro-MMP9, active MMP9 levels 
were significantly reduced in AMD (p<0.05). The reduction in active MMP2 discussed 
above could be explained by the fact that levels of free pro-MMP2 were also 
decreased. In the case of active MMP9 however, the free levels of pro-MMP9 were 
actually raised nearly 3.5-fold (p<0.005). This discrepancy may be related to the fact 
that the measured ‘free’ pool of pro-MMP9 may not necessarily denote free. As 
shown previously (Chapter 3), HMW1 & 2 and pro-MMP9 aggregate to form large 
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macromolecular complexes termed ‘LMMC’ and this complex is released by PBS 
extraction into the ‘free’ pool. However, on solubilisation in SDS sample buffer for 
zymography, this complex breaks up releasing its content of pro-MMP9 molecules. 
Thus the ‘free’ pool of pro-MMP9 in Table 2 is an over-estimation. Further work is 
required to estimate the contribution of the LMMC species to the free pool of pro-
MMP9. 
 The MMP pathway developed in the previous chapter and given again in 
Figure 4.5 is useful in understanding the nature of the gelatinase changes in Bruch’s 
membrane of AMD donors. 
 
 








 The formation and age-related increase of HMW1 and HMW2 is expected to 
diminish the free pool of pro-MMPs 2 & 9. The recruitment of pro-MMP9 in the 
formation of LMMC will further serve to diminish the pool of free pro-MMP9. The 
presence of polymorphisms with increased cytosine-adenine repeats in the promoter 
region in subjects with AMD will further serve (by increasing production of pro-MMP9) 
to drive the MMP pathway towards the left. This may or may not affect the level of 
free pro-MMP9 (because of the higher expression) but is expected to further 
decrease the level of free-MMP2. Further work is required to clarify the truly free pool 
of pro-MMP9 given the complication discussed earlier concerning release from 
LMMC during the zymographic assays. The ideal method would be to use short gel 
filtration columns (normally used for desalting purposes) to rapidly separate LMMC 
and then to quantify the isolated free pool of pro-MMP9. Thus the predicted 
reduction in levels of pro-MMPs 2 & 9 in AMD would impact on the conversion to 
activated forms and most likely explain the observed reduction of these species in 
AMD. 
 The study has also highlighted possible problems with the activation process 
for pro-MMP9 in donors with AMD. Normal activation of the 92kDa pro-MMP9 results 
in a partially active 88kDa transitional intermediate leading to the fully activated 
84kDa MMP9 molecule (Ahir et al., 2002). On the zymographic gels (Figure 4.1), this 
84kDa-activated species was distinctly evident in control donors but in AMD donors 
was replaced by a broader smearing of the band. Densitometric scanning of 
electrophoretic bands due to a single protein species normally results in a Gaussian 
bell-shaped profile. In the active MMP9 region in AMD samples, the Gaussian profile 
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was absent suggesting the presence of several intermediates. Whereas the 
transition from inactive pro-MMP9 to the fully activated 84kDa MMP9 molecule was 
clearly apparent in the control samples, a more transitory presence was evident in 
the AMD samples, perhaps suggestive of problems with the activation process in 
these donors. Again, further work is required to activate MMP samples from AMD 
donors with perhaps aminophenylmercuric acetate (APMA) and follow the transitory 
conversion by zymography according to the methodology of Guo et al., 1999 (Guo et 
al., 1999).   
 The present investigation was undertaken with samples derived from the 
peripheral fundus. Peripheral fundus was sampled because in AMD eyes, the 
presence of scar formation in the macular region due to the advanced nature of the 
disease in these aged donors made it virtually impossible to isolate intact specimens. 
In control donors, the ageing changes observed at macular locations were more 
advanced than at peripheral locations. Functional parameters of Bruch’s membrane 
such as the hydraulic transport of fluids and the diffusional transport of high 
molecular weight dextrans declined at faster rates in the macular region (Hussain et 
al., 2010; Moore et al., 1995; Starita et al., 1996). Similarly, whilst active MMP2 
species were frequently observed in the periphery, they were only occasionally 
encountered at macular locations (Guo et al., 1999). If the macular-peripheral 
difference in control donors also existed in AMD, then the changes in the gelatinase 
components in macular regions of these patients would be expected to be much 
more severe. 
 The physiological effects of a reduction in active MMPs -2 & -9 in Bruch’s of 
AMD donors would be augmented by the increased levels of TIMP3 inhibitor (Kamei 
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et al., 1999), inhibition by increased levels of AGEs and ALEs (Nagai et al., 2009) 
and the reduced susceptibility to proteolytic action by the highly cross-linked nature 
of the altered collagen molecule (Vater et al., 1979). The resulting degenerative 
changes in Bruch’s would be expected to initially impact on the metabolic exchange 
processes of the membrane. An early disturbance appears to be in the carrier 
mediated transport of vitamin A giving rise to reduced scotopic thresholds in the very 
elderly and early maculopathy (Chen et al., 1992; Owsley et al., 2001; Owsley et al., 
2006; Steinmetz et al., 1993). A further compromise in the homeostatic mechanisms 
for exchange of nutritional and waste products across Bruch’s is expected to impact 
initially on the RPE followed by deterioration in photoreceptor function.  
 The degenerative changes in functional parameters of Bruch’s associated 
with normal ageing nevertheless maintain sufficient support so as not to impact on 
visual function during a normal life span (Hussain et al., 2010; Moore et al., 1995; 
Starita et al., 1996). In AMD, the decreased degradative capacity documented in the 
present study due to lowered levels of active MMPs 2 & 9 may lead to the advanced 
















MODULATION OF THE GELATINASE SYSTEM BY METAL CHELATION:  





5 MODULATION OF THE GELATINASE SYSTEM BY METAL 
CHELATION: IMPLICATIONS FOR TRANSPORT PROPERTIES 




 Ageing of Bruch’s membrane has been shown to be associated with 
increased level of polymeric forms of the gelatinase MMPs 2&9. There was also an 
increased amount of bound or ‘sequestrated’ gelatinases within the matrix of the 
membrane. All these changes were much exaggerated in AMD leading to the 
construction of the MMP pathway to partly explain the observed reduction in active 
levels of MMPs 2&9 in this disease. 
 The mechanisms governing the polymerisation and/or sequestration of MMP 
species is not known. However, considerable insight has been gained from 
investigations of the polymerisation potential of the amyloid-beta protein (Aβ) that is 
thought to underlie the formation of senile plaques in Alzheimer’s disease.  
 In most globular proteins, the hydrophobic amino acid chains are buried within 
the interior of the protein. Thermodynamic perturbations are thought to expose these 
hydrophobic regions allowing the possibility for dimerization and polymerization. This 
initial conformational alteration can also arise from various physiological and 
pathological insults. It has been suggested that complexation of metals may 
overcome the thermodynamic barrier to autopolymerisation of Aβ (Bush, 2003; Exley 
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et al., 2001) and may underlie the significant elevation in concentrations of Fe(3+), 
AL(3+), Cu (2+) and Zn (2+) found co-localised with Aβ in senile plaques 
(Beauchemin et al., 1998). 
       Metal ions have been reported to significantly influence the processes of 
aggregation of Aβ protein (Huang et al., 2004; Ricchelli et al., 2005). In the case of 
aluminium and iron, this initial aggregation leads to the formation of higher order 
structures termed fibrils. With Zn, Aβ protein rapidly forms amorphous aggregates, 
most likely due to increased hydrophobic interactions that only slowly progress to 
fibrils (Bolognin et al., 2011; Frederickson et al., 2001; Noy et al., 2008; Tougu et al., 
2009). Metal chelators such as EDTA or desferrioxamine were able to dissolve the 
aggregates and fibrils formed by Aβ protein polymerisation (Atwood et al., 1998; 
House et al., 2004; Huang et al., 1997).  
 The initial conformational changes lead to non-covalent interactions between 
the monomeric protein subunits. However, these transitory changes may lead on to 
changes in the redox state of the metal involved, exposure of highly reactive groups 
on proteins, and metal mediated formation of reactive oxygen species (Hayashi et al., 
2007; Nakamura et al., 2007). Such protein-metal interactions can lead to 
deleterious effects on enzymic activity (Cuajungco et al., 2000; Duce et al., 2010).  
 There are many similarities between the behaviour of Aβ protein and the 
gelatinase system of Bruch’s membrane. Pro-MMP9 has been shown to exist in a 
dimer configuration, stabilised by non-covalent linkages. Both pro-MMPs 2&9 
undergo co-polymerisation by way of disulphide bridging to yield the high molecular 
weight structures HMW1 &2. Progress to higher order structures occurs via the 
incorporation of HMW1, HMW2, pro-MMP9 and some pro-MMP2 to yield the 
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supramolecular entity LMMC. This age-related structural shift towards high molecular 
weight complexes is exemplified by the MMP pathway established in chapter 3. 
  A question however remains regarding the likely involvement of metals 
in the polymerisation and sequestration process of gelatinases of Bruch’s membrane. 
An age-related increase in metal deposition within Bruch’s has been reported with 
considerably elevated levels in donors with AMD (Dentchev et al., 2005; Dunaief, 
2006). If these metals were to participate in protein polymerisation and deposition, 
the ensuing high molecular weight structures would be expected to interfere with the 
transport pathways of the membrane. Metals also bind to the phosphate polar heads 
of phospholipids stabilising them in their micellar or membraneous location. This 
would also aid in the entrapment and stabilisation of the lipid-rich debris observed in 
ageing Bruch’s membrane. Metals would also be expected to participate in the 
binding of proteins to structural and deposited elements of the membrane. Heavy 
metals such as zinc and iron, through redox reactions, can generate reactive oxygen 
species that will further increase the risk of oxidative damage to Bruch’s leading to 
increased cross-link formation and oxidative damage to structural and transport 
proteins.    
 The present study was therefore designed to assess the effect of removing 
metals on (a) the gelatinase system and (b) on the transport properties of Bruch’s 
membrane. Perfusion studies were undertaken to assess the degree of metal-
mediated sequestration (if any) of gelatinase species by the structural components of 
Bruch’s membrane. Similarly, incubation studies with metal chelators were 
undertaken to assess the potential for activation of the MMP system. Effect of metal 
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chelation on the transport system was studied by determining the hydraulic 





5.2.1 Human Tissue Preparation 
 As previously, all human eyes utilised in this study were obtained with 
corneas removed from the Bristol Eye Bank (UK). Whole globes were dissected in a 
Petri dish lined with filter paper (Grade50  Whatman, Maidstone, UK) moistened in 
0.1 M phosphate buffered saline (PBS) with an antibiotic/antimycotic mixture (Sigma-
Aldrich, UK). The globes were hemisected by a circumferential incision at the pars 
plana, and the remaining anterior segment, lens, and vitreous discarded. The 
posterior globe was then opened in the form of a Maltese cross and the four 
quadrants separated. Overlying neural retina was gently peeled away exposing the 
underlying RPE cells. These were gently brushed away with a fine camel hairbrush. 
The Bruch’s membrane-choroid complex was carefully separated from the sclera 
using blunt dissection and floated onto a moistened nylon (8µm-mesh) filter with 





5.2.2 Chamber Assembly for Perfusion with PBS and EGTA 
 A modified open-type Ussing chamber was used for the elution studies 
(Figure 5.1 to 5.3). It consisted of two half chambers that could be clamped together 
with the aid of guiding pins. The bottom plate had a central aperture of 6mm 
diameter with an entry port for perfusion medium and an exit port that was connected 
to a pressure transducer. The top unit had a central 8 mm diameter aperture with a 1 
mm lip near the surface adjacent to the mounted tissue sample. Thus only 6mm 
diameter of the tissue preparation was exposed and the lip facilitated the retrieval of 
the eluted sample without risking damage to the preparation since the pipette tip 




Figure 5.1 Open-type Ussing chamber used in the perfusion studies. 
A. Photograph showing the components of the chamber. Tissue samples held on 
nylon filters are clamped between the two half-compartments. 
B. Schematic of the operation of the perfusion chamber. A2 & a1 are the top and 
bottom half chambers; p, guiding pin. The lip in the upper plate allowed removal of 




Figure 5.2 Assembled Ussing chamber. 
A,C: Top and side views of the clamped chamber. B, Higher magnification 


















 Tissue mounting was carried out as follows. The 8 mm Bruch’s-choroid-nylon 
filter preparation (with Bruch’s membrane facing upwards) was mounted over the 
aperture of the bottom unit of the chamber. With the aid of the locating pins, the top 
plate was lowered gently onto the preparation and the chamber clamped by applying 
a torque of 70cN to the three screws. Using a syringe, PBS was introduced into the 
bottom half-chamber and all trapped air bubbles were removed by carefully tilting the 




the hydrostatic pressure was adjusted to 200 mmH2O. A water moistened filter pad 
was placed near the open aperture of the top plate and covered by a petri dish to 
maintain a humidified atmosphere so as to reduce eluant losses from evaporation. 
 Fluid eluted across the membrane preparation and entering the upper half-
chamber was collected every hour and weighed to calculate its volume. After 6-8 
hours perfusion, the perfusate was switched to 10 mM EGTA (Ethylene glycol 
tetraacetic acid) prepared in PBS and pH adjusted to 7.4. Further timed eluant 
collections were taken and at the end of the experiment, the chamber was 
dismantled and a central 6mm diameter tissue trephine was removed. Eluted 
fractions and tissue samples were subjected to gelatin zymography for MMP 
analysis.  
 
5.2.3 Effect of metal chelation on the gelatinase system of Bruch’s 
membrane 
 The perfusion experiments were designed to assess the likelihood of metal 
involvement in the sequestration or binding of MMP species to the structural 
elements of Bruch’s membrane. Possible changes in the polymeric configuration of 
gelatinases on exposure to metal chelators was studied in both intact preparations 
and isolated free compartments of Bruch’s membrane. In the former, 8mm discs of 
Bruch’s-choroid were incubated with 10mM EGTA, pH 7.4 for one hour followed by 
zymographic analysis. In the latter, extracted fractions from Bruch’s membrane were 





5.2.4 Gelatin zymography for metalloproteinase activity 
 Zymography was performed as described previously (section 2.2.2). Briefly, 
10% SDS-PAGE gels (1.0 mm thick) containing 4 % stacking layer and 0.1 % gelatin 
in the separating layer were utilised (Novex gels, Invitrogen, UK). Aliquots of the 
eluant were loaded into lanes with pre-stained molecular weight standards 
(Invitrogen, UK) and 20% foetal calf serum (FCS, Sigma-Aldrich UK) as an internal 
standard to correct for variations between gels in background staining. After 
electrophoresis, gels were incubated twice in 2.5 % Triton X-100 for half an hour 
each to remove SDS and renature the proteins. Then they were then incubated with 
reaction buffer (50 mM Tris-HCl, 10 mM CaCl2, 75 mM NaCl, and 0.02 % NaN3, pH 
7.4) for 18 hours at 37 ºC to allow proteolytic digestion of gelatin. After incubation, 
gels were rinsed 3 times with distilled water for 5 min periods and stained with 
SimplyBlue SafeStain (Invitrogen, UK) containing Coomassie G-250 for 2 hours on 
an orbital shaker. Gels were destained with distilled water for 1 hour.  
 
5.2.5 Calculation of hydraulic conductivity 
 The perfusion of the samples was carried out under a hydrostatic pressure of 
200mmH2O (1962 Pa). The eluant collected over a time t (sec) was weighed and 
assuming a density of 1g/ml, its volume (Vm3) was calculated. The exposed area of 
the preparation was 2.83 x 10-5 m2 (6mm diameter disc). Thus the hydraulic 






 The tissue preparations were initially perfused with PBS for a period of 8 
hours. Hydraulic conductivity was determined at various periods to obtain a base-line. 
At the 8-hour mark, PBS was replaced with 10mM EGTA. Fluid collections were 
taken every hour and thus the hydraulic conductivity determined was an average 
over that period. This hydraulic conductivity point was assigned as the value 
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5.3.1 Elution of MMPs from Bruch’s membrane 
 The rate at which MMPs are eluted from the membrane preparation will be 
dependent on the applied hydrostatic pressure and the age of the donor. Although 
elution profiles could have been conducted at a faster rate by employing a high 
hydrostatic pressure, the risk of damage to the preparation would have been 
substantial. For this reason, a hydrostatic pressure of 200mmH2O was chosen to 
mimic intra-ocular pressure resulting in elution periods of 8-12 hours over the donor 
age-range examined. 
 A representative zymogram of the composition of the eluant obtained in a 

















Figure 5.4 PBS elution of Bruch’s membrane from a donor aged 59 years. 
Elution was undertaken for 10 hours with sample collections every 2 hours. At 
termination of experiment, the 6mm diameter exposed sample of Bruch’s-choroid 
was removed and together with the eluant samples, processed for zymography. 
 
 
 The elution samples showed the presence of all gelatinase species with the 
notable exception of active MMP9 and this species was also absent from the tissue 
sample analysed. Most of the releasable pool of MMPs was eluted within the first two 
hours of perfusion, with decreasing amounts being released thereafter. After 8 hours 
elution, release of MMPs was considerably reduced and at the limit of visual 
detection. Examination of the tissue sample after the elution procedure showed the 
presence of a substantial amount of MMPs. Thus the pool of MMPs of Bruch’s 
membrane exists in bound and free compartments. 
 The elution profiles for the various gelatinase species were examined in 12 













in the preparation was calculated by adding activity in the various elution fractions 
plus that present in the tissue after the elution procedure. Then the amount released 
was expressed as a percentage of total activity (Figure 5.5). 
 Elution release profiles were different for the different MMP species. The 
amount of HMW2 released accounted for no more than 10% of the total content in 
the preparation. Release of HMW1 showed a hyperbolic profile diminishing the total 
pool by about 50% over an elution time of 12-14 hours. By contrast, the elution of 
pro-MMP2 was rapid with release of 80-90% of total activity within 4 hours of elution. 
The amount remaining bound was calculated to be about 10-20% of total activity. 
Since the molecular weights of active and pro-MMP2 are similar (58 & 65 kDa 
respectively), their elution profiles would be expected to be similar. However, active 
MMP2 was released much more slowly than pro-MMP2. This difference in elution 
profiles suggests that active MMP2 most probably exists in dynamic equilibrium 
between free and bound forms so that as the free species is removed by the elution 
process, more of the bound form is released. A similarly sustained release was also 
observed for pro-MMP9. Levels of active MMP9 were low or absent in the tissue 










Figure 5.5 Elution profiles of the various gelatinase species of Bruch’s 
membrane. 









5.3.2 Effect of EGTA on elution profiles of MMPs 
 Duplicate preparations were obtained for six of the donors utilised in the study 
of Figure 5.5. PBS elution was undertaken in one set for a period of 12 hours, 
contributing to the elution profiles presented in Figure 5.5. The other set was used to 
compare the effects of EGTA on the latter aspects of the elution profiles, i.e., at a 
stage when most of the free MMPs had been eluted out. 
 Standard PBS elution was started in the experimental set and maintained for 
8 hours. This period of perfusion would have been sufficient to remove most of the 
free and mobile gelatinase component of the membrane (compare profile of pro-
MMP2 in Figure 5.5). The continued release of other gelatinase species at or beyond 
8 hours perfusion was most likely due to slow release from bound stores. After the 
eluant collection at 8 hours, the perfusing solution was switched to 10mM EGTA 
(prepared in PBS and pH adjusted to 7.4) and subsequent eluant aliquots collected. 
A representative zymogram of the eluant fractions under these experimental 







Figure 5.6 Effect of EGTA on the elution of MMPs from Bruch’s membrane of a 
donor aged 68 years. 
PBS was perfused for 8 hours and then switched to 10mM EGTA and perfusion 
continued for another 6 hours. At the end of the perfusion, the tissue sample and 
eluant fractions were processed for zymography. 
 
 
 Switching to 10mM EGTA after the preliminary elution with PBS had little 
affect (if any) on the elution of all the gelatinase species except active MMP2. The 
first two hours of EGTA elution were marked by increased release of active MMP2.  
The tissue sample (assessed at the end of the EGTA perfusion) contained very little 
pro- and active MMP2 species. The loss of pro-MMP2 is understandable given the 
overall duration of 14 hours elution.  
 The amount of gelatinase species released was quantified to allow 
comparisons between PBS and EGTA perfusion. The amount of individual 
gelatinase species in the eluant fraction 2-hours prior to the switch to EGTA 
(expressed as a percentage of total) was compared to the level obtained 2 hours 




Figure 5.7 Effect of EGTA on the elution profiles of MMPs. Donor set of 6 eyes, 
age-range 65-84 years. Data given as Mean ± SEM. (*p<0.05) 
 
 
 The amount of HMW1, HMW2, pro-MMP9 and pro-MMP2 released after 
introduction of EGTA was lower than in the previous 2-hour period (with PBS) and is 
consistent with the diminishing release established earlier in Figure 5.5. However, 
EGTA considerably increased the amount of active MMP2 released (p<0.05). 
 The time course of release of active-MMP2 following application of EGTA has 





Figure 5.8 Effect of EGTA on the rate of release of active MMP2 from Bruch’s 
membrane. Data given as Mean ± SD (n), n=6. 
 
 PBS elution showed the release of active MMP2 up to the 8 hours of elution. 
Introduction of EGTA accelerated this release so that virtually all of the endogenous 
active MMP2 was removed from the bound fraction.  
 Unlike Pro-MMP9 and HMW 1&2, pro-MMP2 is eluted out rapidly from the 
membrane preparation suggesting that if it binds to the matrix, it does so with very 
little affinity. Active MMP2 on the other hand appears to be bound and is released 
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slowly, this release being accelerated in the presence of EGTA. The corresponding 
change in the ratio of active to total MMP2 species ([active MMP2 / (active + latent)] 
in the combined eluant fractions (8-12 hour collections) and in the tissue preparation 
at the end of elution was determined (Figure 5.9). 
 
 
Figure 5.9 Alterations in the ratio of active over total MMP2 species in 
response to metal chelation by EGTA. (*p<0.05; ***p<0.001) 
Six donors, age range 65-84 years. 
 
 The greater release of active MMP2 in comparison to pro-MMP2 following 
application of EGTA resulted in an increase of active MMP2 from 21 to 72% of total 







































active MMP2, tissue samples still contained a higher percentage of active MMP2 
after exposure to EGTA (p<0.05). The latter result implies that tissue pro-MMP2 
levels after EGTA must have also been reduced. Since most of pro-MMP2 was 
released by 8 hours of incubation, further release due to EGTA would have been 
very low and beyond the detection limits of zymography. 
 Eyes from young donors were rare. Elution experiments were undertaken in 
three young donor eyes (age 21-28 years) and the basal release of active MMP2 
(determined as the ratio of active MMP2 to total MMP2 species) increased from 27% 
with PBS to 71% after perfusion with EGTA (p<0.01), a finding consistent with the 
results from the elderly donors. (Data not shown) 
 
5.2.3. Effect of EGTA on the activity of MMPs of Bruch’s membrane 
 The effect of EGTA on the stability of various gelatinases species was 
assessed in isolated MMP extracts and in intact tissue. Eyes of donors of age 83 and 
79 years were used to obtain the required MMP fractions. One quadrant was 
homogenised and spun at 10000g to obtain the soluble fraction. One aliquot was 
incubated with PBS and the other with 10mM EGTA. Two adjacent 8mm trephines 
were also obtained from the peripheral fundus and one incubated in PBS and the 
other in 10 mM EGTA. Following incubation for 1 hour at 37°C, the incubation buffer 
and the tissue were processed for zymography. The resulting zymograms are shown 


















Figure 5.10 Effect of EGTA on stability and binding of MMP species of Bruch’s 
membrane. 
Samples A1 and A2 represent the soluble extract, incubated in PBS and EGTA 
respectively. Samples A3 and A4 represent 8mm diameter tissue discs incubated in 
PBS and EGTA respectively. The incubation medium overlying these tissue disc 
samples is represented by A3S and A4S respectively. Gel A and B represent 83 and 





















 In the soluble extract, activities of HMW1 and Pro-MMPs 2&9 were slightly 
reduced after incubation with EGTA for 1 hour in comparison to incubation with PBS. 
Incubation of tissue discs with PBS showed some release of HMW species 1&2 and 
considerable release of pro-MMPs 2&9. Whereas active MMP2 was also released, 
active MMP9 remained bound to the membrane. Incubation with EGTA resulted in 
considerable loss of the pro-MMP9 signal. The reduction in the release of this 
species was not the result of greater amounts being bound to the tissue. Although 
some pro-MMP9 may be lost due to the action of EGTA (compare A1 with A2), the 
major fraction of the ‘lost’ enzyme appears to have been polymerised to high 
molecular weight forms (lane A4).  EGTA was without affect on the release of pro-
MMP2 but considerably increased the release of active MMP2. 
 
5.2.4. Effect of EGTA on the hydraulic conductivity of Bruch’s membrane. 
 Hydraulic conductivity was determined in 20 donors age-range 58-93 years 
using PBS over a period of 8 hours and there were no statistical differences between 
the early measurements and those near the 8-hour perfusion period. In pilot 
experiments, there was no change in basal hydraulic conductivity when the perfusion 
period was extended to 24 hours (data not shown). In seven donor preparations (age 
range 59-84 years), the 8-hour PBS perfusion was followed with an exposure to 
10mM EGTA for a period of 3 hours. EGTA resulted in an increase in hydraulic 
conductivity of 2.3-fold over the first hour (p<0.05), 3.2-fold over the second hour 
(p<0.05), and 7.2-fold (p<0.005) over the third hour of perfusion compared to values 





Figure 5.11 Effect of EGTA on the hydraulic conductivity of human Bruch’s 
membrane. 
Bruch’s choroid preparations from 20 donors (age-range 58-93 years) were perfused 
with PBS for a period of 8 hours. In seven of these preparations (age range 59-84 
years), EGTA was then substitited for PBS and perfusion continued for another 3 
hours. Measurement of eluted volumes over a given time period were used to 
calculate the hydraulic conductivity at several intervals. Data is given as Mean ± 












 The elution studies with PBS provide an insight as to the level of bound and 
free gelatinases species and the ease with which they can be eluted from Bruch’s 
membrane. HMW2, being the largest gelatinase species (apart from LMMC) remains 
tightly bound and elution over 12 hours resulted at most in loss of about 10% of the 
species. Pro-MMP2 on the other hand was rapidly eluted out and this free fraction 
accounted for nearly 90% of the total pool, the remaining 10% being tightly bound or 
trapped within the membrane complex. For quantitative purposes, it is important that 
dissection times are minimised so that release of pro-MMP2 into the dissection 
medium is minimised.  
 Although active MMP2 has a similar molecular weight to pro-MMP2, its 
behaviour in the elution profiles was very different. There was a slow and sustained 
release of this species over the time course of the elution procedure. The hyperbolic 
elution profile suggests a shift in the bound/free pool as the elution medium removes 
the released species. Similar hyperbolic plots were also obtained for HMW1 and pro-
MMP9 and therefore these species must also exist largely in the bound form. A 
similar situation may also exist with HMW2 but the binding constants must be very 
high since so little was released over the 12-hour elution scheme employed in the 
present study.  
 Several mechanisms may be involved in the binding of proteins to the interior 
of extracellular matrices. In the case of the gelatinase species examined in the 
present study, elution would signify that these are not covalently bound. Similarly, 
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SDS extraction of the bound fraction also supports this conclusion. Non-covalent 
binding can occur via hydrophobic and/or hydrophilic interactions. The latter would 
include ionic interactions between the charged groups on proteins and the charged 
surfaces on matrix proteins such as the sulphated proteoglycans. Metal ions, by 
providing coordination points could also serve to anchor proteins to the matrix. 
 Metal chelators would therefore be expected to ‘break’ such interactions either 
directly or by modifying the structural matrix to release proteins. EGTA chelation was 
particularly effective in releasing active MMP2 species from Bruch’s membrane.
 Chelation of metals by EGTA was without effect on the activity of active-
MMP9 or on its removal from the bound compartment. However, under static 
conditions, i.e., when the tissue was simply incubated and not perfused, in the 
presence of EGTA, very little pro-MMP9 was actually released into the medium. The 
amount bound was also reduced. There was evidence that EGTA diminished the 
activity of pro-MMP9 (Figure 5.10, Lanes A vs. B). This was only a minor reduction 
and cannot explain the major loss of this species on incubating the tissue with EGTA. 
It would appear that the released pro-MMP9 species rapidly polymerises to form 
HMW2 since the level of this species was raised (Figure 5.10, Lanes A4). 
 Perfusion of tissue samples with EGTA resulted in marked improvement in the 
hydraulic conductivity of Bruch’s membrane. Whether this was due to enhanced 
release of active MMP2 or to the release and removal of proteo-lipid debris within the 
membrane requires further investigation. It could be argued that with PBS perfusion, 
there is release of active MMP2 (Figure 5.5) but without alterations in hydraulic 
conductivity over the first 8-hours of perfusion (Figure 5.11). On the other hand, the 
PBS mediated release of active MMP2 was slow and its removal by the perfusing 
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medium may not have allowed sufficient time for proteolytic activity. With EGTA, 
there was a large increase in active MMP2, elevating local concentrations, and 
therefore the likelihood of proteolytic action may have been enhanced. Introducing 
activated MMP2 into Bruch’s has previously been shown to improve the hydraulic 
conductivity of the membrane (Ahir et al., 2002). Therefore, metal chelation that can 
raise the free-pool of active MMP2 would be beneficial in improving the transport 
characteristics of Bruch’s membrane. In the present modality of the perfusion 
procedure, released active MMP2 had diminished ‘dwell’ times within the membrane 
since it was removed by the pressure induced flow of fluid. Despite this, considerable 
improvement in hydraulic conductivity was obtained. Experimental designs that 
introduce EGTA into the membrane and then stop flow through the preparation 
would be expected to produce a larger effect on hydraulic conductivity. Metal 
chelation therapy would therefore appear to be a valid avenue for addressing the 
advanced ageing associated with AMD since, as indicated earlier, this disease is 
characterised by diminished transport pathways and considerably reduced levels of 
active MMPs 2&9. 
 EGTA would not be a good candidate for such a therapeutic approach since it 
may also result in polymerisation of pro-MMP9. Alternative metal chelators such as 






















 Extracellular matrices (ECMs) play important roles that are crucial to the 
survival of adjacent cellular elements. Structural and functional modifications of 
ECMs are associated with both pathological and physiological situations. In 
neovascular processes, extracellular matrix in front of the leading edge of the 
growing capillary tube needs to be ‘dissolved’ allowing growth and expansion of the 
capillary bed. This ‘clearing’ of ECM is attributed to the release of activated MMPs by 
endothelial cells at the growing end of the capillary tube. Under inflammatory 
conditions, macrophage invasion also requires the release of active MMPs to clear a 
pathway through the matrix. Similarly in the wound healing process, cells detaching 
and migrating to close the wound also release activated MMPs. Under normal 
physiological conditions, the most important process is the homeostatic turnover of 
the extracellular matrix. By tightly coupling the degradative (mediated by MMPs) and 
synthetic pathways, the matrix can be ‘rejuvenated’ thereby maintaining its structural 
and functional characteristics. 
 In the case of Bruch’s membrane, the homeostatic turnover of the matrix is 
particularly important. Its location in a highly oxidative environment, the presence of 
damaged but highly reactive outer segment debris discarded by the RPE, and the 
very high metabolic traffic through it all make Bruch’s highly susceptible to damage 




 As such, the presence of the MMP machinery has previously been 
demonstrated in Bruch’s membrane (Alexander et al., 1990; Guo et al., 1999; Hunt 
et al., 1993; Vranka et al., 1997). However, several studies have shown that despite 
the presence of a rejuvenation potential, ageing of Bruch’s leads to deterioration in 
structural and functional parameters (Moore et al., 1995; Sarks, 1976). Thus, ageing 
of Bruch’s is associated with thickening and accumulation of debris enriched in lipids 
(Okubo et al., 1999; Ramrattan et al., 1994). Functional parameters of hydraulic 
conductivity and protein diffusion also show deterioration and this change was 
beyond that predicted by the changes in thickness of the membrane (Hussain et al., 
2010; Moore et al., 2001; Moore et al., 1995; Starita et al., 1996). Nonetheless, 
despite the severity of these changes, sufficient functional integrity was maintained 
to support photoreceptor function throughout the life-time of an individual although 
scotopic thresholds in the very elderly were indeed affected (Owsley et al., 2006; 
Steinmetz et al., 1993). In advanced ageing, associated with age-related macular 
degeneration, the changes in Bruch’s are therefore expected to impact on the 
functional support provided to the RPE and photoreceptor layer. 
 The work of Karwatowski et al., (1995) on the nature of collagenous changes 
in ageing Bruch’s membrane provided an insight into the status of the MMP 
machinery. These workers showed considerable oxidative damage and denaturation 
of collagen molecules with levels approaching 50% of the total collagen content in 
the very elderly. Thus, despite the presence of substrates, MMP activity appeared to 
be considerably subdued. In support was the observation that active MMP 2&9 
species were rarely encountered in Bruch’s membrane from macular regions (Guo et 
al., 1999). The level of the natural MMP inhibitor, TIMP3 was also elevated with 
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ageing and some authors have suggested that the increased TIMP3/MMP level may 
be responsible for the reduction in proteolytic activity (Kamei et al., 1999). However, 
this is unlikely since levels of pro-MMPs were also increased in ageing Bruch’s (Guo 
et al., 1999). 
 The level of latent MMPs does not reflect on the proteolytic activity within 
Bruch’s membrane. It is the level of active-enzymes that dictates the degree of 
proteolytic hydrolysis. Nonetheless, the free level of latent or pro-MMPs may govern 
the rate of conversion to activated forms and this is best illustrated with regards to 
pro-MMP2. Pro-MMP2 is activated on the basolateral surfaces of the RPE. The first 
step in the activation process requires the formation of a ternary complex between 
MMP14, TIMP2 and pro-MMP2 on the surface of the RPE. The final step is the 
cleavage of the pro-peptide on pro-MMP2 by MMP14. Thus the free concentration of 
pro-MMP2 is vital in the initial formation of the primary ternary complex. Determining 
total levels of pro-MMP2 does not provide an assessment of the potential for 
activation; free levels need to be determined.  
 Activation mechanisms for pro-MMP9 are not clear. Certainly pro-MMP9 can 
be activated within the RPE cell and released onto Bruch’s membrane but the pro-
form within Bruch’s can also be activated. Current work suggests that activation can 
occur following interaction with damaged substrate collagen molecules (Overall et al., 
2007; Rosenblum et al., 2010). Following activation, the molecule remains bound to 
the substrate and this may be the reason why active MMP9 is only found bound to 
the matrix of the membrane. Active MMP9 has translational freedom and can 
therefore move along the collagen molecule during its proteolytic action.  
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 In the present study, active levels of MMP9 were found in elderly donors and 
this would appear to contradict the results of Karwatowski et al., 1995 since elderly 
donors showed the large presence of abnormal collagen. One possibility to explain 
this anomaly is that highly damaged collagen molecules may not allow translational 
movement of active MMP9 and thus, although present, active MMP9 remains 
functionally inactive. This is supported by studies where addition of exogenously 
activated MMP9 resulted in marked improvement in the transport properties of 
Bruch’s from elderly donors (Ahir et al., 2002). This study also suggests the 
possibility that pro-MMP9 may not be accessible to altered collagen but that the 
addition of activated species does result in proteolytic hydrolysis.  
 Understanding the factors that regulate the free level of pro-MMPs 2&9 is 
therefore very important in determining the potential for activation and the 
subsequent proteolytic activity of the MMP system. Initial screening of Bruch’s 
showed the presence of other gelatinase activities in addition to those expected from 
pro- and active forms of MMPs 2&9. Further analyses of these ‘unknown’ species 
showed them to be homo- and/or hetero polymers of pro-MMPs 2&9 and were 
named as HMW1 and HMW2 with molecular weights of 122 ± 9kDa and 344 ± 
22kDa (Mean ± SD(n), n=24) respectively. Their presence in SDS-zymographic gels 
was indicative of covalent bonding between the monomers and the disulphide-
mediated bonding was confirmed by hydrolysis with thiol reacting agents (APMA).  
 Gel filtration chromatography allows the analysis of non-covalently bonded 
complexes and this approach has identified the presence of a much larger MMP 
complex termed LMMC that incorporated HMW1, HMW2, pro-MMP9 and traces of 
pro-MMP2. A knowledge of the different gelatinase species and their age-related 
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changes in levels has allowed the formulation of the MMP pathway (reproduced 
below) to explain the observed alterations in the level of active species present in 
ageing Bruch’s membrane.   
 
 
Figure 6.1 The MMP pathway in Bruch’s membrane. 
 
 
 Figure 6.1 describes the interrelationships between the various gelatinase 
species in their free form within Bruch’s membrane. To this, another layer of 
complexity must be added i.e., the equilibrium that these species have with respect 
to free and bound forms. The conversion of pro-MMPs 2&9 to high molecular 
species effectively sequesters these species from the activation process. Ageing of 
Bruch’s leads to increased levels of HMW1 & 2 and therefore greater sequestration 
of pro-MMP9. In addition to this conversion, there is also binding of these species to 
the matrix of the membrane.  
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 Ageing was associated with increased binding of pro-MMP9 and a decrease 
in the free pool. The currently measured ‘free’ pool of pro-MMP9 may not necessarily 
reflect the true value because on SDS solubilisation, pro-MMP9 released from 
LMMC would also add to the free pool. Thus ageing of Bruch’s leads to greater 
sequestration of latent monomers of pro-MMPs 2&9 diminishing the availability for 
activation. Overall, ageing drives the MMP pathway towards the left and may 
account for the reduced gelatinase activity in aged tissue. 
 The potential for shifting the equilibrium between bound and free forms of 
gelatinase species was assessed by perfusing tissue samples with PBS. Within the 
first 2-4 hours of perfusion, most of the pro-MMP2 content was eluted out indicative 
of a low binding affinity for this species. The other species were eluted out very 
slowly suggestive of a shift between bound and free stores but the amount of HMW2 
released was very low suggesting this species to be tightly bound. 
 In AMD, the ageing changes in the MMP system were advanced. Levels of 
HMW1 & 2 were much increased the sequestration of pro-MMPs 2&9. The greater 
shift towards the left in the MMP pathway was associated with very much reduced 
levels of free and bound pro-MMP2. However, the apparent free level of pro-MMP9 
was very elevated. As indicated earlier, this apparent increase may be misleading 
since the contribution of pro-MMP9 from the LMMC pool has not been taken into 
account.  
 Increased levels of pro-MMP9 may be an important factor in the pathogenesis 
of AMD. Increased levels are more likely to drive the MMP pathway towards the left. 
Raised levels of pro-MMP9 are not restricted to ocular tissues since raised levels 
were also noted in the plasma of these patients (Chau et al., 2008). These raised 
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levels may be the result of the polymorphisms in the micro-satellite promoter region 
of the MMP9 gene. The length of the cytosine-adenine (CA) repeats in this region 
appears to regulate the expression of the MMP9 pool and longer repeats (with 
greater expression of pro-MMP9) have been associated with patients with AMD 
(Fiotti et al., 2005).  
 The most significant finding in donors with AMD was the reduced level of 
active MMPs 2&9 in Bruch’s membrane, a result that could be predicted by a shift of 
the MMP pathway towards the left. The severely diminished levels of active MMPs 
may therefore explain the reduced degradative capacity in AMD that leads to the 
observed changes in structural and functional parameters of Bruch’s membrane in 
this disease. Such a reduction in active MMPs is further complicated by the 
increased presence of AGEs and ALEs that are also known to inhibit the proteolytic 
activity of MMPs (Haas et al., 1998; Howard et al., 1996; Rittie et al., 1999; Scott et 
al., 1998).  
 The MMP pathway described above offers possible therapeutic strategies for 
intervention in AMD. The primary goal of any interventionist procedure would be to 
shift the pathway towards the right. The shift in the equilibrium between bound and 
free levels of active enzymes is one possibility. These active forms may be bound to 
the matrix by hydrophobic, ionic or metal-mediated interactions. If metal mediated 
entrapment is operative in the membrane, then the increased deposition of divalent 
metals in both ageing and AMD samples of Bruch’s could be a contributory factor in 
active enzyme sequestration. Removal of divalent metals using the chelator EGTA 
was associated with release of active MMP2 from the bound fraction of the 
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membrane. Effect on active MMP9 could not be assessed due to the very low levels 
of this species and low sensitivity for detecting with zymography.  
 The EGTA mediated release of active MMP2 was also associated with 
improvements in the hydraulic conductivity of Bruch’s membrane. These results 
suggest that bound active MMP2 was trapped and unable to participate in the 
proteolytic process but that on ‘freeing’ was able to act on substrates. The 
improvement in transport occurred despite the fact that most of the released active 
species was lost due to the perfusion process. A greater improvement would be 
expected if the membrane preparation was simply incubated in EGTA.  EGTA is not 
suitable as a therapeutic agent since it also appeared to promote the polymerisation 
of pro-MMP9, a side-effect that must be avoided given the above discussion. 
Alternative metal chelators need to be assessed for their therapeutic potential. 
 Therapeutic intervention dictates that the MMP pathway must be shifted to the 
right. Improved knowledge of the biophysical and biochemical properties of the high 
molecular weight species and the potential for drug-mediated dissolution will in the 
future assist in developing novel strategies for this avenue for intervention in AMD. If 
the pathway cannot be shifted to the right, an alternative strategy would be to directly 
increase the levels of active MMPs. This means inducing the release of these 
species from the RPE.  
 The wound healing process provides just such a strategy. Proliferating RPE 
cells are known to release copious amounts of activated MMPs 2&9 in a cell-cycle 
dependent manner (Ahir et al., 2002). Thus a small lesion that damages RPE cells 
will result in a wound healing response with RPE cells on the margins of the lesion 
migrating to fill the vacant spaces. In so doing they would release active MMPs as 
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they migrate and thereby ‘clean’ underlying Bruch’s membrane. In pan-retinal 
photocoagulation (argon blue-green laser at 250mW, 100msec duration, 200μm spot 
size) applied to human RPE explants in culture, the wound healing response was 
associated with increased expression of MMPs 2&3 by migrating/dividing RPE cells 
(Flaxel et al., 2007). Several groups using conventional retinal lasers have shown 
partial removal of drusen in AMD patients (Cleasby et al., 1979; Figueroa et al., 1994; 
Ho et al., 1999; Owens et al., 1999). 
 With the newly introduced short pulse lasers, microbubble formation around 
melanosomes within the RPE leads to disintegration of cellular architecture and cell 
death without any acute effects on Bruch’s or photoreceptors (Brinkmann et al., 2000; 
Framme et al., 2009; Roegener et al., 2004; Roider et al., 1993). The laser-mediated 
lesions therefore induce expression and release of active MMPs. Increased 
presence of active MMPs has already been shown to improve the functional 
characteristics of Bruch’s membrane (Ahir et al., 2002). 
 In AMD patients, RPE cells are already under stress and the active MMP 
release following laser lesions may not be as robust as in healthy RPE cells. Thus 
supplementation of this procedure with metal chelating agents that release bound 
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